Naar www.iknl.nl
- Gastroenterologie > Colorectaal carcinoom
Notificatie richtlijn E-mail richtlijn Naar startpagina oncoline
----------

Versie: 3.0, gewijzigd 2014-04-16 , Verantwoording: Landelijke werkgroep Gastro Intestinale Tumoren, Type: Landelijke richtlijn

Referentielijst

1 - Abdel-Razek AA
Abdel-Razek AA, bu-Zeid MM, Bilal M, Abdel-Wahab NM. Virtual CT colonoscopy versus conventional colonoscopy: a prospective study. Hepatogastroenterology 2005;52(66),1698-1702.
 
2 - Ackerstaff AH
Ackerstaff AH, Hilgers FJ. Rehabilitation after head and neck cancer. In: Jones AS, Philips DE, Hilgers FJ (eds). Diseases of the head and neck and nose and throat. London: Arnold, 1998:435-48.
 
3 - Ackland SP
Ackland SP, Jones M, Tu D, Simes J, Yuen J, Sargeant AM et al. A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. Br J Cancer 2005;93,11-1243.
 
4 - Acunas B
Acunas B, Rozanes I, Caunas G et al. Preoperative staging of colon carcinoma (excluding the recto-sigmiod region). Eur J Radiol 1990;11:150-3.
 
5 - Ajaj W
Ajaj W, Lauenstein TC, Pelster G, Holtmann G, Ruehm SG, Debatin JF et al. MR colonography in patients with incomplete conventional colonoscopy. Radiology 2005;234:452-9.
 
6 - Allen DC
Allen DC, Fon LJ, McAleer JJ, Irwin ST. Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy. Ulster Med J 1998;68:17-21.
 
7 - Amos EH
Amos EH, Mendenhall WM, McCarty PJ, Gage JO, Emlet JL, Lowrey GC et al. Postoperative radiotherapy for locally advanced colon cancer. Ann.Surg.Oncol. 1996;3:431-6.
 
8 - Andre T
Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al. Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004 Jun 3;350:2343-51.
 
9 - Andre T
Andre T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. J Clin Oncol. 2003 Aug 1;21(15):2896-903.
 
10 - Arora NK
Arora NK, McHorney CA. Patient preferences for medical decision making: who really wants to participate? Med Care 2000;38:335-41.
 
11 - Araujo SE
Araujo SE, da Silva eSousa AH Jr, de Campos FG, Habr-Gama A, Dumarco RB, Caravatto PP et al. Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. Rev Hosp Clin Fac Med Sao Paulo 2003;58(3):133-40.
 
12 - Aslinia F
Aslinia F, Uradomo L, Steele A, Greenwald BD, Raufman JP. Quality assessment of colonoscopic intubation: an analysis of 6 years of continuous practice at a university hospital. Am J Gastroenterol. 2006 Apr;101(4):721-31.
 
13 - Barton
Barton, JB, Langdale LA, Cummins JS, Stelzner M, Lynge DC, Mock CN et al. The utility of routine preoperative computed tomography scanning in the management of veterans with colon cancer. Am J Surg 2002;183: 499-503.
 
14 - Beart RW Jr
Beart RW Jr. Follow-up: does it work? Can we afford it? Surg Oncol Clin N Am 2000; 9(4):827-34.
 
15 - Beattie GC
Beattie GC, McAdam TK, Elliott S, Sloan JM, Irwin ST. Improvement in quality of colorectal cancer pathology reporting with a standardized proforma--a comparative study. Colorectal Dis 2003;5:558-62.
 
16 - Berberoglu U
Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology 2004;51:1689-93.
 
17 - Beresford M
Beresford M, Glynne-Jones R, Richman P, Makris A, Mawdsley S, Stott D et al. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol 2005;17:448-55.
 
18 - Berger AC
Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005 Dec 1;23(34):8706-12.
 
19 - Bipat S
Bipat S, van Leeuwen MS, IJzermans JNM, Bossuyt PMM, Greve JW, Stoker J. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey. Neth J Med. 2006;64:147-51.
 
20 - Blanchard CG
Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med 1988;27:1139-45.
 
21 - Blazeby JM
Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003;39:1384-94.
 
22 - Bleeker WA
Bleeker WA, Mulder NH, Hermans J, Otter R, Plukker JT. Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer. Br J Surg 2001; 88(1), 101-106.
 
23 - Boer AG de
Boer AG de, Genovesi PI, Sprangers MA, Sandick JW van, Obertop H, Lanschot JJ van. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000;87:1716-21.
 
24 - Bonjer
Bonjer (unpublished) The Trans Atlantic Laparoscopically-Assisted versus Open Colectomy Trials Study Group. Laparoscopically assisted versus open colectomy for colon cancer – a meta-analysis.
 
25 - Borie F
Borie F, Combescure C, Daures JP, Tretarre B, Millat B. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. World J Surg 2004;28(6):563-9.
 
26 - Borie F
Borie F, Daures JP, Millat B, Tretarre B. Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study. J Gastrointest Surg 2004;8(5):552-8.
 
27 - Borne HW van den
Borne HW van den, Pruyn JFA. Lotgenotencontact bij kankerpatiënten. Assen: Van Gorcum, 1985.
 
28 - Bosker RJ
Bosker RJ, Eddes EH, Ter Borg F, Ledeboer M, Jaspers MM, Eeftinck Schattenkerk M. The use of a self-expanding stent as palliation or before elective surgery in patients with obstructive colorectal carcinoma. Ned Tijdschr Geneeskd. 2005;149:21-1163.
 
29 - Bowles CJA
Bowles CJA, Leicester R, Romaya C, Swarbrick E, Williamns CB, Epstein O. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut. 2004;53:277-83.
 
30 - Branston LK
Branston LK, Greening S, Newcombe RG, Daoud R, Abraham JM, Wood F et al. The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer 2002;38:764-72.
 
31 - Breukink SO
Breukink SO, Pierie JP, Wiggers T. Laparoscopic versus open total mesorectal excision for rectal cancer; a systematic review. Thesis. Groningen, 2006.
 
32 - Van den Brink M
Van den Brink M, Stiggelbout AM, Van den Hout WB, Kievit J, Klein Kranenbarg E, Marijnen CA et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 2004;22:3958-64.
 
33 - Bull AD
Bull AD, Biffin AH, Mella J, Radcliffe AG, Stamatakis JD, Steele RJ et al. Colorectal cancer pathology reporting: a regional audit. J Clin Pathol 1997;50:138-42.
 
34 - Buie WD
Buie WD, Attard JA. Follow-up recommendations for colon cancer. Clin Colon Rectal Surg 2005;18:3-243.
 
35 - Caplin S
Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998;83:666-72.
 
36 - Carmichael J
Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A et al. Randomized comparative study of tegafur/uracil and oral leucovorin vs. parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology 2002;20:3617-27.
 
37 - Cassileth BR
Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and participation preferences among cancer patients. Ann Intern Med 1980;92:832-6.
 
38 - Charles C
Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999;49:651-61.
 
39 - Chong A
Chong A, Shah JN, Levine MS, Rubesin SE, Laufer I, Ginsberg GG et al. Diagnostic yield of barium enema examination after incomplete colonoscopy. Radiology 2002; 223(3):620-4.
 
40 - Cianchi F
Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002;26:384-9.
 
41 - Guillou PJ
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne D, Smith AM et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365:1718-26.
 
42 - Cocconi G
Cocconi G, Cunningham D, Van Cutsem E, Francois E, Gustavsson B, Van Hazel G et al. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group. Journal of Clinical Oncology 1998;16:2943-52.
 
43 - Veldkamp R
Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ et al. Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 2005;6(7):477-84.
 
44 - Colorectal Cancer Collaborative Group
Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. BMJ 2000;321(7260):531-5.
 
45 - Comella P
Comella P, Massidda B, Farris A. Oxaliplatin vs irinotecan plus leucovorin/bolus as first-line treatment of advanced colorectal carcinoma. 2004; European Medical Oncology Annual Meeting, 2004; conference presentation.
 
46 - Compton CC
Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979-94.
 
47 - O'Connell MJ
O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol. 1997 Jan;15(1):246-50.
 
48 - Clinical Outcomes of Surgical Therapy Study Group
COST 2004 - Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004;350(20):2050-9.
 
49 - Cotton PB
Cotton PB, Connor P, McGee D, Jowell P, Nickl N, Schutz S et al. Colonoscopy: practice variation among 69 hospital-based endoscopists. Gastrointest Endosc 2003;57:352-357.
 
50 - Cserni G
Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol 2002;81:63-9.
 
51 - Cunningham D
Cunningham D, Zalcberg JR, Rath U, Oliver I, Van Cutsem E, Svensson C et al. Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. ‘Tomudex’ Colorectal Cancer Study Group. Annals of Oncology 1996;7:961-5.
 
52 - Cunningham D
Cunningham D, Glimelius B. A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy. V301 Study Group. Seminars in Oncology 1999;26:6-12.
 
53 - Cunningham D
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. New England Journal of Medicine 2004;351:337-45.
 
54 - Curet MJ
Curet MJ, Putrakul K, Pitcher DE, Josloff RK, Zucker KA. Laparoscopically assisted colon resection for colon carcinoma: perioperative results and long-term outcome. Surg Endosc 2000;14(11):1062-6.
 
55 - Van Cutsem E
Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J.Clin.Oncol. 2001; 19(21):4097-106.
 
56 - Dafnis G
Dafnis G, Granath F, Pahlman L, Ekbom A, Blomqvist P. Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis 2005;37:113-8.
 
57 - Denis B
Denis B, Weiss AM, Peter A, Bottlaender J, Chiappa P. Quality assurance and gastrointestinal endoscopy: an audit of 500 colonoscopic procedures. Gastroenterol Clin Biol 2004;28:1245-55.
 
58 - Detmar SB
Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH. How are you feeling? Who wants to know? Patients’ and oncologists’ preferences for discussing health-related quality-of-life issues. J Clin Oncol 2000;18:3295-301.
 
59 - Douillard JY
Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041-7.
 
60 - Douillard JY
Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P et al. Multicenter phase III study of uracil/tegafur and oral leucovorin vs 5-fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. Journal of Clinical Oncology 2002;20:3605-16.
 
61 - Evidence-based Richtlijnontwikkeling
Evidence-based Richtlijnontwikkeling. Handleiding voor werkgroepleden Kwaliteitsinstituut voor de Gezondheidszorg CBO, april 2005.
 
62 - Falk PM
Falk PM, Gupta NC, Thorson AG, Frick MP, Boman BM, Christensen MA et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis.Colon Rectum 1994;37(2):153-6.
 
63 - Feingold DL
Feingold DL, Addona T, Forde KA, Arnell TD, Carter JJ, Huang EH et al. Safety and reliability of tattooing colorectal neoplasms prior to laparoscopic resection. J Gastrointest Surg. 2004;8(5):543-6.
 
64 - Figueredo A
Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol. 2004 Aug 15;22(16):3395-407.
 
65 - Figueredo A
Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S, and members of the Gastrointestinal Disease Site Group. Adjuvant Therapy for Stage II Colon Cancer Following Complete Resection. Practice Guideline Report # 2-1. December 2000 Cancer Care Ontario Program.
 
66 - Figueredo A
Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S, and members of the Gastrointestinal Cancer Disease Site Group. Adjuvant Therapy for Stage III Colon Cancer Following Complete Resection. Practice Guideline Report # 2-2. December 2000 Cancer Care Ontario Program.
 
67 - Figueredo A
Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zuraw L, Zwaal C. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.
 
68 - Filippone A
Filippone A, Ambrosini R, Fuschi M, Marinelli T, Genovesi D, Bonomo L. Preoperative T and N staging of colorectal cancer : accuracy of contrast enhanced multi-detector row CT colonography – initial experience. Radiology 2004;231:83-90.
 
69 - Folprecht G
Folprecht G, Cunningham D, Ross P, Glimelius B, Di-Costanzo F, Wils J et al. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann.Oncol. 2004;15(9):1330-8.
 
70 - Fu KI
Fu KI, Fujii T, Kato S, Sano Y, Koba I, Mera K et al. A new endoscopic tattooing technique for identifying the location of colonic lesions during laparoscopic surgery: a comparison with the conventional technique. Endoscopy. 2001;33(8):687-91.
 
71 - Gallo TM
Gallo TM, Galatola G, Fracchia M, Delazio G, De Bei F, Pera A et al. Computed tomography colonography in routine clinical practice. Eur J Gastroenterol Hepatol. 2003;15:1323-31.
 
72 - Gattellari M
Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med 2001;52:1865-78.
 
73 - Giacchetti S
Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology 2000;18:136-47.
 
74 - Gill S
Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004 May 15;22(10):1797-806.
 
75 - Glavassevich M
Glavassevich M, McKibon A, Thomas S. Information needs of patients who undergo surgery for head and neck cancer. Can Oncol Nurs J 1995;5:9-11.
 
76 - Goldberg RM
Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
 
77 - Goldstein NS
Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996;106:209-16.
 
78 - Goldstein NS
Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer 2000;88:2228-38.
 
79 - Govindarajan A
Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smiths AJ, Law CH. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst. 2006;98:1474-81.
 
80 - De Gramont A
De Gramont A, Boni C, Navarro M, Tabernero J, Hickish T, Topham C et al. Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: efficacy results with a median follow-up of 4 years. J Clin Oncol. 2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16S, Part I of II (June 1 Supplement), 2005:3501.
 
81 - de Gramont A
de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938-47.
 
82 - Graupe F
Graupe F, Schwenk W, Bracht B, Kroner-Herwig B, Stock W. Die psychische Belastung von Patienten in der Tumornachsorge nach R0-Resektion colorectaler Carcinome. [Psychological stress on patients in tumor after-care after R0 resection of colorectal carcinomas]. Chirurg 1996:67(6):604-9.
 
83 - Grossmann EM
Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol 2004;13(2-3):119-24.
 
84 - Grothey A
Grothey A, Deschler B, Kroening H. Phase III study of bolus 5-fluorouracil (5-FU)/ folinic acid (FA) (Mayo) vs weekly high-dose 24h 5-FU infusion/FA + oxaliplatin (OXA) (FUFOX) in advanced colorectal cancer (ACRC). Proc Am Soc Clin Oncol 2002; Abstract: 512.
 
85 - Grothey A
Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol. 2004;22(7):1209-14.
 
86 - Gumus M
Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F et al. What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori 2005;91:168-72.
 
87 - Gunderson LL
Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R et al. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation ± 5-FU. Int J radiation oncology boil Phys 1997;37:601-614.
 
88 - Hagenthau P
Hagenthau P, Wagner HJ, Stinner B, Klose KJ. Die Wertigkeit der Kolondoppelkontrastuntersuchung bei unzureichender koloskopischer Diagnostik. Radiologe 1995;35(5):356-60.
 
89 - Haller DG
Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. J Clin Oncol. 2005 Dec 1;23(34):8671-8.
 
90 - Halligan S
Halligan S, Altman DG, Taylor SA, Mallett S, Deeks JJ, Bartram CI et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005;237(3):893-904.
 
91 - Harewood GC
Harewood GC. Relationship of colonoscopy completion rates and endoscopist features. Dig Dis Sci 2005;50:47-51.
 
92 - Harris JE
Harris JE, Ryan L, Hoover HC Jr, Stuart RK, Oken MM, Benson AB 3rd et al. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol. 2000 Jan;18(1):148-57.
 
93 - Harrison JC
Harrison JC, Dean PJ, el-Zeky F, Vander-Zwaag R. Impact of the Crohn\'s-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum Pathol 1995;26:31-8.
 
94 - van Harten WH
van Harten WH, van Noort O, Warmerdam R, Hendricks H, Seidel E. Assessment of rehabilitation needs in cancer patients. Int J Rehabil Res 1998;21:247-57.
 
95 - Hartmann D
Hartmann D, Bassler B, Schilling D, Pfeiffer B, Jakobs R, Eickhoff A et al. Incomplete conventional colonoscopy: magnetic resonance colonography in the evaluation of the proximal colon. Endoscopy 2005;37(9):816-20.
 
96 - Hasegawa H
Hasegawa H, Kabeshima Y, Watanabe M, Yamamoto S, Kitajima M. Randomized controlled trial of laparoscopic versus open colectomy for advanced colorectal cancer. Surg Endosc 2003;17(4):636-40.
 
97 - Helgeson VS
Helgeson VS, Cohen S, Schulz R, Yasko J. Education and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry 1999;56:340-7.
 
98 - Hewitt PM
Hewitt PM, Ip SM, Kwok SP, Somers SS, Li K, Leung KL et al. Laparoscopic-assisted vs. open surgery for colorectal cancer: comparative study of immune effects. Dis Colon Rectum 1998;41(7):901-9.
 
99 - Hind D
Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A. The use of irinotecan, oxaliplatin and raltirexed for the treatment of avanced colorectal cancer: systematic review and economic valuation (review of guidance no. 33). NHS R&D HTA program, January 2005.
 
100 - Hoff PM
Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J.Clin Oncol. 2001;19(8) :2282-92.
 
101 - Hurwitz H
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N.Engl.J.Med. 2004;350(23):2335-42.
 
102 - Impact
Impact. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995 Apr 15;345(8955):939-44.
 
103 - IMPACT-B2
IMPACT-B2. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol. 1999 May;17(5):1356-63.
 
104 - Irvine D
Irvine D, Brown B, Crooks D, Roberts J, Browne G. Psychosocial adjustment in women with breast cancer. Cancer 1991;67:1097-117.
 
105 - Isbister WH
Isbister WH, al-Sanea O. The utility of pre-operative abdominal computerized tomography scanning in colorectal surgery. J.R.Coll.Surg.Edinb. 1996;41(4):232-4.
 
106 - Jacobs M
Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc 1991;1:144-50.
 
107 - Jansen SJT
Jansen SJT. Dokter, wat vindt u?, de patiënt helpen beslissen. Kanker bij de oudere patiënt: wat is er anders. Boerhaavecursus, 2002:21-36.
 
108 - Jeffery GM
Jeffery GM, Hickey BE, Hider P: Follow-up strategies for patients treated for non-metastatic colorectal cancer (Cochrane review). The Cochrane Library Issue 1 Oxford; Update Software; 2003.
 
109 - Jenkins V
Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001;84:48-51.
 
110 - Johnson R
Johnson R, Marsh R, Corson J, Seymour K. A comparison of two methods of palliation of large bowel obstruction due to irremovable colon cancer. Ann R.Coll.Surg Engl 2004;86:2-103.
 
111 - Jonker DJ
Jonker DJ, Maroun JA, Kocha W. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials. Br J Cancer 2000 82(11):1789-94.
 
112 - Jouret-Mourin A
Jouret-Mourin A. Recommendations for pathological examination and reporting for colorectal cancer. Belgian consensus. Acta Gastroenterol Belg 2004;67:40-5.
 
113 - Kabbinavar F
Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, Lieberman G et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol. 2003 1;21(1):60-5.
 
114 - Kabbinavar FF
Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Hecht JR et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.J Clin Oncol. 2005 23(16):3697-705.
 
115 - Kabbinavar FF
Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol. 2005 (B)23(16):3706-12.
 
116 - Kaiser AM
Kaiser AM, Kang JC, Chan LS, Vukasin P, Beart RW Jr. Laparoscopic-assisted vs. open colectomy for colon cancer: a prospective randomized trial. J Laparoendosc Adv Surg Tech A 2004;14(6):329-34.
 
117 - Kantorová I
Kantorová I, Lipská L, Belohlávek O, Visokai V, Truba? M, Scheiderová M. Routine 18F-FDG-PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003;44:1784-8.
 
118 - Keating J
Keating J, Lolohea S, Kenwright D. Pathology reporting of rectal cancer: a national audit. N Z Med J 2003;116:U514.
 
119 - Khot UP
Khot UP, Lang AW, Murali K, Parker MC. Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002;89(9):1096-1102.
 
120 - Kievit J
Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002;38(7):986-99.
 
121 - Kim SH
Kim SH, Milsom JW, Gramlich TL, Toddy SM, Shore GI, Okuda J et al. Does laparoscopic vs. conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer? Dis Colon Rectum 1998;41(8):971-8.
 
122 - King PM
King PM. Open versus laparoscopic surgery for colorectal cancer: a randomised study embedded within an enhanced recovery programme (unpublished).
 
123 - Kjeldsen BJ
Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999;34(5):509-15.
 
124 - Kjeldsen BJ
Kjeldsen BJ, Kronborg O, Fenger C, Jørgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997;84:666-9.
 
125 - Klein Poelhuis EH
Klein Poelhuis EH, Schadé E, Kiezebrink ML, Pruyn JFA, Razenberg PPA, Wijnberg AES. Bewaakte overgangen; continuiteit in de zorg voor patiënten met kanker. Eindhoven: IKZ, 1997.
 
126 - Koppenol-van Hooijdonk M
Koppenol-van Hooijdonk M, van Boxtel R. De bespreekbaarheid van ziekte en een naderende dood bij niet-westerse patiënten. Ned Tijdschr Palliat Zorg 2002;3:65-9.
 
127 - Kocha W
Kocha W, Maroun J, Jonker D, Rumble RB, Zuraw L. Oral capecitabine in the first line treatment of metastasic colorectal cancer. 1. A clinical practice guideline & 2. a systematic review. Cancer Care Ontario, February 2005.
 
128 - Kohne CH
Kohne CH, van Cutsem E, Wils JA et al. Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: Results of EORTC GI Group study 40986. Proc Am Soc Clin Oncol 2003;22:254-Abstract 1018.
 
129 - Koopman M
Koopman M, Antonini NF, Douma J, Wals J, Honkooop AH, Erdkamp FL et al. Sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 2007;370:135-42.
 
130 - Körner H
Körner H, Soreide K, Stokkeland PJ, Soreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 2005;9(3):320-8.
 
131 - Kronawitter U
Kronawitter U, Kemeny NE, Heelan R, Fata F, Fong Y. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999;86:229-235.
 
132 - Kronborg O
Kronborg O. Acute obstruction from tumour in the left colon without spread. A randomized trial of emergency colostomy versus resection. Int.J Colorectal Dis 1995;10(1):1-5.
 
133 - Kronborg O
Kronborg O. Emergency colorectal surgery in perforated sigmoid diverticulitis and obstructive carcinoma of the left colon. Seminars-in-Colon-and-Rectal-Surgery. 2002;13:1-95.
 
134 - Lacy AM
Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM et al. Laparoscopyassisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002;359(9325):2224-9.
 
135 - Law WL
Law WL, Choi HK, Chu KW. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br J Surg 2003;90(11):1429-33.
 
136 - Law WL
Law WL, Choi HK, Lee YM, Chu KW. Palliation for Advanced Malignant Colorectal Obstruction by Self-Expanding Metallic Stents: Prospective Evaluation of Outcomes. Dis Colon Rectum 2004;47:1-43.
 
137 - Lembersky BC
Lembersky BC, Wieand HS, Petrelli NJ, O\'Connell MJ, Colangelo LH, Smith RE et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol. 2006 May 1;24(13):2059-64.
 
138 - Lemmens VEPP
Lemmens VEPP, Coebergh JWW. Epidemiologie van colorectale tumoren. IKR Bulletin 2006; 30 (december):4-7.
 
139 - Leung KL
Leung KL, Kwok SP, Lam SC, Lee JF, Yiu RY, Ng SS et al. Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 2004;363(9416):1187-92.
 
140 - Le Voyer TE
Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003 Aug 1;21(15):2912-9.
 
141 - Lim JF
Lim JF, Tang CL, Seow-Choen F, Heah SM. Prospective, randomized trial comparing intraoperative colonic irrigation with manual decompression only for obstructed left-sided colorectal cancer. Dis Colon Rectum 2005;48(2):205-9.
 
142 - Liver Infusion Meta-analysis Group
Liver Infusion Meta-analysis Group. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. J.Natl.Cancer Inst. 1997;89(7):497-505.
 
143 - Luna Pérez P
Luna Pérez P, Rodriguez RS, Alvarado I, Gutierrez-De-La BM, Labastida S. Prognostic significance of retrieved lymph nodes per specimenin resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Research 2003;34:281-6.
 
144 - Macari M
Macari M, Berman P, Dicker M, Milano A, Megibow AJ. Usefulness of CT colonography in patients with incomplete colonoscopy. AJR Am.J Roentgenol. 1999;173(3), 561-4.
 
145 - Maeda K
Maeda K, Inoue T, Yashiro M, Nishihara T, Nishiguchi Y, Hirakawa K. Successful treatment using a self-expandable metallic stent in the palliation for unresectable malignant obstruction of the colon and rectum. Digestive Endoscopy. 2004;16:4-336.
 
146 - Makela JT
Makela JT, Laitinen SO and Kairaluoma MI: Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995;130:1062-7.
 
147 - Mamounas E
Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol. 1999 May;17(5):1349-55.
 
148 - Marsoni S
Marsoni S; International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Semin Oncol. 2001 Feb;28(1 Suppl 1):14-9.
 
149 - Martenson JA Jr
Martenson JA Jr, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL et al. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. J Clin Oncol. 2004;22(16):3277-83.
 
150 - Martinez F
Martinez F, Kondylis P, Reilly J. Limitations of barium enema performed as an adjunct to incomplete colonoscopy. Dis.Colon Rectum 2005;48(10):1951-4.
 
151 - Maughan TS
Maughan TS, James RD, Kerr DJ, Ledermann JA, McArdle C, Seymour MT et al. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: A multicentre randomised trial. Lancet 2002;359:1555-63.
 
152 - McAndrew MR
McAndrew MR, Saba AK. Efficacy of routine preoperative computed tomography scans in colon cancer. Am.Surg. 1999;65(3):205-8.
 
153 - McLarty AJ
McLarty AJ, Deschamps C, Trastek VF, Allen MS, Pairolero PC, Harmsen WS. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997;63:1568-72.
 
154 - Meisner S
Meisner S, Hensler M, Knop FK, West F, Wille-Jorgensen P. Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center. Dis Colon Rectum 2004;47(4):444-50.
 
155 - Meyer TJ
Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol 1995;14:101-8.
 
156 - Meta-analysis Group In Cancer
Meta-analysis Group In Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J.Clin.Oncol. 1998;16(1):301-8.
 
157 - Meyerhardt JA
Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol 2003;30:3-360.
 
158 - Milsom JW
Milsom JW, Bohm B, Hammerhofer KA, Fazio V, Steiger E, Elson P. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J Am Coll Surg 1998;187(1):46-54.
 
159 - Mock V
Mock V, Olsen M. Current management of fatigue and anemia in patients with cancer. Semin Oncol Nurs 2003;19(4 suppl 2):36-41.
 
160 - Moertel CG
Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990 Feb 8;322(6):352-8.
 
161 - Monges G
Monges G, Piard F. Recommandations pour la redaction des comptes rendus anatomopathologiques des cancers colorectaux. [Recommendations for editing pathology reports of colorectal cancer]. Ann Pathol 1998;18:444-9.
 
162 - Morrin MM
Morrin MM, Kruskal JB, Farrell RJ, Goldberg SN, McGee JB, Raptopoulos V. Endoluminal CT colonography after an incomplete endoscopic colonoscopy. AJR Am.J Roentgenol. 1999;172(4) :913-8.
 
163 - Mulhall BP
Mulhall BP, Veerappan GR, Jackson JL. Meta-Analysis: Computed Tomographic Colonography. Ann Intern Med. 2005;142:635-50.
 
164 - Murray A
Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A et al. Systematic review of the clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer. Health Technol Asess. 2006 Nov;10(45):1-160.
 
165 - Nagtegaal ID
Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729-34.
 
166 - Neri E
Neri E, Giusti P, Battolla L, Vagli P, Boraschi P, Lencioni R, et al. Colorectal cancer: role of CT colonography in preoperative evaluation after incomplete colonoscopy. Radiology 2002;223(3):615-9.
 
167 - Neudecker J
Neudecker J, Junghans T, Ziemer S, Raue W, Schwenk W. Prospective randomized trial to determine the influence of laparoscopic and conventional colorectal resection on intravasal fibrinolytic capacity. Surg Endosc 2003;17(1):73-7.
 
168 - NICE
NICE. Guidance for Commissioning Cancer Services. Improving Outcomes in Colorectal Cancers. Research Evidence for the Manual Update. NICE 2004.
 
169 - NICE
NICE. Overview. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of dvanced colorectal cancer. February 2005.
 
170 - Norum J
Norum J, Olsen JA. A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer. Ann Oncol. 1997;8(11):1081-7.
 
171 - Otchy D
Otchy D, Hyman NH, Simmang C, Anthony T, Buie WD, Cataldo P et al. Practice parameters for colon cancer. Dis Colon Rectum. 2004;47:1269-84.
 
172 - Ohlsson B
Ohlsson B, Breland U, Ekberg H, Graffner H, Trannberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995,38:619-26.
 
173 - Ohlsson B
Ohlsson B, Pålsson B. Follow-up after colorectal cancer surgery. Acta Oncol 2003;42(8):816-26.
 
174 - Ong LJM
Ong LJM, Hoos AM, Laarhoven FJ van, Molenaar S, Visser MRM. De arts als boodschapper. In: Haes JC de, Hoos AM, Everdingen JJ van (eds). Communiceren met patiënten. Maarssen: Elsevier/Bunge, 1999:49-62.
 
175 - Ontwikkeling van een informatieprotocol, 1997
Ontwikkeling van een informatieprotocol, 1997.
 
176 - Palermo JA
Palermo JA, Richards F, Lohman KK, Lovelace JV, Atkinson J, Case LD et al. Phase II trial of adjuvant radiation and intraperitoneal 5-fluorouracil for locally advanced colon cancer: results with 10-year follow-up. Int.J.Radiat.Oncol.Biol.Phys. 2000;47(3):725-33.
 
177 - Pandor A
Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliff P. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. Health Technol Assess. 2006 Nov;10(41):iii-iv, xi-xiv,1-185.
 
178 - Pazdur R
Pazdur R, Vincent M. Raltitrexed (Tomudex) versus 5-fluorouracil and leucovorin (5FU+LV) in patients with advanced colorectal cancer (ACC): results of a randomized, multicenter, North American trial. Proc Am Soc Clin Oncol 1997;16:228a-Abstr 801.
 
179 - Pietra N
Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 1998;41:1127-33.
 
180 - Povoski SP
Povoski SP, Fong Y, Sgouros SC, Kemeney NE, Downey RJ, Blumgart LH. Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann Surg Oncol 1998;5:9-15.
 
181 - Purkayastha S
Purkayastha S, Tekkis PP, Athanasiou T, Aziz O, Negus R, Gedroyc W et al. Magnetic resonance colonography versus colonoscopy as a diagnostic investigation for colorectal cancer: a meta-analysis. Clinical Radiology 2005;60:980–9.
 
182 - QUASAR Collaborative Group
QUASAR Collaborative Group. Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet. 2000 May 6;355(9215):1588-96.
 
183 - Ratto C
Ratto C, Ricci R, Rossi C, Morelli U, Vecchio FM, Doglietto GB. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum 2002;45:733-42.
 
184 - Rex DK
Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D et al. American Cancer Society; US Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterol 2006;130:1865-71.
 
185 - Reza MM
Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg. 2006 Jul 17;93(8):921-8.
 
186 - Renehan AG
Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intense follow-up after curative resection of colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ 2002;324:1-8.
 
187 - Renehan AG
Renehan AG, O'Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ 2004;328:81.
 
188 - Rigby K
Rigby K, Brown SR, Lakin G, Balsitis M, Hosie KB. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl 1999;81:401-3.
 
189 - Rodriguez-Moranta F
Rodriguez-Moranta F, Salo J, Arcusa A, Boadas J, Pinol V, Bessa X et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006;24(3):386-93.
 
190 - Rothenberg ML
Rothenberg ML, Oza AM, Bigelow RH, Berlin JD, Marshall JL, Ramanathan RK et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol. 2003;21(11):2059-69.
 
191 - Rougier P
Rougier P, van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca R et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.[erratum appears in Lancet 1998;352(9140):1634]. Lancet 1998;352:1407-12.
 
192 - Saltz LB
Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343:905-14.
 
193 - De-Salvo GL
De-Salvo GL, Gava C, Pucciarelli S, Lise M. Curative surgery for obstruction from primary left colorectal carcinoma: primary or staged resection? Cochrane Database Syst Rev 2004 [2], CD002101
 
194 - Sastre J
Sastre J, Marcuello E, Masutti B, Navarro M, Gil S, Anton A, et al.Cooperative Group for the Treatment of Digestive Tumors. Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. J Clin Oncol. 2005 May 20;23(15):3545-51.
 
195 - Schild SE
Schild SE, Gunderson LL, Haddock MG, Wong WW, Nelson H. The treatment of locally advanced colon cancer. Int.J.Radiat.Oncol.Biol.Phys. 1997;37(1):51-8.
 
196 - Schrameijer F
Schrameijer F, Brunenberg W. Psychosciale zorg bij kankerpatiënten en hulpverleners over problemen en hulpaanbod. Utrecht: Nederlands Centrum Geestelijke Volksgezondheid, 1992. 614 -Nisso X. Verlost van kanker, nog altijd vermoeid. Tijdschr Kanker 2002;26:32-3.
 
197 - Schwartz AL
Schwartz AL. Physical activity after a cancer diagnosis: psychosocial outcomes. Cancer Invest 2004;22:82-92.
 
198 - Sprangers MA
Sprangers MA. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 2002;41:229-37.
 
199 - Sweed MR
Sweed MR, Schiech L, Barsevick A, Babb JS, Goldberg M. Quality of life after esophagectomy for cancer. Oncol Nurs Forum 2002;29:1127-31.
 
200 - Schoemaker D
Schoemaker D, Black R, Giles L. Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14.
 
201 - Schwenk W
Schwenk W, Bohm B, Haase O, Junghans T, Muller JM. Laparoscopic versus conventional colorectal resection: a prospective randomised study of postoperative ileus and early postoperative feeding. Langenbecks Arch Surg 1998;383(1):49-55.
 
202 - The SCOTIA Study Group
The SCOTIA Study Group. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. Subtotal Colectomy versus On-table Irrigation and Anastomosis. Br J Surg 1995;82(12):1622-7.
 
203 - Sebastian S
Sebastian S, Johnston S, Geoghegan T, Torreggiani W, Buckley M. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004;99(10):2051-7.
 
204 - Secco GB
Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G et al. Efficacy and cost of risk-adapted followup in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002;28(4):418-23.
 
205 - Seymour MT
Seymour MT, Maughan TS, Ledermann JA, topham C, James R, Swyther SJ et al. FOCUS Trial Investigators: National Cancer Research Institute Colorectal Clinical Studies Group. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised trial. Lancet 2007:370:143-52.
 
206 - Simmonds PC
Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000;321(7260):531-5.
 
207 - Sobin LH
Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). TNM Prognostic Factors Project, International Union Against Cancer, Washington, DC, USA.
 
208 - Sobin LH
Sobin LH, Wittekind CH (Eds). TNM Classification of Malignant Tumours, 6th Edition. International Union Against Cancer, Washington, DC, USA, 2002.
 
209 - Sosna J
Sosna J, Morrin MM, Kruskal JB, Lavin PT, Rosen MP, Raptopoulos V. CT colonography of colorectal polyps: a metaanalysis. Am J Roentgenol. 2003;181(6):1593-8.
 
210 - Stage JG
Stage JG, Schulze S, Moller P, Overgaard H, Andersen M, Rebsdorf-Pedersen VB et al. Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma. Br J Surg 1997;84(3):391-6.
 
211 - Stiggelbout AM
Stiggelbout AM, de Haes JC, Vree R, van de Velde CJ, Bruijninckx CM, van Groningen K et al. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997;75(6):914-20.
 
212 - Swanson RS
Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003;10:65-71.
 
213 - Tang CL
Tang CL, Eu KW, Tai BC, Soh JGS, MacHin D, Seow-Choen F. Randomized clinical trial of the effect of open versus laparoscopically assisted colectomy on systemic immunity in patients with colorectal cancer. Br J Surg 2001;88(6):801-7.
 
214 - Tappenden P
Tappenden P, Jones R, Paisley S, Carroll C. The use of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. NHS R&D HTA program, February 2006.
 
215 - Targownik LE
Targownik LE, Spiegel BM, Sack J, Hines OJ, Dulai GS, Gralnek IM et al. Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: A decision analysis. Gastrointest.Endosc. 2004;60:6-874.
 
216 - Tattersall MH
Tattersall MH, Butow PN, Clayton JM. Insights from cancer patient communication research. Hematol Oncol Clin North Am 2002;6:731-43.
 
217 - Taylor WE
Taylor WE, Donohue JH, Gunderson LL, Nelson H, Nagorney DM, Devine RM et al. The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann.Surg.Oncol. 2002;9(2):177-85.
 
218 - Tekkis PP
Tekkis PP, Senagore AJ, Delaney CP, Fazio VW. Evaluation of the Learning Curve in Laparoscopic Colorectal Surgery: Comparison of Right-Sided and Left-Sided Resections. Ann Surg. 2005 Jul;242(1):83-91.
 
219 - Thirion P
Thirion P, Michiels S, Pignon JP, Buyse M, Braud AC, Carlson RW et al. Meta-Analysis Group in Cancer. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol. 2004;22(18):3766-75.
 
220 - TNM 1997
TNM 1997.
 
221 - TNM 2002
TNM 2002.
 
222 - Tournigand C
Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol, 2004;22:229-37.
 
223 - Tournigand C
Tournigand C, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M et al. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. J Clin Oncol. 2006;24(3):394-400.
 
224 - Trijsburg RW
Trijsburg RW, Knippenberg FC van, Rijpma SE. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 1992;54:489-517.
 
225 - Twelves C
Twelves C, Xeloda Colorectal Cancer Group. Capecitabine as first-line treatment in colorectal cancer: Pooled data from two large, phase III trials. Eur J Cancer. 2002; 38(suppl. 2):15-20.
 
226 - Twelves C
Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005 Jun 30;352(26):2696-704.
 
227 - Ueno H
Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 1998;41:55-61.
 
228 - Vardulaki K
Vardulaki K, Bennett-Lloyd BD, Parfitt J, Normond C, Paisley S, Darzi A et al. A systematic review of the effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer. July 2000:http://www.nice.org.uk/pdf/HTAreportonlapsurgcoloreccanc. pdf [1 October 2005].
 
229 - Vermorken JB
Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S et al. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet. 1999 Jan 30;353(9150):345-50.
 
230 - Vignali A
Vignali A, Braga M, Zuliani W, Frasson M, Radaelli G, Di C, V. Laparoscopic colorectal surgery modifies risk factors for postoperative morbidity. Dis Colon Rectum 2004;47(10):1686-93.
 
231 - Villar JM
Villar JM, Martinez AP, Villegas MT, Muffak K, Mansilla A, Garrote D et al. Surgical options for malignant left-sided colonic obstruction. Surgery-Today. 2005;35:4-281.
 
232 - Wang C
Wang C, Zhou Z, Wang Z, Zheng Y, Zhao G, Yu Y et al. Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum. Langenbeck\'s Archives of Surgery 2005;390:312-8.
 
233 - Ward S
Ward S, Kaltenthaler E, Cowan J, Brewer N. A review of the evidence for the clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer. NHS R&D HTA program, September 2002.
 
234 - Watt E
Watt E, Whyte F. The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer.Eur J Cancer Care (Engl) 2003;12:183-93.
 
235 - Wei JT
Wei JT, Miller EA, Woosley JT, Martin CF, Sandler RS. Quality of colon carcinoma pathology reporting: a process of care study. Cancer 2004;100:1262-7.
 
236 - Welch S
Welch S, Kocha W, Rumble RB, Spithoff K, Aroun J. The role of bevacizumab combined with chemotherapy in the treatment of patient with advianced colorectal cancer. part 1. A clinical practice guideline & part 2. A systematic review. Cancer Care Ontario 2005.
 
237 - Willett CG
Willett CG, Fung CY, Kaufman DS, Efird J, Shellito PC. Postoperative radiation therapy for high-risk colon carcinoma. J Clin Oncol.1993;11:1112-7.
 
238 - Willett CG
Willett CG, Goldberg S, Shellito PC, Grossbard M, Clark J, Fung C et al. Does postoperative irradiation play a role in the adjuvant therapy of stage T4 colon cancer? Cancer J.Sci.Am. 1999;5(4):242-7.
 
239 - Winawer SJ
Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329(27):1977-81.
 
240 - Xinopoulos D
Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, Tsamakidis K, Bitsakou G, Plataniotis G et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysis. Surg Endosc. 2004;18(3):421-6.
 
241 - Yoshimatsu K
Yoshimatsu K, Ishibashi K, Umehara A, Yokomizo H, Yoshida K, Fujimoto T et al. How many lymph nodes should be examined in Dukes\' B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology 2005;52:1703-6.
 
242 - Zaniboni A
Zaniboni A, Labianca R; Gruppo Italiano per lo Studio e la Cura dei Tumori del Digerente. Adjuvant therapy for stage II colon cancer: an elephant in the living room? Ann Oncol 2004;15:1310-8.
 
243 - Zhou ZG
Zhou ZG, Hu M, Li Y, Lei WZ, Yu YY, Cheng Z et al. Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc 2004;18(8):1211-5.
 
244 - De Zwart I
De Zwart I, Griffioen G, Shaw MP, Lamers CB, de Roos A. Barium enema and endoscopy for the detection of colorectal neoplasia: sensitivity, specificity, complications and its determinants. Clin Radiol 2001;56:401-9.
 
245 - Arkenau HT
Arkenau HT, Rettig K, Porschen R. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion. Int J Colorectal Dis. 2005 May;20(3):258-61. Epub 2004 Nov 11.
 
246 - Schmoll HJ
Schmoll HJ. Improving longevity in advanced intestinal cancer]. Krankenpfl J. 2005;43(1-3):48
 
247 - Kalofonos HP
Kalofonos HP, Aravantinos G, Kosmidis P, Papakostas P, Economopoulos T, Dimopoulos M et all. Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study. Ann Oncol. 2005 Jun;16(6):869-77. Epub 2005 Apr 26.
 
248 - Lal R
Lal R, Dickson J, Cunningham D, Chau I, Norman AR, Ross PJ, Topham C et all. A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer. J Clin Oncol 2004 Aug 1;22(15):3023-31
 
249 - Verwaal VJ
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H et all. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003 Oct 15;21(20):3737-43.
 
250 - Nordic Study
[No authors listed] Expectancy or primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. J Clin Oncol. 1992 Jun;10(6):904-11.  
 
251 - Abdalla EK (2001)
Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001;88:165-75.
 
252 - Abdalla EK (2004)
Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metstases. Ann Surg. 2004 Jun;239(6):818-25.
 
253 - Abdel-Razek AA (2005)
Abdel-Razek AA, bu-Zeid MM, Bilal M, Abdel-Wahab NM. Virtual CT colonoscopy versus conventional colonoscopy: a prospective study. Hepatogastroenterology 2005;52(66),1698-702.
 
254 - Abraham A (2013)
Abraham A, Habermann EB, Rothenberger DA, Kwaan M, Weinberg AD, Parsons HM, et al. WB. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines Cancer. 2013 Jan 15;119(2):395-403. doi: 10.1002/cncr.27755. Epub 2012 Jul 17.
 
255 - Ackerstaff AH (1998)
Ackerstaff AH, Hilgers FJ. Rehabilitation after head and neck cancer. In: Jones AS, Philips DE, Hilgers FJ (eds). Diseases of the head and neck and nose and throat. London:Arnold,1998:435-48.
 
256 - Ackland SP (2005)
Ackland SP, Jones M, Tu D, Simes J, Yuen J, Sargeant AM et al. A meta-analysis of two randomised trials of early chemotherapy in asymptomatic metastatic colorectal cancer. Br J Cancer 2005;93,11:1236-43.
 
257 - Acunas B (1990)
Acunas B, Rozanes I, Caunas G, Celik L, Sayi I, Gökmen E. Preoperative staging of colon carcinoma (excluding the recto-sigmiod region). Eur J Radiol 1990;11:150-3.
 
258 - Adam R (1997)
Adam R, Akpinar E, Johann M, Kunstlinger F, Majno P, Bismuth H. Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997;225:39-8.
 
259 - Adam R (2001)
Adam R, Avisar E, Ariche A, Giachetti S, Azoulay D, Castaing D. Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal.Ann Surg Oncol 2001; 8:347-53.
 
260 - Adam R (1997)
Adam R, Bismuth H, Castaing D, Waechter F, Navarro F, Abascal A, et al. Repeat hepatectomy for colorectal liver metastases. Ann Surg 1997; 225:51-60.
 
261 - Adam R (2004)
Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240:644-57.
 
262 - Adam R (2002)
Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg 2002;137:1332-9.
 
263 - Adam R (2000)
Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg 2000;232:777-785.
 
264 - Adam R (2003)
Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H. Liver resection for colorectal metastases: the third hepatectomy.Ann Surg 2003;238:871-883.
 
265 - Adams RA (2011)
Adams RA, Meade AM, Seymour MT, Wilson RH, Madi A, Fisher D, et al. Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet Oncol. 2011 Jul;12(7):642-53. doi: 10.1016/S1470-2045(11)70102-4. Epub 2011 Jun 5.
 
266 - ACCMAP (1994)
Advanced Colorectal Cancer Meta-Analysis Project. Meta-analysis of randomised trials testing the biochemical modulation of fluorouracil by methotrexate in metastatic colorectal cancer. J Clin Oncol 1994; 12:960-969.
 
267 - ACCMAP (1992)
Advanced Colorectal Cancer Meta-analysis Project. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. J Clin Oncol 1992; 10:896-903.
 
268 - Agcaoglu O (2013)
Agcaoglu O, Aliyev S, Karabulut K, El-Gazzaz G, Aucejo F, Pelley R, et al. Complementary Use of Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastases: An Analysis of 395 Patients. World J Surg. 2013 Jun;37(6):1333-9.
 
269 - Aigner KR (1988)
Aigner KR, Walther H, Link KH. Isolated liver perfusion with MMC/5-FU; surgical technique, harmacokinetics, clinical results. Contr Oncol 1988;29:229-46.
 
270 - Aigner KR (1984)
Aigner KR, Walther H, Tonn JC, Link KH, Schoch P, Schwemmle K. Isolated liver perfusion in advanced metastases of colorectal cancers]. Onkologie 1984;7:13-21.
 
271 - Ajaj W (2005)
Ajaj W, Lauenstein TC, Pelster G, Holtmann G, Ruehm SG, Debatin JF et al. MR colonography in patients with incomplete conventional colonoscopy. Radiology 2005;234:452-9.
 
272 - Akasu T (2006)
Akasu T, Moriya Y, Ohashi Y, Yoshida S, Shirao K, Kodaira S; National Surgical Adjuvant Study of Colorectal Cancer. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenoectomy: a multicentre randomized controlled trial. Jap J Clin Oncol 2006;36:237-44.
 
273 - Alberts SR (2012)
Alberts SR, Sargent DJ, Nair S, Mahoney MR, Mooney M, Thibodeau SN, et al. Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA. 2012 Apr 4;307(13):1383-93. doi: 10.1001/jama.2012.385.
 
274 - Alcántara M (2011)
Alcántara M, Serra-Aracil X, Falcó J, Mora L, Bombardó J, Navarro S. Prospective, controlled, randomized study of intraoperative colonic lavage versus stent placement in obstructive left-sided colonic cancer. World J Surg. 2011 Aug;35(8):1904-10.
 
275 - Alexander HR Jr (1998)
Alexander HR Jr, Bartlett DL, Libutti SK, Fraker DL, Moser T, Rosenberg SA. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J Clin Oncol 1998;16:1479-89.
 
276 - Alexander HR Jr (2003)
Alexander HR Jr, Libutti SK, Pingpank JF, et al. Hyperthermic isolated hepatic perfusion using melphalan for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2003 ;9:6343-49.
 
277 - Alexander HR (2000)
Alexander HR, Libutti SK, Bartlett DL, Puhlmann M, Fraker DL, Bachenheimer LC. A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. Clin Cancer Res 2000;6:3062-70.
 
278 - Allaix ME (2011)
Allaix ME, Rebecchi F, Giaccone C, Mistrangelo M, Morino M. Long-term functional results and quality of life after transanal endoscopic microsurgery. Br J Surg. 2011 Nov;98(11):1635-43.
 
279 - Allegra CJ (2009)
Allegra CJ, Jessup JM, Somerfield MR, Hamilton SR, Hammond EH, Hayes DF, McAllister PK, Morton RF, Schilsky RL. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. Clin Oncol. 2009 Apr 20;27(12):2091-6. doi: 10.1200/JCO.2009.21.9170. Epub 2009 Feb 2.
 
280 - Allegra CJ (2011)
Allegra CJ, Yothers G, O'Connell MJ, Sharif S, Petrelli NJ, Colangelo LH, et al. Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. J Clin Oncol. 2011 Jan 1;29(1):11-6. doi: 10.1200/JCO.2010.30.0855. Epub 2010 Oct 12.
 
281 - Allen DC (1998)
Allen DC, Fon LJ, McAleer JJ, Irwin ST. Pathology of rectal adenocarcinoma following preoperative adjuvant radiotherapy and chemotherapy. Ulster Med J 1998;68:17-21.
 
282 - Allen-Mersh TG (1994)
Allen-Mersh TG, Earlam S, Fordy C, Abrams K, Houghton J. Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994;344:1255-60.
 
283 - Allen-Mersh TG (2000)
Allen-Mersh TG, Glover C, Fordy C, et al: Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases. Eur J Surg Oncol 2000;26:468-73.
 
284 - Allgayer H (2005)
Allgayer H, Dietrich CF, Rohde W, Koch GF, Tuschhoff T. Prospective comparison of short- and long-term effects of pelvic floor exercise/biofeedback training in patients with fecal incontinence after surgery plus irradiation versus surgery alone for colorectal cancer: clinical, functional and endoscopic/endosonographic findings. Scand J Gastroenterol 2005 40(10): 1168-75.
 
285 - Aloia TA (2006)
Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006 May;141(5):460-6.
 
286 - Al-Sukhni E (2013)
Al-Sukhni E, Messenger DE, Charles Victor J, McLeod RS, Kennedy ED. Do MRI reports contain adequate preoperative staging information for end users to make appropriate treatment decisions for rectal cancer? Ann Surg Oncol. 2013 Apr;20(4):1148-55.
 
287 - Al-Sukhni E (2012)
Al-Sukhni E, Milot L, Fruitman M, Beyene J, Victor JC, Schmocker S, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012 Jul;19(7):2212-23. doi: 10.1245/s10434-011-2210-5.
 
288 - Amado RG (2008)
Amado RG, Wolf M, Peeters M, Van Cutsem E, Siena S, Freeman DJ, Juan T et al. Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer. J Clin Oncol. 2008 Apr 1;26(10):1626-34. doi: 10.1200/JCO.2007.14.7116. Epub 2008 Mar 3.
 
289 - Ambiru S (1999)
Ambiru S, Miyazaki M, Isono T, Ito H, Nakagawa K, Shimizu H, et al. Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum 1999;42:632-9.
 
290 - Ambrosino G (2009)
Ambrosino G, Polistina F, Costantin G,Francescon P, Guglielmi R, Zanco P, et al. Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results. Anticancer Res 2009 Aug;29(8):3381-4.
 
291 - Amin Z (1993)
Amin Z, Bown SG, Lees WR. Local treatment of colorectal liver metastases: a comparison of interstitial laser photocoagulation (ILP) and percutaneous alcohol injection (PAI). Clin Radiol 1993; 48:166-71.
 
292 - Amos EH (1996)
Amos EH, Mendenhall WM, McCarty PJ, Gage JO, Emlet JL, Lowrey GC et al. Postoperative radiotherapy for locally advanced colon cancer. Ann.Surg.Oncol. 1996;3:431-6.
 
293 - Andre T (2004)
Andre T, Boni C, Mounedji-Boudiaf L, Navarro M, Tabernero J, Hickish T et al. Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med. 2004 Jun 3;350:2343-51.
 
294 - André T (2009)
André T, Boni C, Navarro M, Tabernero J, Hickish T, Topham C, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009 Jul 1;27(19):3109-16.
 
295 - Andre T (2003)
Andre T, Colin P, Louvet C, Gamelin E, Bouche O, Achille E et al. Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial. J Clin Oncol. 2003 Aug 1;21(15):2896-903.
 
296 - André T (1998)
André T, Louvet C, Raymond E, et al. Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen. Ann Oncol 1998;9:1251-1253.
 
297 - Angelica M (2003)
Angelica M, Fong Y, Weber S, Gonen M, DeMatteo RP, Conlon K, et al. The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 2003;10:183-9.
 
298 - Aparicio T (2001)
Aparicio T, Jouve JL, Teillet L, Gargot D, Subtil F, Le Brun-Ly V, et al. Geriatric Factors Predict Chemotherapy Feasibility: Ancillary Results of FFCD 2001-02 Phase III Study in First-Line Chemotherapy for Metastatic Colorectal Cancer in Elderly Patients. J Clin Oncol. 2013 Apr 10;31(11):1464-70.
 
299 - Araujo SE (2003)
Araujo SE, da Silva eSousa AH Jr, de Campos FG, Habr-Gama A, Dumarco RB, Caravatto PP et al. Conventional approach x laparoscopic abdominoperineal resection for rectal cancer treatment after neoadjuvant chemoradiation: results of a prospective randomized trial. Rev Hosp Clin Fac Med Sao Paulo 2003;58(3):133-40.
 
300 - Arkenau HT (2008)
Arkenau HT, Arnold D, Cassidy J, Diaz-Rubio E, Douillard JY, Hochster H. et al. Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials. J Clin Oncol. 2008 Dec 20;26(36):5910-7.
 
301 - Arkenau HT (2005)
Arkenau HT, Rettig K, Porschen R. Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion. Int J Colorectal Dis. 2005 May;20(3):258-61. Epub 2004 Nov 11.
 
302 - Arora NK (2000)
Arora NK, McHorney CA. Patient preferences for medical decision making: who really wants to participate? Med Care 2000;38:335-41.
 
303 - Arteaga-González I (2006)
Arteaga-González I, Martín-Malagón A, Fernández EM, Arranz-Durán J, Parra-Blanco A, Nicolas-Perez D, The use of preoperative endoscopic tattooing in laparoscopic colorectal cancer surgery for endoscopically advanced tumors: a prospective comparative clinical study.World J Surg 2006
 
304 - Aschele C (2011)
Aschele C, Cionini L, Lonardi S, Pinto C, Cordio S, Rosati G, et al. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol. 2011 Jul 10;29(20):2773-80.
 
305 - Askin MP (2002)
Askin MP, Waye JD, Fiedler L, Harpaz N. Tattoo of colonic neoplasms in 113 patients with a new sterile carbon compound. Gastrointest Endosc. 2002 Sep;56(3):339-42.
 
306 - Aslinia F (2006)
Aslinia F, Uradomo L, Steele A, Greenwald BD, Raufman JP. Quality assessment of colonoscopic intubation: an analysis of 6 years of continuous practice at a university hospital. Am J Gastroenterol. 2006 Apr;101(4):721-31.
 
307 - Atkin W (2013)
Atkin W, Dadswell E, Wooldrage K, et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet 2013 doi.org/10.1016/S0140-6736(12)62186-2
 
308 - Audisio RA (2012)
Audisio RA, Papamichael D.Treatment of colorectal cancer in older patients. Nat Rev Gastroenterol Hepatol 2012;9:716-25.
 
309 - Audisio RA (1996)
Audisio RA, Setti-Carraro P, Segala M et al. Follow-up in colorectal cancer patients: a cost-benefit analysis. Ann Surg Oncol 1996;3:349-57.
 
310 - Azoulay D (2000)
Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000;231:480-6.
 
311 - Baas JM (2011)
Baas JM, Krens LL, Guchelaar HJ, Morreau H, Gelderblom H. Concordance of predictive markers for EGFR inhibitors in primary tumors and metastases in colorectal cancer: a review. Oncologist. 2011;16(9):1239-49. doi: 10.1634/theoncologist.2011-0024. Epub 2011 Jul 8.
 
312 - Babineau TJ (1994)
Babineau TJ, Lewis WD, Jenkins RL, et al. Role of staging laparoscopy in the treatment of hepatic malignancy. Am J Surg 1994;167:151-4.
 
313 - Bach SP (2009)
Bach SP, Hill J, Monson JR, Simson JN, Lane L, Merrie A, Warren B, et al. A predictive model for local recurrence after transanal endoscopic microsurgery for rectal cancer. Br J Surg. 2009 Mar;96(3):280-90. doi: 10.1002/bjs.6456.
 
314 - Badiani S (2012)
Badiani S, et al., TEMS as treatment for early rectal cancer: A single regional referral centre experience. Colorectal Disease 2012. 14: 19-20.
 
315 - Badiani (2012)
Badiani, S., et al., Organ preservation is possible: Local excision of early rectal cancer with Transanal Endoscopic Microsurgery (TEMS). Colorectal Disease, 2012. 14: p. 16.
 
316 - Bali C (2004)
Bali C, Nousias V, Fatouros M, Stefanou D, Kappas AM. Assessment of local stage in rectal cancer using endorectal ultrasonography (EUS). Tech Coloproctol. 2004 Nov;8 Suppl 1:s170-3.
 
317 - Baravelli C (2009)
Baravelli C, Krishnasamy M, Pezaro C, Scholfield P, Lotfi-Jam K, Rogers M, et al. The views of bowel cancer survivors and health care professionals regarding survivorschip care plans and post treatment follow up. J Cancer Surviv. 2009 Jun;3(2):99-108.
 
318 - Barbaro B (2009)
Barbaro B, Fiorucci C, Tebala C, Valentini V, Gambacorta MA, Vecchio FM, et al. Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 2009;250:730-9.
 
319 - Barbot DJ (1997)
Barbot DJ, Marks JH, Feld RI, Liu JB, Rosato FE. Improved staging of liver tumors using laparoscopic intraoperative ultrasound. J Surg Oncol 1997;64:63-7.
 
320 - Barendse RM (2012)
Barendse RM, Doornebosch PG, Bemelman WA, Fockens P, Dekker E, de Graaf EJ. Transanal employment of single access ports is feasible for rectal surgery. Ann Surg, 2012Dec 256(6): 1030-3.
 
321 - Bartlett DL (2001)
Bartlett DL, Libutti SK, Figg WD, Fraker DL, Alexander HR. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer. Surgery 2001;129:176-87.
 
322 - Bartlett L (2011)
Bartlett L, Sloots K, et al. Biofeedback therapy for symptoms of bowel dysfunction following surgery for colorectal cancer. Tech Coloproctol 2011 15(3): 319-326
 
323 - Barton (2002)
Barton, JB, Langdale LA, Cummins JS, Stelzner M, Lynge DC, Mock CN et al. The utility of routine preoperative computed tomography scanning in the management of veterans with colon cancer. Am J Surg 2002;183: 499-503.
 
324 - Ba-Ssalamah A (2000)
Ba-Ssalamah A, Heinz-Peer G, Schima W, Schibany N, Schick S, Prokesch RW et al. Detection of focal hepatic lesions: comparison of unenhanced and SHU 555 A-enhanced MR imaging versus biphasic helical CTAP. J Magn Reson Imaging 2000; 11:665-72.
 
325 - Baulieu F (2001)
Baulieu F, Bourlier P, Scotto B, Mor C, Eder V, Picon L, et al. The value of immunoscintigraphy in the detection of recurrent colorectal cancer. Nucl Med Commun 2001;22:1295-304.
 
326 - Bauwens S (2009)
Bauwens S, Baillon C, Distelmans W, Theuns P. The 'Distress Barometer': validation of method of combining the Distress Thermometer with a rated complaint scale. Psychooncology 2009;18(5):534-42.
 
327 - Beart RW Jr (2000)
Beart RW Jr. Follow-up: does it work? Can we afford it? Surg Oncol Clin N Am 2000; 9(4):827-34.
 
328 - Beattie GC (2003)
Beattie GC, McAdam TK, Elliott S, Sloan JM, Irwin ST. Improvement in quality of colorectal cancer pathology reporting with a standardized proforma--a comparative study. Colorectal Dis 2003;5:558-62.
 
329 - Becker D (1999)
Becker D, Hansler JM, Strobel D, Hahn EG. Percutaneous ethanol injection and radio-frequency ablation for the treatment of nonresectable colorectal liver metastases - techniques and results. Langenbecks Arch Surg 1999;384:339-43.
 
330 - Becker GL (1990)
Becker GL, Whitlock WL, Schaefer PS, Tenholder MF. The impact of thoracic computed tomography in clinically staged T1, N0, M0 chest lesions. Arch Intern Med 1990;150:557-9.
 
331 - Beckurts KT (1997)
Beckurts KT, Holscher AH, Thorban S, Bollschweiler E, Siewert JR. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 1997; 84:1081-4.
 
332 - Bedrosian I (2004)
Bedrosian I, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA et al. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg 2004;8:56-62.
 
333 - Beets-Tan RG (2011)
Beets-Tan RG, Beets GL. Local staging of rectal cancer: a review of imaging. J Magn Reson Imaging. 2011 May;33(5):1012-9. doi: 10.1002/jmri.22475. Review.
 
334 - Beets-Tan RGH (2012)
Beets-Tan RGH, Lambregts DMJ, Maas M, Bipat S, Barbaro B, Caseiro-Alves F, et al. Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. European radiology 2013, in press
 
335 - Belli G (2002)
Belli G, D'Agostino A, Ciciliano F, Fantini C, Russolillo N, Belli A. Liver resection for hepatic metastases: 15 years of experience. J Hepatobiliary Pancreat Surg 2002;9:607-13.
 
336 - Bellomi M (2007)
Bellomi M, Rizzo S, Travaini LL, Bazzi L, Trifirň G, Zampino MG, Radice D, Paganelli G. Role of multidetector CT and FDG-PET/CT in the diagnosis of local and distant recurrence of resected rectal cancer. Radiol Med. 2007 Aug;112(5):681-90. Epub 2007 Jul 26
 
337 - Belluco C (2011)
Belluco C, De Paoli A, Canzonieri V, Sigon R, Fornasarig M, Buonadonna A, et al. Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol. 2011 Dec;18(13):3686-93.
 
338 - Benizri EI (2012)
Benizri EI, Bereder JM, Rahili A, Bernard JL, Vanbiervliet G, Filippi J, et al. Additional colectomy after colonoscopic polypectomy for T1 colon cancer: A fine balance between oncologic benefit and operative risk. Int J Colorectal Dis. 2012;27(11):1473-8.
 
339 - Ben-Josef E (2005)
Ben-Josef E, Normolle D, Ensminger WD, et al. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies. J Clin Oncol 2005 Dec 1;23(34):8739-47.
 
340 - Bennouna J (2013)
Bennouna J, Sastre J, Arnold D, Österlund P, Greil R, Van Cutsem E, et al. Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial. 1. Lancet Oncol. 2013 Jan;14(1):29-37. doi: 10.1016/S1470-2045(12)70477-1. Epub 2012 Nov 16.
 
341 - Bentrem DJ (2005)
Bentrem DJ, Okabe S, Wong WD, Guillem JG, Weiser MR, Temple LK et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg 2005;242:472-7.
 
342 - Berber E (2005)
Berber E, Pelley R, Siperstein AE. Predictors of Survival After Radiofrequency Thermal Ablation of Colorectal Cancer Metastases to the Liver: A Prospective Study. J Clin Oncol 2005;23:1358-1364.
 
343 - Berber E (2008)
Berber E, Tsinberg M, Tellioglu G, Simpfendorfer CH, Siperstein AE. Resection versus laparoscopic radiofrequency thermal ablation of solitary colorectal liver metastasis. J Gastrointest Surg. 2008 Nov;12(11):1967-72.
 
344 - Berberoglu U (2004)
Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4N0M0 colorectal cancer. Hepatogastroenterology 2004;51:1689-93.
 
345 - Beresford M (2005)
Beresford M, Glynne-Jones R, Richman P, Makris A, Mawdsley S, Stott D, et al. The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. Clin Oncol 2005;17:448-55.
 
346 - Berger AC (2005)
Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005 Dec 1;23(34):8706-12.
 
347 - Berman JM (2000)
Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet 2000;355:395-9.
 
348 - Bertolini F (2011)
Bertolini F, Malavasi N, Scarabelli L, Fiocchi F, Bagni B, Del Giovane C, et al. FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer. Br J Cancer 2011;104:1079-84.
 
349 - Biagi JJ (2011)
Biagi JJ, Raphael MJ, Mackillop WJ, Kong W, King WD, Booth CM. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: a systematic review and meta-analysis. JAMA. 2011 Jun 8;305(22):2335-42.
 
350 - Bilchik AJ (2000)
Bilchik AJ, Wood TF, Allegra D, Tsioulias GJ, Chung M, Rose DM, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg 2000;135:657-62.
 
351 - Bilimoria KY (2008)
Bilimoria KY, Stewart AK, Edge SB, Ko CY. Lymph node examination rate, survival rate, and quality of care in colon cancer. JAMA. 2008 Feb 27;299(8):896-7.
 
352 - Bipat S (2004)
Bipat S, Glas AS, Slors FJ, Zwinderman AH, Bossuyt PM, Stoker J. Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging - a meta-analysis. Radiology 2004; 232:773-83.
 
353 - Bipat S (2005)
Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Stoker J. Computed tomography, magnetic resonance imaging, positron emission tomography in the diagnosis of colorectal liver metastases: a meta-analyses. Radiology 2005;237:123-131.
 
354 - Bipat S (2006)
Bipat S, van Leeuwen MS, IJzermans JNM, Bossuyt PMM, Greve JW, Stoker J. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey. Neth J Med. 2006;64:147-51.
 
355 - Bipat S (2012)
Bipat S, Niekel MC, Comans EF, Nio CY, Bemelman WA, Verhoef C, Stoker J. Imaging modalities for the staging of patients with colorectal cancer. Neth J Med. 2012 Jan;70(1):26-34.
 
356 - Birbeck KF (2002)
Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449-57.
 
357 - Birkenkamp-Demtroder K (2005)
Birkenkamp-Demtroder K, Olesen SH, Sřrensen FB, Laurberg S, Laiho P, Aaltonen LA, et al. Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut 2005;54:374-84.
 
358 - Blanchard CG (1988)
Blanchard CG, Labrecque MS, Ruckdeschel JC, Blanchard EB. Information and decision-making preferences of hospitalized adult cancer patients. Soc Sci Med 1988;27:1139-45.
 
359 - Blazeby JM (2003)
Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M, et al. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 2003;39:1384-94.
 
360 - Bleeker WA (2001)
Bleeker WA, Mulder NH, Hermans J, Otter R, Plukker JT. Value and cost of follow-up after adjuvant treatment of patients with Dukes' C colonic cancer. Br J Surg 2001; 88(1), 101-6.
 
361 - Bleicher RJ (2003)
Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ. Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 2003;10:52-8.
 
362 - Blomgren H (1998)
Blomgren H, Lax I, Göranson H, Kraepelien T. Radiosurgery for Tumors in the Body: Clinical Experience Using a New Method. Journal of Radiosurgery 1998;1(1):63-74.
 
363 - Blomgren H (1995)
Blomgren H, Lax I, Naslund I, Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995;34(6):861-70.
 
364 - Blumberg D (1999)
Blumberg D, Paty PB, Guillem JG, Picon AI, Minsky BD, Wong WD, et al. All patients with small intramural rectal cancers are at risk for lymph node metastasis. Dis Colon Rectum 1999;42:881-5.
 
365 - Blumberg D (1998)
Blumberg D, Paty PB, Picon AI, Guillem JG, Klimstra DS, Minsky BD, et al. Stage I rectal cancer: identification of high-risk patients. J Am Coll Surg 1998;186:574-9.
 
366 - Boer AG de (2000)
Boer AG de, Genovesi PI, Sprangers MA, Sandick JW van, Obertop H, Lanschot JJ van. Quality of life in long-term survivors after curative transhiatal oesophagectomy for oesophageal carcinoma. Br J Surg 2000;87:1716-21.
 
367 - Bokemeyer C (2011)
Bokemeyer C, Bondarenko I, Hartmann JT, de Braud F, Schuch G, Zubel A, et al. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study. Ann Oncol. 2011 Jul;22(7):1535-46. doi: 10.1093/annonc/mdq632. Epub 2011 Jan 12.
 
368 - Boland CR (1998)
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998 Nov 15;58(22):5248-57
 
369 - Bonjer HJ (2007)
Bonjer HJ, Hop WC, Nelson H, Sargent DJ, Lacy Am Castells A et al. The Trans Atlantic Laparoscopically-Assisted versus Open Colectomy Trials Study Group. Laparoscopically assisted versus open colectomy for colon cancer - a meta-analysis. Arch Surg 2007;Mar 142(3):298-303.
 
370 - Borgelt BB (1981)
Borgelt BB, Gelber R, Brady LW, Griffin T, Hendrickson FR. The palliation of hepatic metastases: results of the Radiation Therapy Oncology Group pilot study. Int J Radiat Oncol Biol Phys 1981 May;7(5):587-91.
 
371 - Borie F (2004)
Borie F, Combescure C, Daures JP, Tretarre B, Millat B. Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model. World J Surg 2004a;28(6):563-9.
 
372 - Borie F (2004)
Borie F, Daures JP, Millat B, Tretarre B. Cost and effectiveness of follow-up examinations in patients with colorectal cancer resected for cure in a French population-based study. J Gastrointest Surg 2004b;8[5]:552-8.
 
373 - Borne HW van den (1985)
Borne HW van den, Pruyn JFA. Lotgenotencontact bij kankerpatiënten. Assen: Van Gorcum, 1985.
 
374 - Borschitz T (2006)
Borschitz T, Heintz A, Junginger T. The influence of histopathologic criteria on the long-term prognosis of locally excised pT1 rectal carcinomas: results of local excision (transanal endoscopic microsurgery) and immediate reoperation. Dis Colon Rectum. 2006 Oct;49(10):1492-506; discussion 1500-5
 
375 - Bosker RJ (2005)
Bosker RJ, Eddes EH, Ter Borg F, Ledeboer M, Jaspers MM, Eeftinck Schattenkerk M. The use of a self-expanding stent as palliation or before elective surgery in patients with obstructive colorectal carcinoma. Ned Tijdschr Geneeskd. 2005;149:21-1163.
 
376 - Bosset JF (2004)
Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, et al; EORTC Radiotherapy Group. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004;40:219-24.
 
377 - Bosset JF (2005)
Bosset JF, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921. J Clin Oncol 2005; 23:5620-7.
 
378 - Bosset JF (2006)
Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al; EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006; 355:1114-23.
 
379 - Boulis-Wassif S (1984)
Boulis-Wassif S, Gerard A, Loygue J, Camelot D, Buyse M, Duez N. Final results of a randomized trial on the treatment of rectal cancer with preoperative radiotherapy alone or in combination with 5-fluorouracil, followed by radical surgery. Trial of the European Organization on Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. Cancer 1984; 53: 1811-8.
 
380 - Bouzourene H (2003)
Bouzourene H, Bosman FT, Matter M, Coucke P. Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy. Hum Pathol 2003;34:541-8.
 
381 - Bouzourene H (2002)
Bouzourene H, Bosman FT, Seelentag W, Matter M, Coucke P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer 2002;94:1121-30.
 
382 - Bowles CJA (2004)
Bowles CJA, Leicester R, Romaya C, Swarbrick E, Williamns CB, Epstein O. A prospective study of colonoscopy practice in the UK today: are we adequately prepared for national colorectal cancer screening tomorrow? Gut. 2004;53:277-83.
 
383 - Box B (2005)
Box B, Lindsey I, Wheeler JM, Warren BF, Cunningham C, George BD, et al. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients. Dis Colon Rectum 2005;48:1153-60.
 
384 - Boykin KN (1999)
Boykin KN, Zibari GB, Lilien DL, et al. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg 1999;65:1183-5.
 
385 - Bozzetti F (1997)
Bozzetti F, Mariani L, Miceli R, Montalto F, Baratti D, Andreola S. Impact of distal clearance margin on oncologic outcome after restorative resection of the rectum. Tumori 1997;83:907-11.
 
386 - Brancatisano R (1998)
Brancatisano R, Isla A, Habib N. Is radical hepatic surgery safe? Am J Surg 1998;175:161-3.
 
387 - Brand MI (2000)
Brand MI, Saclarides TJ, Dobson HD, Millikan KW. Liver resection for colorectal cancer: liver metastases in the aged. Am Surg 2000; 66:412-5.
 
388 - Branston LK (2002)
Branston LK, Greening S, Newcombe RG, Daoud R, Abraham JM, Wood F, et al. The implementation of guidelines and computerised forms improves the completeness of cancer pathology reporting. The CROPS project: a randomised controlled trial in pathology. Eur J Cancer 2002;38:764-72.
 
389 - Breukink SO (2005)
Breukink SO, Grond AJ, Pierie JP, Hoff C, Wiggers T, Meijerink WJ. Laparoscopic vs open total mesorectal excision for rectal cancer: an evaluation of the mesorectum's macroscopic quality. Surg Endosc 2005;19:307-10.
 
390 - Breukink SO (2006)
Breukink SO, Pierie JP, Wiggers T. Laparoscopic versus open total mesorectal excision for rectal cancer; a systematic review. Thesis. Cochrane Database Syst Rev. 2006 Oct 18;(4):CD005200.
 
391 - Brienza S (1999)
Brienza S, Bensmaine M, Soulie P, Louvet C, Gamelin E, François E, et al. Oxaliplatin added to 5-fluorouracil-based therapy (5-FU+/- FA) in the treatment of 5-FU pretreated patients with advanced colorectal carcinoma: results from the European compassionate-use program. Ann Oncol 1999;10:1311-6.
 
392 - Brown G (2003)
Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003 May; 227(2):371-7
 
393 - Bruinvels DJ (1994)
Bruinvels DJ, Stiggelbout AM, Kievit J, van Houwelingen HC, Habbema JD, van de Velde CJ. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg 1994;219:174-82.
 
394 - Brush J (2011)
Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, et al. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: A systematic review and economic evaluation. Health Technol Assess 2011;15(35):i-142.
 
395 - Buie WD (2005)
Buie WD, Attard JA. Follow-up recommendations for colon cancer. Clin Colon Rectal Surg 2005;18:3;232-43.
 
396 - Bujko K (2010)
Bujko K, Glynne-Jones R, Bujko M. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials. Ann Oncol 2010;21:1743-50.
 
397 - Bujko K (2006)
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006;93:1215-23.
 
398 - Bujko K (2004)
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudelko M, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004;72:15-24.
 
399 - Bujko K (2012)
Bujko K, Rutkowski A, Chang GJ, Michalski W, Chmielik E, Kusnierz J. Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol 2012 Mar;19(3):801-8. doi: 10.1245/s10434-011-2035-2. Epub 2011 Aug 31.
 
400 - Bujko K (2012)
Bujko K, Rutkowski A, Chang GJ, Michalski W, Chmielik E, Kusnierz J. Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol. 2012 Mar;19(3):801-8.
 
401 - Bull AD (1997)
Bull AD, Biffin AH, Mella J, Radcliffe AG, Stamatakis JD, Steele RJ, et al. Colorectal cancer pathology reporting: a regional audit. J Clin Pathol 1997;50:138-42.
 
402 - Bullard KM (2005)
Bullard KM, Trudel JL, Baxter NN, Rothenberger DA. Primary perineal wound closure after preoperative radiotherapy and abdominoperineal resection has a high incidence of wound failure. Dis Colon Rectum. 2005 Mar;48(3):438-43.
 
403 - Burton TP (2013)
Burton TP, Mittal A, Soop M. Nonsteroidal anti-inflammatory drugs and anastomotic dehiscence in bowel surgery: systematic review and meta-analysis of randomized, controlled trials. Dis Colon Rectum. 2013 Jan;56(1):126-34. doi: 10.1097/DCR.0b013e31825fe927.
 
404 - Butte JM (2012)
Butte JM, Tang P, Gonen M, Shia J, Schattner M, Nash GM, et al. Rate of residual disease after complete endoscopic resection of malignant colonic polyp.[Erratum appears in Dis Colon Rectum. 2012 Apr;55(4):498 Note: Nash, Garret M [corrected to Nash, Garrett M]]. Dis Colon Rectum. [Journal Article]. 2012 Feb
 
405 - Buyse M (2000)
Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P. Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Lancet 2000; 356:373-8.
 
406 - Cady B (1998)
Cady B, Jenkins RL, Steele GD Jr, Lewis WD, Stone MD, McDermott WV, et al. Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg 1998;227:566-71.
 
407 - Cafiero F (2003)
Cafiero F, Gipponi M, Lionetto R. Randomised clinical trial of adjuvant postoperative RT vs. sequential postoperative RT plus 5-FU and levamisole in patients with stage II-III resectable rectal cancer: a final report. J Surg Oncol 2003; 83:140-6.
 
408 - Cafiero F (2000)
Cafiero F, Gipponi M, Peressini A, Bertoglio S, Lionetto R. Preliminary analysis of a randomized clinical trial of adjuvant postoperative RT vs. postoperative RT plus 5-FU and levamisol in patients with TNM stage II-III respectable rectal cancer. J Surg Oncol 2000;75:80-8.
 
409 - Cairns SR (2002)
Cairns SR, Scholefield JH, Steele RJ, Dunlop MG, Thomas HJ, Evans GD, et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut. 2010 May;59(5):666-89.
 
410 - Callender GG (2010)
Callender GG, Das P, Rodriguez-Bigas MA, Skibber JM, Crane CH, Krishnan S, et al. Local excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer. Ann Surg Oncol. 2010;17(2):441-7.
 
411 - Camilleri-Brennan J (2001)
Camilleri-Brennan J, Steele RJ.. Prospective analyses of quality of life and survival following mesorectal excision for rectal cancer. Br J Surg. 2001 Dec;88(12):1617-22.
 
412 - Camma C (2000)
Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: A meta-analysis. JAMA 2000;284:1008-15.
 
413 - Caplin S (1998)
Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer 1998;83:666-72.
 
414 - Carlsen E (1998)
Carlsen E, Schlichting E, Guldvog I, et al. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998;85:526-9.
 
415 - Carmichael J (2002)
Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, et al. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2002;20:3617-27.
 
416 - Carter R (1996)
Carter R, Hemingway D, Cooke TG, Pickard R, Poon FW, McKillop JA, et al. A prospective study of six methods for detection of hepatic colorectal metastases. Ann R Coll Surg Engl 1996;78:27-30.
 
417 - Cassileth BR (1980)
Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and participation preferences among cancer patients. Ann Intern Med 1980;92:832-6.
 
418 - Castells A (1998)
Castells A, Bessa X, Daniels M, Ascaso C, Lacy AM, García-Valdecasas JC,et al. Value of postoperative surveillance after radical surgery for colorectal cancer: results of a cohort study. Dis Colon Rectum 1998;41:714-23.
 
419 - Chan AK (2005)
Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:665-77.
 
420 - Chan K (2012)
Chan K, Welch S, Walker-Dilks C, Raifu A, Ontario provincial Gastrointestinal Disease Site Group. Evidence-based guideline recommendations on the use of positron emission tomography imaging in colorectal cancer. Clin Oncol (R Coll Radiol) 2012 May;24(4):232-49.
 
421 - Chang AE (1987)
Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomised trial of regional versus continuous 5-fluorodeoxuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-93.
 
422 - Chang DT (2011)
Chang DT, Swaminath A, Kozak M, Weintraub J, Koong AC, Kim J, et al. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis. Cancer 2011 Sep 1;117(17):4060-9.
 
423 - Chaparro M (2009)
Chaparro M, Gisbert JP, Del Campo L, Cantero J, Maté J. Accuracy of computed tomographic colonography for the detection of polyps and colorectal tumors: a systematic review and meta-analysis. Digestion. 2009;80(1):1-17. doi: 10.1159/000215387. Epub 2009 May 4.
 
424 - Charles C (1999)
Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med 1999;49:651-61.
 
425 - Cheeseman SL (2002)
Cheeseman SL, Joel SP, Chester JD, Wilson G, Dent JT, Richards FJ, et al. A 'modified de Gramont' regimen of fluorouracil, alone and with oxaliplatin, for advanced colorectal cancer. Br J Cancer. 2002 Aug 12;87(4):393-9.
 
426 - Chen YY (2013)
Chen YY, Liu ZH, Zhu K, Shi PD, Yin L. Transanal Endoscopic Microsurgery versus Laparoscopic Lower Anterior Resection for the Treatment of T1-2 Rectal Cancers. Hepatogastroenterology. 2013 Jun;60(124):727-32.
 
427 - Cheung HY (2009)
Cheung HY, Chung CC, Tsang WW, Wong JC, Yau KK, Li MK. Endolaparoscopic approach vs conventional open surgery in the treatment of obstructing left-sided colon cancer: a randomized controlled trial. Arch Surg. 2009 Dec;144(12):1127-32. doi: 10.1001/archsurg.2009.216.
 
428 - Chibaudel B (2009)
Chibaudel B, Maindrault-Goebel F, Lledo G, Mineur L, André T, Bennamoun M, et al. Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study. J Clin Oncol 2009;27:5727-33.
 
429 - Cho YB (2007)
Cho YB, Lee WY, Yun HR, Lee WS, Yun SH, Chun HK. Tumor localization for laparoscopic colorectal surgery. World J Surg. 2007 Jul;31(7):1491-5. Epub 2007 May 30.
 
430 - Chong A (2002)
Chong A, Shah JN, Levine MS, Rubesin SE, Laufer I, Ginsberg GG et al. Diagnostic yield of barium enema examination after incomplete colonoscopy. Radiology 2002; 223(3):620-4.
 
431 - Christoforidis D (2009)
Christoforidis D, Cho HM, Dixon MR, Mellgren AF, Madoff RD, Finne CO. Transanal endoscopic microsurgery versus conventional transanal excision for patients with early rectal cancer. Ann Surg. 2009 May;249(5):776-82. doi: 10.1097/SLA.0b013e3181a3e54b.
 
432 - Christophi C (2004)
Christophi C, Nikfarjam M, Malcontenti-Wilson C, Muralidharan V. Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy. World J Surg 2004; 28:987-94.
 
433 - Chua SC (2007)
Chua SC, Groves AM, Kayani I, Menezes L, Gacinovic S, Du Y, Bomanji JB, Ell PJ. The impact of 18F-FDG PET/CT in patients with liver metastases. Eur J Nucl Med Mol Imaging. 2007 Dec;34(12):1906-14. Epub 2007 Aug 23.
 
434 - Chun YS (2009)
Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M, et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009 Dec 2;302(21):2338-44. doi: 10.1001/jama.2009.1755.
 
435 - Cianchi F (2002)
Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002;26:384-9.
 
436 - Cirocchi R (2012)
Cirocchi R, Trastulli S, Boselli C, Montedori A, Cavaliere D, Parisi A, et al. Radiofrequency ablation in the treatment of liver metastases from colorectal cancer. Cochrane Database Syst Rev. 2012 Jun 13;6:CD006317.
 
437 - Civalleri D (1994)
Civalleri D, Pector J, Hakansson L, Arnaud JP, Duez N, Buyse M. Treatment of patients with unresectable liver metastases from colorectal cancer by chemo-occlusion with degradable microspheres. Br J Surg 1994;81:1338-41.
 
438 - Clavien PA (2002)
Clavien PA, Selzner N, Morse M, Selzner M, Paulson E. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery 2002;131:433-42
 
439 - COST (2004)
Clinical Outcomes of Surgical Therapy Study Group. COST 2004 - A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004;350(20):2050-9.
 
440 - Cocconi G (1998)
Cocconi G, Cunningham D, Van Cutsem E, Francois E, Gustavsson B, Van Hazel G, et al. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group. Journal of Clinical Oncology 1998; 16 2943-52.
 
441 - Coenegrachts K (2009)
Coenegrachts K, De Geeter F, ter Beek L, Walgraeve N, Bipat S, Stoker J,, et al. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol. 2009 Feb;19(2):370-9. doi: 10.1007/s00330-008-1163-y. Epub 2008 Sep 16
 
442 - Collette L (2007)
Collette L, Bosset JF, Den Dulk M, Nguyen F, Mineur L, Maingon P, et al. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: Does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the EORTC Radiation Oncology Group. J Clin Oncol 2007;25:4379-86
 
443 - CCCSGJ (1995)
Colorectal Cancer Chemotherapy Study Group of Japan. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol 1995;25:91-103.
 
444 - CCCG (2001)
Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: a systematic overview of 8,507 patients from 22 randomised trials. Lancet. 2001 Oct 20;358(9290):1291-304.
 
445 - CCCG (2000)
Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. BMJ 2000;321(7260):531-5.
 
446 - Comella P (2004)
Comella P, Massidda B, Farris A. Oxaliplatin vs irinotecan plus leucovorin/bolus as first-line treatment of advanced colorectal carcinoma. 2004; European Medical Oncology Annual Meeting, 2004; conference presentation.
 
447 - Compton CC (1999)
Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:979-94.
 
448 - Compton CC (2007)
Compton CC. Optimal pathologic staging: defining stage II disease. Clin Cancer Res. 2007 Nov 15;13(22 Pt 2):6862s-70s.
 
449 - Conaghan PJ (2011)
Conaghan PJ, Maxwell-Armstrong CA, Garrioch MV, Hong L, Acheson AG. Leaving a mark: the frequency and accuracy of tattooing prior to laparoscopic colorectal surgery. Colorectal Dis 2011;13: 1184-7.
 
450 - COST (2004)
COST 2004 - Clinical Outcomes of Surgical Therapy Study Group. A comparison of laparoscopically assisted and open colectomy for colon cancer. N Engl J Med 2004;350(20):2050-9.
 
451 - Cotton PB (2003)
Cotton PB, Connor P, McGee D, Jowell P, Nickl N, Schutz S et al. Colonoscopy: practice variation among 69 hospital-based endoscopists. Gastrointest Endosc 2003;57:352-7.
 
452 - Croner RS (2009)
Croner RS, Merkel S, Papadopoulos T, Schellerer V, Hohenberger W, Goehl J. Multivisceral resection for colon carcinoma. Dis Colon Rectum 2009 Aug;52(8):1381-6. doi: 10.1007/DCR.0b013e3181ab580b.
 
453 - Cserni G (2002)
Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol 2002;81:63-9.
 
454 - Cukier M (2012)
Cukier M, Smith AJ, Milot L, Chu W, Chung H, Fenech D et al. Neoadjuvant chemoradiotherapy and multivisceral resection for primary locally advanced adherent colon cancer: a single institution experience. Eur J Surg Oncol. 2012 Aug;38(8):677-82. doi: 10.1016/j.ejso.2012.05.001. Epub 2012 May 24.
 
455 - Cunningham D (1999)
Cunningham D, Glimelius B. A phase III study of irinotecan (CPT-11) versus best supportive care in patients with metastatic colorectal cancer who have failed 5-fluorouracil therapy. V301 Study Group. Seminars in Oncology 1999;26:6-12.
 
456 - Cunningham D (2004)
Cunningham D, Humblet Y, Siena S, Khayat D, Bleiberg H, Santoro A et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. New England Journal of Medicine 2004;351:337-45.
 
457 - Cunningham D (2013)
Cunningham D, Lang I, Marcuello E, Lorusso V, Ocvirk J, Shin DB, et al. Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial. Lancet Oncol 2013;14:1077-85
 
458 - Cunningham D (1998)
Cunningham D, Pyrhonen S, James RD et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352:1413-1418.
 
459 - Cunningham D (1996)
Cunningham D, Zalcberg JR, Rath U, Oliver I, Van Cutsem E, Svensson C et al. Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. ‘Tomudex’ Colorectal Cancer Study Group. Annals of Oncology 1996;7:961-5.
 
460 - Curet MJ (2000)
Curet MJ, Putrakul K, Pitcher DE, Josloff RK, Zucker KA. Laparoscopically assisted colon resection for colon carcinoma: perioperative results and long-term outcome. Surg Endosc 2000;14(11):1062-6.
 
461 - Curley SA (1999)
Curley SA, Izzo F, Delrio P, Ellis LM, Granchi J, Vallone P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999;230:1-8.
 
462 - Curvo-Semedo L (2011)
Curvo-Semedo L, Lambregts DM, Maas M, Thywissen T, Mehsen RT, Lammering G, et al. Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy--conventional MR volumetry versus diffusion-weighted MR imaging. Radiology. 2011 Sep;260(3):734-43. doi: 10.1148/radiol.11102467. Epub 2011 Jun 14.
 
463 - da Luz Moreira A (2010)
da Luz Moreira A, Kiran RP, Kirat HT, Remzi FH, Geisler DP, Church JM, et al. Laparoscopic versus open colectomy for patients with American Society of Anesthesiology (ASA) classifications 3 and 4: the minimally invasive approach is associated with significantly quicker recovery and reduced costs. Surg Endosc. 2010 Jun;24(6):1280-6. doi: 10.1007/s00464-009-0761-3. Epub 2009 Dec 24.
 
464 - Dafnis G (2005)
Dafnis G, Granath F, Pahlman L, Ekbom A, Blomqvist P. Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis 2005;37:113-8.
 
465 - Dahabreh IJ (2011)
Dahabreh IJ, Terasawa T, Castaldi PJ, Trikalinos TA. Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer. Ann Intern Med 2011;154:37-49
 
466 - Dahlberg M (1998)
Dahlberg M, Glimelius B, Graf W, Pahlman L. Preoperative irradiation affects functional results after surgerey for rectal cancer: results from a randomized study. Dis Colon Rectum 1998 May;41(5):543-9.
 
467 - Dalibard F (1994)
Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopahotologic correlations. Cancer. 1994 Jun 1;73(11):2680-6.
 
468 - D'Angelica M (1997)
D'Angelica M, Brennan MF, Fortner JG, Cohen AM, Blumgart LH, Fong Y. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg 1997;185:554-9.
 
469 - Daniels IR (2006)
Daniels IR, Strassburg J, Moran BJ. The need for future surgical low rectal cancer studies. Colorectal Dis 2006; 8 Suppl 3:25-29.
 
470 - Davila RE (2005)
Davila RE, Rajan E, Adler D, Hirota WK, Jacobson BC, Leighton JA, et al. ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. Gastrointest Endosc. 2005 Jan;61(1):1-7.
 
471 - Dawson LA (2000)
Dawson LA, McGinn CJ, Normolle D, Ten Haken RK, Walker S, Ensminger W,et al. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 2000 Jun;18(11):2210-8.
 
472 - de Baere T (1996)
de Baere T, Roche A, Elias D, Lasser P, Lagrange C, Bousson V. Preoperative portal vein embolization for extension of hepatectomy indications. Hepatology 1996;24:1386-91.
 
473 - De Graaf EJ (2009)
De Graaf EJ, Doornebosch PG, Tollenaar RA, Meershoek-Klein Kranenbarg E, de Boer AC, Bekkering FC, et al. Transanal endoscopic microsurgery versus total mesorectal excision of T1 rectal adenocarcinomas with curative intention. Eur J Surg Oncol. 2009 Dec;35(12):1280-5. doi: 10.1016/j.ejso.2009.05.001. Epub 2009 May 31.
 
474 - de Graaf EJR (2002)
de Graaf EJR, Doornebosch PG, Stassen LP, Debets JM, Tetteroo GW, Hop WC. Transanal endoscopic microsurgery for rectal cancer. Eur J Cancer 2002; 38:904-10.
 
475 - De Gramont A (2005)
De Gramont A, Boni C, Navarro M, Tabernero J, Hickish T, Topham C et al. Oxaliplatin/5FU/LV in the adjuvant treatment of stage II and stage III colon cancer: efficacy results with a median follow-up of 4 years. J Clin Oncol. 2005 ASCO Annual Meeting Proceedings. Vol 23, No. 16S, Part I of II (June 1 Supplement), 2005:3501.
 
476 - De Gramont A (2007)
De Gramont A, Buyse M, Abrahantes JC, et al. Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer. J Clin Oncol 2007;25:3224-9.
 
477 - De Gramont A (2000)
De Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. Journal of Clinical Oncology 2000;18:2938-47.
 
478 - De Gramont A (2010)
De Gramont A, Hubbard J, Shi Q, O'Connell MJ, Buyse M, Benedetti J, et al. Association between disease-free survival and overall survival when survival is prolonged after recurrence in patients receiving cytotoxic adjuvant therapy for colon cancer: simulations based on the 20,800 patient ACCENT data set. Clin Oncol. 2010 Jan 20;28(3):460-5. doi: 0.1200/JCO.2009.23.1407. Epub 2009 Dec 14.
 
479 - De Gramont A (2012)
De Gramont A, Van Cutsem E, Schmoll HJ, Tabernero J, Clarke S, Moore MJ, et al. Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial. Lancet Oncol. 2012 Dec;13(12):1225-33. doi: 10.1016/S1470-2045(12)70509-0. Epub 2012 Nov 16.
 
480 - de Miguel M (2010)
de Miguel M, Oteiza F, Ciga MA, Armendáriz P, Marzo J, Ortiz H. Sacral nerve stimulation for the treatment of faecal incontinence following low anterior resection for rectal cancer. Colorectal Dis 2010 13(1): 72-7.
 
481 - De Roock W (2010)
De Roock W, Claes B, Bernasconi D, et al. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy if cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis. Lancet Oncology 2010;11:753-62
 
482 - De Roock W (2010)
De Roock W, Jonker DJ, Di Nicolantonio F, Sartore-Bianchi A, Tu D, Siena S, Lamba S, et al. Association of KRAS p.G13D mutation with outcome in patients with chemotherapy-refractory metastatic colorectal cancer treated with cetuximab. JAMA. 2010 Oct 27;304(16):1812-20. doi: 10.1001/jama.2010.1535.
 
483 - De Sousa E Melo F (2013)
De Sousa E Melo F, Wang X, Jansen M, Fessler E, Trinh A, de Rooij LP, et al. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nat Med. 2013 May;19(5):614-8. doi: 10.1038/nm.3174. Epub 2013 Apr 14.
 
484 - De Vargas Macciucca M (2004)
De Vargas Macciucca M, Manganaro L, Ballesio L, Ricci F Casale A et al. Preoperative locoregional staging of rectal carcinoma: comparison of MR, TRUS and Multislice CT. Personal experience. Radiol Med (Torino) 2004 Apr;107(4):344-55.
 
485 - De Vries MR (1998)
De Vries MR, Rinkes IH, van de Velde CJ, Wiggers T, Tollenaar RA, Kuppen PJ, et al. Isolated hepatic perfusion with tumor necrosis factor alpha and melphalan: experimental studies in pigs and phase I data from humans. Recent Results Cancer Res 1998;147:107-19.
 
486 - De Zwart I (2001)
De Zwart I, Griffioen G, Shaw MP, Lamers CB, de Roos A. Barium enema and endoscopy for the detection of colorectal neoplasia: sensitivity, specificity, complications and its determinants. Clin Radiol 2001;56:401-9.
 
487 - Decadt B (2004)
Decadt B, Siriwardena AK. Radiofrequency ablation of liver tumours: systematic review. Lancet Oncol 2004;5:550-60.
 
488 - Degner LF (1992)
Degner LF, Sloan JA. Decision making during serious illness: what role do patients really want to play? J Clin Epidemiol 1992;45:941-50.
 
489 - Del Frate C (2002)
Del Frate C, Bazzocchi M, Mortele KJ, Zuiani C, Londero V, Como G, et al. Detection of liver metastases: comparison of gadobenate dimeglumine-enhanced and ferumoxides-enhanced MR imaging examinations. Radiology 2002;225:766-72.
 
490 - Delbeke D (1997)
Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK Jr et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med. 1997;38:1196-1201.
 
491 - DeMatteo RP (2000)
DeMatteo RP, Palese C, Jarnagin WR, Sun RL, Blumgart LH, Fong Y. Anatomic segmental hepatic resection is superior to wedge resection as an oncologic operation for colorectal liver metastases. J Gastrointest Surg 2000;4:178-184.
 
492 - den Dulk M (2007)
den Dulk M, Smit M, Peeters KC, Kranenbarg EM, Rutten HJ, Wiggers T, Putter H, van de Velde CJ; Dutch Colorectal Cancer Group. A multivariate analysis of limiting factors for stoma reversal in patients with rectal cancer entered into the total mesorectal excision (TME) trial: a retrospective study. Lancet Oncol. 2007 Apr;8(4):297-303. 
 
493 - den Dulk M (2007)
den Dulk M, van de Velde CJ. Considerations and restrictions for non-operative treatment of rectal cancer in selected patients. Lancet Oncol. 2007 Jul;8(7):570-1.
 
494 - Denis B (2004)
Denis B, Weiss AM, Peter A, Bottlaender J, Chiappa P. Quality assurance and gastrointestinal endoscopy: an audit of 500 colonoscopic procedures. Gastroenterol Clin Biol 2004;28:1245-55.
 
495 - Des Guetz G (2010)
Des Guetz G, Nicolas P, Perret GY, Morere JF, Uzzan B. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer. 2010 Apr;46(6):1049-55.
 
496 - Des Guetz G (2009)
Des Guetz G, Schischmanoff O, Nicolas P, Perret GY, Morere JF, Uzzan B. Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis. Eur J Cancer. 2009 Jul;45(10):1890-6.
 
497 - Des Guetz G (2010)
Des Guetz G, Uzzan B, Morere JF, Perret G, Nicolas P. Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007046. doi: 10.1002/14651858.CD007046.pub2.
 
498 - De-Salvo GL (2004)
De-Salvo GL, Gava C, Pucciarelli S, Lise M. Curative surgery for obstruction from primary left colorectal carcinoma: primary or staged resection? Cochrane Database Syst Rev 2004 [2], CD002101
 
499 - Desnoo L (2006)
Desnoo L, Faithfull S. A qualitative study of anterior resection syndrome: the experiences of cancer survivors who have undergone resection surgery. Eur J Cancer Care (Engl). 2006 Jul;15(3):244-51.
 
500 - Detmar SB (2000)
Detmar SB, Aaronson NK, Wever LD, Muller M, Schornagel JH. How are you feeling? Who wants to know? Patients\' and oncologists\' preferences for discussing health-related quality-of-life issues. J Clin Oncol 2000;18:3295-301.
 
501 - Detmar SB (2002)
Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK. Health-Related Quality of Life Assessments and Patient-Physician Communication. A Randomized controlled Trial. JAMA. 2002 Dec 18;288(23):3027-34.
 
502 - Dewas S (2012)
Dewas S, Bibault JE, Mirabel X, Fumagalli I, Kramar A, Jarraya H, et al. Prognostic factors affecting local control of hepatic tumors treated by Stereotactic Body Radiation Therapy. Radiat Oncol 2012;7:166.
 
503 - Di Gregorio C (2012)
Di Gregorio C, Bonetti LR, de Gaetani C, Pedroni M, Kaleci S, Ponz de Leon M. Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature. Intern Emerg Med. 2012 Mar 27.
 
504 - Díaz-Rubio E (2012)
Díaz-Rubio E, Gómez-Espańa A, Massutí B, et al. First-line XELOX plus bevacizumab followed by XELOX plus bevacizumab or single-agent bevacizumab as maintenance therapy in patients with metastatic colorectal cancer: the phase III MACRO TTD study. Oncologist 2012;17:15-25
 
505 - Dick EA (2003)
Dick EA, Joarder R, de Jode M, Taylor-Robinson SD, Thomas HC, Foster GR, et al. MR-guided laser thermal ablation of primary and secondary liver tumours. Clin Radiol 2003; 58:112-20.
 
506 - Dick EA (2002)
Dick EA, Taylor-Robinson SD, Thomas HC, Gedroyc WM. Ablative therapy for liver tumours. Gut 2002;50:733-9.
 
507 - Diez M (2003)
Diez M, Ramos P, Medrano MJ, Muguerza JM, Villeta R, Lozano O, et al. Preoperatively irradiated rectal carcinoma: Analysis of the histopathologic response and predictive value of proliferating cell nuclear antigen immunostaining. Oncology 2003;64:213-9.
 
508 - Dinkel E (1990)
Dinkel E, Mundinger A, Schopp D, Grosser G, Hauenstein KH. Diagnostic imaging in metastatic lung disease. Lung 1990;168 Suppl:1129-36.
 
509 - Dixon AR (1991)
Dixon AR, Maxwell WA, Thornton Holmes J. Carcinoma of the rectum: a 10 year experience. Br J Surg 1991;78:308-11.
 
510 - Dixon E (2005)
Dixon E, Vollmer CM, Jr., Bathe OF, Sutherland F. Vascular occlusion to decrease blood loss during hepatic resection. Am J Surg 2005;190:75-86.
 
511 - Donckier V (2003)
Donckier V, Van Laethem JL, Goldman S, Van Gansbeke D, Feron P, Ickx B, Wikler D, Gelin M. F-18 fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol. 2003 Dec;84(4):215-23. [link]
 
512 - Douillard J (2000)
Douillard J, Cunningham D, Roth A, Navarro M, James RD, Karasek P, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first line treatment for colorectal cancer: a multicenter randomised trial. Lancet 2000;355:1041-7.
 
513 - Douillard JY (2000)
Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 2000;355:1041-7.
 
514 - Douillard JY (2002)
Douillard JY, Hoff PM, Skillings JR, Eisenberg P, Davidson N, Harper P, et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.J Clin Oncol 2002;20:3605-16.
 
515 - Douillard JY (2013)
Douillard JY, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, et al. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer NEJM 2013;369:1023-34
 
516 - Douillard JY (2010)
Douillard JY, Siena S, Cassidy J, Tabernero J, Burkes R, Barugel M, Humblet Y, et al. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study. J Clin Oncol. 2010 Nov 1;28(31):4697-705. doi: 10.1200/JCO.2009.27.4860. Epub 2010 Oct 4.
 
517 - Dresen RC (2009)
Dresen RC, Beets GL, Rutten HJ, Engelen SM, Lahaye MJ, Vliegen RF, de Bruďne AP et al . Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 2009 : 252: 71-80
 
518 - Dube S (1997)
Dube S, Heyen F, Jenicek M. Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis. Dis Colon Rectum. 1997;40(1):35-41.
 
519 - Ducreux M (2013)
Ducreux M, Adenis A, Pignon JP et al. Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: Final results from a randomised phase ii study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study). Eur J Cancer 2013;Jan 24 Epub ahead of print
 
520 - Duek SD (2008)
Duek SD, Issa N, Hershko DD, Krausz MM. Outcome of transanal endoscopic microsurgery and adjuvant radiotherapy in patients with T2 rectal cancer. Dis Colon Rectum, 2008 51(4): 379-84; discussion 384.
 
521 - Duncan JR (1999)
Duncan JR, Hicks ME, Cai SR, Brunt EM, Ponder KP. Embolization of portal vein branches induces hepatocyte replication in swine: a potential step in hepatic gene therapy.Radiology 1999;210:467-477.
 
522 - Elias D (1998)
Elias D, Cavalcanti A, Sabourin JC, Lassau N, Pignon JP, Ducreux M, et al. Resection of liver metastases from colorectal cancer: the real impact of the surgical margin. Eur J Surg Oncol 1998;24:174-9.
 
523 - Elias D (1998)
Elias D, Cavalcanti A, Sabourin JC, Pignon JP, Ducreux M, Lasser P. Results of 136 curative hepatectomies with a safety margin of less than 10 mm for colorectal metastases. J Surg Oncol 1998; 69:88-93.
 
524 - Elias D (1999)
Elias D, de Baere T, Roche A, Mducreux, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86:784-8.
 
525 - Elias D (2003)
Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003;90:567-74.
 
526 - Emami B (1991)
Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991 May 15;21(1):109-22.
 
527 - Endreseth BH (2005)
Endreseth BH, Myrvold HE, Romundstad P, Hestvik UE, Bjerkeset T, Wibe A, et al. Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum 2005; 48:1380-8.
 
528 - Erce C (2003)
Erce C, Parks RW. Interstitial ablative techniques for hepatic tumours. Br J Surg 2003; 90:272-289.
 
529 - EBRO (2005)
Evidence-based Richtlijnontwikkeling Handleiding voor werkgroepleden, Kwaliteitsinstituut voor de Gezondheidszorg CBO, april 2005.
 
530 - Facey F (2007)
Facey F, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess 2007;11(44):iii-85.
 
531 - Falcone A (2013)
Falcone A, Cremolini C, Masi G, et al. FOLFOXIRI/bevacizumab versus FOLFIRI/bevacizumab as first-line treatment in unresectable metastatic colorectal cancer patients: results of the phase III TRIBE trial by GONO group. Proc ASCO 2013;abstract [link]
 
532 - Falk PM (1994)
Falk PM, Gupta NC, Thorson AG, Frick MP, Boman BM, Christensen MA, et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994;37(2):153-6.
 
533 - Feingold DL (2004)
Feingold DL, Addona T, Forde KA, Arnell TD, Carter JJ, Huang EH et al. Safety and reliability of tattooing colorectal neoplasms prior to laparoscopic resection. J Gastrointest Surg. 2004;8(5):543-6.
 
534 - Figer A (2007)
Figer A, Perez-Staub N, Carola E, Tournigand C, Lledo G, Flesch M, et al. FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study. Cancer 2007;110:2666-71.
 
535 - Figueras J (2001)
Figueras J, Valls C, Rafecas A, Fabregat J, Ramos E, Jaurrieta E. Resection rate and effect of postoperative chemotherapy on survival after surgery for colorectal liver metastases. Br J Surg 2001; 88:980-5.
 
536 - Figueredo A (2004)
Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group. J Clin Oncol. 2004 Aug 15;22(16):3395-407.
 
537 - Figueredo A (2008)
Figueredo A, Coombes ME, Mukherjee S. Adjuvant therapy for completely resected stage II colon cancer. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD005390.
 
538 - Figueredo A (2000)
Figueredo A, Fine S, Maroun J, Walker-Dilks C, Wong S, and members of the Gastrointestinal Cancer Disease Site Group. Adjuvant Therapy for Stage III Colon Cancer Following Complete Resection. Practice Guideline Report 2-2. December 2000 Cancer Care Ontario Program. [link]
 
539 - Figueredo A (2000)
Figueredo A, Germond C, Maroun J, Browman G, Walker-Dilks C, Wong S, and members of the Gastrointestinal Disease Site Group. Adjuvant Therapy for Stage II Colon Cancer Following Complete Resection. Practice Guideline Report 2-1. December 2000 Cancer Care Ontario Program. [link]
 
540 - Figueredo A (2003)
Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, et al. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.
 
541 - Figueredo A (2003)
Figueredo A, Zuraw L, Wong RK, Agboola O, Rumble RB, Tandan V. The use of preoperative radiotherapy in the management of patients with clinically resectable rectal cancer: a practice guideline. BMC Med 2003;1:1-14.
 
542 - Filippone A (2004)
Filippone A, Ambrosini R, Fuschi M, Marinelli T, Genovesi D, Bonomo L. Preoperative T and N staging of colorectal cancer : accuracy of contrast enhanced multi-detector row CT colonography – initial experience. Radiology 2004;231:83-90.
 
543 - Fiori E (2004)
Fiori E, Lamazza A, De Cesare A, Bononi M, Volpino P, Schillaci A, Cavallaro A, Cangemi V. Palliative management of malignant rectosigmoidal obstruction. Colostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004 Jan-Feb;24(1):265-8
 
544 - Fisher B (1988)
Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham D, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP Protocol R-01. J Natl Cancer Inst 1988;80:21-9.
 
545 - Fitzgerald-Smith AM (2003)
Fitzgerald-Smith AM, Srivastava P, Hershman MJ. The role of the nurse in colorectal cancer follow up. Hosp Med. 2003 Jun;64(6):344-7.
 
546 - Foley EF (1998)
Foley EF, Kolecki RV, Schirmer BD. The accuracy of laparoscopic ultrasound in the detection of colorectal cancer liver metastases. Am J Surg 1998;176:262-4.
 
547 - Folkesson J (2005)
Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005;23:5644-50.
 
548 - Folprecht G (2004)
Folprecht G, Cunningham D, Ross P, Glimelius B, Di-Costanzo F, Wils J, et al. Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials. Ann.Oncol. 2004;15[9]:1330-8.
 
549 - Folprecht G (2010)
Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, et al. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol. 2010 Jan;11(1):38-47.
 
550 - Fong Y (1994)
Fong Y, Blumgart LH, Cohen A, Fortner J, Brennan MF. Repeat hepatic resections for metastatic colorectal cancer. Ann Surg 1994; 220:657-62.
 
551 - Fong Y (1997)
Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997; 15:938-46.
 
552 - Fong Y (1999)
Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-18.
 
553 - Fountzilas G (1999)
Fountzilas G, Zisiadis A, Dafni U, Konstantaras C, Hatzitheoharis G, Liaros A, et al. Postoperative radiation and concomitant bolus fluorouracil with or without additional chemotherapy with fluorouracil and high-dose leucovorin in patients with high-risk rectal cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 1999;10:671-6.
 
554 - Foxtrot (2012)
Foxtrot Collaborative Group. Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial. Lancet Oncol. 2012 Nov;13(11):1152-60. doi: 10.1016/S1470-2045(12)70348-0. Epub 2012 Sep 25.
 
555 - Fransén K (2004)
Fransén K, Klintenäs M, Osterström A, Dimberg J, Monstein HJ, Söderkvist P. Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. Carcinogenesis 2004;25:527-33.
 
556 - Frigell A (1990)
Frigell A, Ottander M, Stenbeck H, Pahlman L. Quality of life of patients treated with abdominoperineal resection or anterior resection for rectal carcinoma. Ann Chir Gynaecol. 1990;79(1):26-30.
 
557 - Frykholm GJ (1993)
Frykholm GJ, Glimelius B, Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 1993;36:564-72.
 
558 - Fu KI (2001)
Fu KI, Fujii T, Kato S, Sano Y, Koba I, Mera K et al. A new endoscopic tattooing technique for identifying the location of colonic lesions during laparoscopic surgery: a comparison with the conventional technique. Endoscopy. 2001;33(8):687-91.
 
559 - Fuchs CS (2008)
Fuchs CS, Marshall J, Barrueco J. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study. J Clin Oncol. 2008 Feb 1;26(4):689-90.
 
560 - Fuchs CS (2007)
Fuchs CS, Marshall J, Mitchell E, Wierzbicki R, Ganju V, Jeffery M. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study. J Clin Oncol. 2007 Oct 20;25(30):4779-86.
 
561 - Fujita S (2000)
Fujita S, Akasu T, Moriya Y. Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol 2000; 30:7-11.
 
562 - Furuhata T (2003)
Furuhata T, Okita K, Tsuruma T, Hata F, Kimura Y, Katsuramaki T, et al. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas. Dig Surg 2003; 20:321-5.
 
563 - Fusai G (2003)
Fusai G, Davidson BR. Strategies to increase the resectability of liver metastases from colorectal cancer. Dig Surg 2003;20:481-96.
 
564 - Gallo TM (2003)
Gallo TM, Galatola G, Fracchia M, Delazio G, De Bei F, Pera A et al. Computed tomography colonography in routine clinical practice. Eur J Gastroenterol Hepatol. 2003;15:1323-31.
 
565 - Garcea G (2004)
Garcea G, Polemonivi N, O'Leary E, Lloyd TD, Dennison AR, Berry DP. Two-stage liver resection and chemotherapy for bilobar colorectal liver metastases.Eur J Surg Oncol 2004;30:759-764.
 
566 - Garcia-Aguilar J (2000)
Garcia-Aguilar J, Mellgren A, Sirivongs P et al. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg 2000; 231:345-51.
 
567 - Garufi C (2010)
Garufi C, Torsello A, Tumolo S, Ettorre GM, Zeuli M, Campanella C, et al. Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial. Br J Cancer. 2010 Nov 9;103(10):1542-7. doi: 10.1038/sj.bjc.6605940. Epub 2010 Oct 19.
 
568 - Gattellari M (2001)
Gattellari M, Butow PN, Tattersall MH. Sharing decisions in cancer care. Soc Sci Med 2001;52:1865-78.
 
569 - Gavin PG (2012)
Gavin PG, Colangelo LH, Fumagalli D, Tanaka N, Remillard MY, Yothers G, et al. Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value. Clin Cancer Res. 2012 Dec 1;18(23):6531-41.
 
570 - Gavioli M (2005)
Gavioli M, Luppi G, Losi L, Bertolini F, Santantonio M, Falchi AM et all. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum. 2005 Oct;48(10):1851-7.
 
571 - Gayowski TJ (1994)
Gayowski TJ, Iwatsuki S, Madariaga JR, Selby R, Todo S, Irish W, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994 Oct;116(4):703-10; discussion 710-1.
 
572 - Gelber RD (1996)
Gelber RD, Goldhirsch A, Cole BF, Wieand H, Schroeder G, Krook J, et al. A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer. J Natl Cancer Inst 1996;88:1039-45.
 
573 - Gennatas C (2004)
Gennatas C, Darfoudas C, Mouratidou D, Tsavaris N, Pouli A, Androulakis G et al. Surgical adjuvant therapy of rectal carcinoma: a controlled evaluation of leucovorin, 5-fluorouracil and radiation therapy with or without interferon-alpha2b. Ann Oncol 2004;14:378-82.
 
574 - Gérard JP (2012)
Gérard JP, Azria D, Gourgou-Bourgade S, Martel-Lafay I, Hennequin C, Etienne PL, et al. Clinical outcome of the ACCORD 12/0405 PRODIGE 2 randomized trial in rectal cancer. Clin Oncol. 2012 Dec 20;30(36):4558-65. doi: 10.1200/JCO.2012.42.8771. Epub 2012 Oct 29.
 
575 - Gérard JP (2010)
Gérard JP, Azria D, Gourgou-Bourgade S, Martel-Laffay I, Hennequin C, Etienne PL, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol. 2010 Apr 1;28(10):1638-44. doi: 10.1200/JCO.2009.25.8376. Epub 2010 Mar 1.
 
576 - Gérard JP (2006)
Gérard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 2006;24:4620-5.
 
577 - Germond et al (2001)
Germond et al. Postoperative adjuvant radiotherapy and / or chemotherapy for resected stage II or III rectal cancer. Cancer Care Ontario program. 2001.
 
578 - Gezondheidsraad (2007)
Gezondheidsraad. (2007). Nacontrole in de oncologie: Doelen onderscheiden, inhoud onderbouwen. Den Haag: Gezondheidsraad publicatienummer 2007/10.
 
579 - Gezondheidsraad (2009)
Gezondheidsraad. Bevolkingsonderzoek naar darmkanker. Den Haag: Gezondheidsraad, 2009; publicatienr. 2009/13)
 
580 - Gezondheidsraad (2011)
Gezondheidsraad. Opsporing van darmkanker in de praktijk, 2011.
 
581 - Giacchetti S (1999)
Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10:663-9.
 
582 - Giacchetti S (2000)
Giacchetti S, Perpoint B, Zidani R, Le Bail N, Faggiuolo R, Focan C, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. Journal of Clinical Oncology 2000; 18 136-47.
 
583 - Giantonio BJ (2007)
Giantonio BJ, Catalano PJ, Meropol NJ, O'Dwyer PJ, Mitchell EP, Alberts SR, et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol. 2007 Apr 20;25(12):1539-44.
 
584 - Gill S (2004)
Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004 May 15;22(10):1797-806.
 
585 - Gillams AR (2004)
Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004;14:2261-7.
 
586 - Gillams AR (2000)
Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum 2000;43:656-61.
 
587 - Gillespie L (1985)
Gillespie L, Barbaric Z, Raz S. Effect of abdominal perineal resection on genitourinary tract. Urology. 1985 Mar;25(3):259-63.
 
588 - Gillissen F (2013)
Gillissen F, Hoff C, Maessen JM, Winkens B, Teeuwen JH, von Meyenfeldt MF, Dejong CH. Structured synchronous implementation of an enhanced recovery program in elective colonic surgery in 33 hospitals in the Netherlands. World J Surg. 2013 May;37(5):1082-93. doi: 10.1007/s00268-013-1938-4.
 
589 - Giorgio A (1998)
Giorgio A, Tarantino L, Mariniello N, De Stefano G, Perrotta A, Aloisio V, et al. Ultrasonography-guided percutaneous ethanol injection in large an/or multiple liver metastases. Radiol Med 1998;96:238-42.
 
590 - Giovanni M (1994)
Giovanni M, Seitz JF. Ultrasound-Guided percutaneous alcohol injection of small liver metastases. Results in 40 patients. Cancer 1994;73: 294-7.
 
591 - Glavassevich M (1995)
Glavassevich M, McKibon A, Thomas S. Information needs of patients who undergo surgery for head and neck cancer. Can Oncol Nurs J 1995;5:9-11.
 
592 - Gleisner AL (2008)
Gleisner AL, Choti MA, Assumpcao L, Nathan H, Schulick RD, Pawlik TM. Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation. Arch Surg. 2008 Dec;143(12):1204-12.
 
593 - Glimelius B (2003)
Glimelius B, Gronberg H, Jarhult J, Wallgren A, Cavallin-Stahl E. A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol. 2003;42:476-92.
 
594 - Glynne-Jones R (2012)
Glynne-Jones R, Hughes R. Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg. 2012 Jul;99(7):897-909. doi: 10.1002/bjs.8732. Epub 2012 Apr 27.
 
595 - Goldberg J (1990)
Goldberg J, Kerr D,Wilmott N, McKillop JH, McArdle CS. Regional chemotherapy for colorectal livermetastases: a phase II evaluation of targeted hepatic arterial 5FU for colorectal liver metastases. Br J Surg 1990;77:1238-40.
 
596 - Goldberg RM (2004)
Goldberg RM, Sargent DJ, Morton RF, Fuchs CS, Ramanathan RK, Williamson SK et al. A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2004;22:23-30.
 
597 - Goldstein NS (1996)
Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1996;106:209-16.
 
598 - Goldstein NS (2000)
Goldstein NS, Turner JR. Pericolonic tumor deposits in patients with T3N+MO colon adenocarcinomas: markers of reduced disease free survival and intra-abdominal metastases and their implications for TNM classification. Cancer 2000;88:2228-38.
 
599 - Goletti O (1998)
Goletti O, Celona G, Galatioto C, Viaggi B, Lippolis PV, Pieri L, et al. Is laparoscopic sonography a reliable and sensitive procedure for staging colorectal cancer? A comparative study. Surg Endosc. 1998 Oct;12(10):1236-41.
 
600 - Goodman KA (2010)
Goodman KA, Wiegner EA, Maturen KE, Zhang Z, Mo Q, Yang G et al. Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 2010 Oct 1;78(2):486-93.
 
601 - Guillou PJ (2005)
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, Heath RM, Brown JM; MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005 May 14-20;365(9472):1718-26
 
602 - Govindarajan A (2006)
Govindarajan A, Coburn NG, Kiss A, Rabeneck L, Smiths AJ, Law CH. Population-based assessment of the surgical management of locally advanced colorectal cancer. J Natl Cancer Inst. 2006;98:1474-81.
 
603 - Govindarajan A (2008)
Govindarajan A, Fraser N, Cranford V, Wirtzfeld D, Gallinger S, Law CH et al. Predictors of multivisceral resection in patients with locally advanced colorectal cancer. Ann Surg Oncol. 2008 Jul;15(7):1923-30. doi: 10.1245/s10434-008-9930-1. Epub 2008 May 13.
 
604 - Graham RA (1990)
Graham RA, Garnsey L, Jessup JM. Local excision of rectal carcinoma. Am J Surg 1990; 160:306-12.
 
605 - Graupe F (1996)
Graupe F, Schwenk W, Bracht B, Kroner-Herwig B, Stock W. Die psychische Belastung von Patienten in der Tumornachsorge nach R0-Resektion colorectaler Carcinome. [Psychological stress on patients in tumor after-care after R0 resection of colorectal carcinomas]. Chirurg 1996:67(6):604-9.
 
606 - Gray B (2001)
Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, et al. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol. 2001 Dec;12(12):1711-20.
 
607 - Greenberg JA (2008)
Greenberg JA, Shibata D, Herndon JE 2nd, Steele GD Jr, Mayer R, Bleday R. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984. Dis Colon Rectum, 2008 51(8):1185-91; discussion 1191-4.
 
608 - Grossmann EM (2004)
Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol 2004; 13[2-3], 119-24.
 
609 - Grothey A (2002)
Grothey A, Deschler B, Kroening H. Phase III study of bolus 5-fluorouracil (5-FU)/ folinic acid (FA) (Mayo) vs weekly high-dose 24h 5-FU infusion/FA + oxaliplatin (OXA) (FUFOX) in advanced colorectal cancer (ACRC). Proc Am Soc Clin Oncol 2002; Abstract: 512.
 
610 - Grothey A (2004)
Grothey A, Sargent D, Goldberg RM, Schmoll HJ. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment. J Clin Oncol. 2004;22(7):1209-14.
 
611 - Grothey A (2005)
Grothey A, Sargent D. Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first line. J Clin Oncol. 2005 Dec 20;23(36):9441-2.
 
612 - Grothey A (2013)
Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, et al. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial. Lancet. 2013 Jan 26;381(9863):303-12. doi: 10.1016/S0140-6736(12)61900-X. Epub 2012 Nov 22.
 
613 - Gruenberger B (2008)
Gruenberger B, Tamandl D, Schueller J, Scheithauer W, Zielinski C, Herbst F, Gruenberger T. Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer. J Clin Oncol. 2008 Apr 10;26(11):1830-5. doi: 10.1200/JCO.2007.13.7679.
 
614 - Gruenberger T (2012)
Gruenberger T, Arnold D, Rubbia-Brandt L. Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival. Surg Oncol. 2012 Dec;21(4):309-15. doi: 10.1016/j.suronc.2012.07.003. Epub 2012 Aug 9
 
615 - Guerrieri M (2008)
Guerrieri M, Baldarelli M, Organetti L, Grillo Ruggeri F, Mantello G, Bartolacci S, et al. Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience. Surg Endosc. 2008;22(9):2030-5.
 
616 - Guillem JG (2005)
Guillem JG, Chessin DB, Shia J, Moore HG, Mazumdar M, Bernard B et al. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J Clin Oncol. 2005 May 20;23(15):3475-9
 
617 - Guillem JG (2003)
Guillem JG, Moore HG, Paty PB, Cohen AM, Wong WD. Adequacy of distal resection margin following preoperative combined modality therapy for rectal cancer. Ann Surg Oncol 2003;10:824.
 
618 - Guillou PJ (2005)
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne D, Smith AM et al. Classic 2005. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365:1718-26.
 
619 - Gumus M (2005)
Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F et al. What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori 2005;91:168-72.
 
620 - Gunderson LL (2010)
Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2010 Jan 10;28(2):264-71. doi: 10.1200/JCO.2009.24.0952. Epub 2009 Nov 30.
 
621 - Gunderson LL (1997)
Gunderson LL, Nelson H, Martenson JA, Cha S, Haddock M, Devine R et al. Locally advanced primary colorectal cancer: intraoperative electron and external beam irradiation ± 5-FU. Int J radiation oncology boil Phys 1997;37:601-614.
 
622 - Gupta AK (2005)
Gupta AK, Melton LJ, 3rd, Petersen GM, Timmons LJ, Vege SS, Harmsen WS, et al. Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: a population-based study. Clin Gastroenterol Hepatol. 2005 Feb;3(2):150-8
 
623 - Gupta AK (2008)
Gupta AK, Brenner DE, Turgeon DK. Early detection of colon cancer: new tests on the horizon. Mol Diagn Ther. 2008;12(2):77-85.
 
624 - Guren MG (2005)
Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK et al. Norwegian Rectal Cancer Group. Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol. 2005 Sep;31(7):735-42.
 
625 - Habr-Gama A (2006)
Habr-Gama A, Perez RO, Proscurshim I, Campos FG, Nadalin W, Kiss D, et al. Patterns of failure and survival for nonoperative treatment of stage c0 distal rectal cancer following neoadjuvant chemoradiation therapy. J Gastrointest Surg. 2006 Dec;10(10):1319-28; discussion 1328-9.
 
626 - Hack TF (2005)
Hack TF, Degner LF, Parker PA. The communication goals and needs of cancer patients: a review. Psychooncology 2005;14:831-45.
 
627 - Hack TF (2006)
Hack TF, Degner LF, Watson P, Sinha L. Do patients benefit from participating in medical decision making? Longitudinal follow-up of women with breast cancer. Psychooncology 2006;15:9-19.
 
628 - Hafstrom LR (1994)
Hafstrom LR, Holmberg SB, Naredi PL, Lindner PG, Bengtsson A, Tidebrant G, et al. Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol 1994;3:103-8.
 
629 - Hagenthau P (1995)
Hagenthau P, Wagner HJ, Stinner B, Klose KJ. Die Wertigkeit der Kolondoppelkontrastuntersuchung bei unzureichender koloskopischer Diagnostik. Radiologe 1995;35(5):356-60.
 
630 - Hagmuller E (1998)
Hagmuller E, Hartung G, Sturm J, Diezler P, Queisser W. [Adjuvant radiochemotherapy with 5-FU and folinic acid in Dukes stage B and C rectum carcinoma: an interim analysis]. [German]. Langenbecks Archiv fur Chirurgie - Supplement - Kongressband 1998;115:1397-9.
 
631 - Hagspiel KD (1995)
Hagspiel KD, Neidl KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: comparison of superparamagnetic iron oxide-enhanced and unenhanced MR imaging at 1.5 T with dynamic CT, intraoperative US, and percutaneous US. Radiology 1995;196:471-8.
 
632 - Hahnloser D (2005)
Hahnloser D, Wolff BG, Larson DW, Ping J, Nivatvongs S. Immediate radical resection after local excision of rectal cancer: an oncologic compromise? Dis Colon Rectum. 2005 Mar;48(3):429-37
 
633 - Haider MA (2002)
Haider MA, Amitai MM, Rappaport DC, et al. Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimation better? Radiology 2002;225:137-142.< /A >
 
634 - Hall NR (1998)
Hall NR, Finan PJ, al-Jaberi T, Tsang CS, Brown SR, Dixon MF, et al. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum 1998;41:979-83.
 
635 - Haller DG (2008)
Haller DG, Cassidy J, Clarke SJ, Cunningham D, Van Cutsem E, Hoff PM, et al. Potential regional differences for the tolerability profiles of fluoropyrimidines. J Clin Oncol. 2008 May 1;26(13):2118-23. doi: 10.1200/JCO.2007.15.2090.
 
636 - Haller DG (2005)
Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, et al. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. J Clin Oncol. 2005 Dec 1;23(34):8671-8.
 
637 - Haller DG (2008)
Haller DG, Rothenberg ML, Wong AO, Koralewski PM, Miller WH Jr, Bodoky G, et al. Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma. J Clin Oncol. 2008 Oct 1;26(28):4544-50. doi: 10.1200/JCO.2008.17.1249.
 
638 - Haller DG (2011)
Haller DG, Tabernero J, Maroun J, de Braud F, Price T, Van Cutsem E, Hill M, Gilberg F, Rittweger K, Schmoll HJ. Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer. J Clin Oncol. 2011 Apr 10;29(11):1465-71.
 
639 - Halligan S (2005)
Halligan S, Altman DG, Taylor SA, Mallett S, Deeks JJ, Bartram CI, et al. CT colonography in the detection of colorectal polyps and cancer: systematic review, meta-analysis, and proposed minimum data set for study level reporting. Radiology 2005;237(3):893-904.
 
640 - Halligan S (2007)
Halligan S, Lilford RJ, Wardle J, Morton D, Rogers P, Wooldrage K, et al. Design of a multicentre randomized trial to evaluate CT colonography versus colonoscopy or barium enema for diagnosis of colonic cancer in older symptomatic patients: the SIGGAR study. Trials. 2007 Oct 27;8:32.
 
641 - Halligan S (2013)
Halligan S, Wooldrage K, Dadswell E, et al. Computed tomographic colonography versus barium enema for diagnosis of colorectal cancer or large polyps in symptomatic patients (SIGGAR): a multicentre randomised trial. Lancet. 2013 Feb 13. doi:pii: S0140-6736(12)62124-2
 
642 - Hamaker ME (2012)
Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older patients with cancer. Oncologist 2012;17:1439-49
 
643 - Han JG (2012)
Han JG, Wang ZJ, Wei GH, Gao ZG, Yang Y, Zhao BC. Randomized clinical trial of conventional versus cylindrical abdominoperineal resection for locally advanced lower rectal cancer. Am J Surg 2012 Sep;204(3):274-82
 
644 - Hanna NN (2012)
Hanna NN, Onukwugha E, Choti MA, Davidoff AJ, Zuckerman IH, Hsu VD, et al. Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using surveillance, epidemiology and end results (SEER)-Medicare data. Colorectal Dis. 2012 Jan;14(1):48-55.
 
645 - Harewood GC (2005)
Harewood GC. Relationship of colonoscopy completion rates and endoscopist features. Dig Dis Sci 2005;50:47-51.
 
646 - Hariharan D (2012)
Hariharan D, Constantinides V, Kocher HM, Tekkis PP. The role of laparoscopy and laparoscopic ultrasound in the preoperative staging of patients with resectable colorectal liver metastases: a meta-analysis. Am J Surg. 2012 Jul;204(1):84-92.
 
647 - Harmantas A (1996)
Harmantas A, Rotstein LE, Langer B. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver. Cancer 1996; 78:1639-45.
 
648 - Harris JE (2000)
Harris JE, Ryan L, Hoover HC Jr, Stuart RK, Oken MM, Benson AB 3rd, et al. Adjuvant active specific immunotherapy for stage II and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol. 2000 Jan;18(1):148-57.
 
649 - Harrison JC (1995)
Harrison JC, Dean PJ, el-Zeky F, VanderZwaag R. Impact of the Crohn's-like lymphoid reaction on staging of right-sided colon cancer: results of multivariate analysis. Hum Pathol 1995;26:31-8.
 
650 - Harten WH van (1998)
Harten WH van, Noort O van, Warmerdam R, Hendricks H, Seidel E. Assessment of rehabilitation needs in cancer patients. Int J Rehabil Res 1998;21:247-57.
 
651 - Hartley JE (2000)
Hartley JE, Kumar H, Drew PJ, Heer K, Avery GR, Duthie GS, et al. Laparoscopic ultrasound for the detection of hepatic metastases during laparoscopic colorectal cancer surgery. Dis Colon Rectum 2000;43:320-4.
 
652 - Hartmann D (2005)
Hartmann D, Bassler B, Schilling D, Pfeiffer B, Jakobs R, Eickhoff A, et al. Incomplete conventional colonoscopy: magnetic resonance colonography in the evaluation of the proximal colon. Endoscopy 2005;37(9):816-20.
 
653 - Hasegawa H (2003)
Hasegawa H, Kabeshima Y, Watanabe M, Yamamoto S, Kitajima M. Randomized controlled trial of laparoscopic versus open colectomy for advanced colorectal cancer. Surg Endosc 2003;17(4):636-40.
 
654 - Hassan C (2005)
Hassan C, Zullo A, Risio M, Rossini FP, Morini S. Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Diseases of the colon and rectum. 2005 Aug;48(8):1588-96.
 
655 - Hatfield P (2009)
Hatfield P, Hingorani M, Radhakrishna G, Cooper R, Melcher A, Crellin A, et al. Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol. 2009 Aug;92(2):210-4. doi: 10.1016/j.radonc.2009.04.007. Epub 2009 May 4.
 
656 - Haward RA (2005)
Haward RA, Morris E, Monson JR, Johnston C, Forman D. The long term survival of rectal cancer patients following abdominoperineal and anterior resection: results of a population-based observational study. Eur J Surg Oncol. 2005 Feb;31(1):22-8.
 
657 - Hazard LJ (2009)
Hazard LJ, Shrieve DC, Sklow B, Pappas L, Boucher KM. Local Excision vs. Radical Resection in T1-2 Rectal Carcinoma: Results of a Study From the Surveillance, Epidemiology, and End Results (SEER) Registry Data. Gastrointest Cancer Res. 2009 May;3(3):105-14.
 
658 - Hecht JR (2009)
Hecht JR, Mitchell E, Chidiac T, Scroggin C, Hagenstad C, Spigel D, et al. A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer. J Clin Oncol. 2009 Feb 10;27(5):672-80. doi: 10.1200/JCO.2008.19.8135. Epub 2008 Dec 29.
 
659 - Heijstek (2013)
Heijstek, J. et al. Namens de Projectgroep. Blauwdruk vaste contactpersoon in de oncologische keten. Cancer Center UMCU. Op 27 februari 2013 ontleend aan: http://www.umcutrecht.nl/NR/rdonlyres/CC31753A-8B6E-4E88-AC10-85DFAB9F19D7/32189/UMCUtrechtCancerCenter_brochure_vastecontactpersoo.pdf
 
660 - Heinemann V et al (2013)
Heinemann V et al. Analysis of KRAS/NRAS and BRAF mutations in FIRE-3: a randomized phase III study of FOLFIRI plus cetuximab or bevacizumab as Ffrst-line treatment for wildtype KRAS (exon2) metastatic colorectal cancer patients. Proc ECCO/ESMO/ESTRO European Cancer Congress 2013b;abstract LBA17
 
661 - Heinemann V (2013)
Heinemann V, Fischer von Weikerstahl L, Decker T, et al. Randomized comparison of FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment of KRAS-wildtype metastatic colorectal cancer: German AIO study KRK-0306 (FIRE-3). Proc ASCO 2013a;abstract LBA3506] [link]
 
662 - Heintz A (1998)
Heintz A, Morschel M, Junginger T. Comparison of results after transanal endoscopic microsurgery and radical resection for T1 carcinoma of the rectum. Surg Endosc 1998;12:1145-8.
 
663 - Helgeson VS (1999)
Helgeson VS, Cohen S, Schulz R, Yasko J. Education and peer discussion group interventions and adjustment to breast cancer. Arch Gen Psychiatry 1999;56:340-7.
 
664 - Hemming AW (2003)
Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003;237:686-91.
 
665 - Hemming AW (2002)
Hemming AW, Reed AI, Langham MR, Fujita S, van der Werf WJ, Howard RJ. Hepatic vein reconstruction for resection of hepatic tumors. Ann Surg 2002;235:850-858.
 
666 - Hemming AW (2004)
Hemming AW, Reed AI, Langham MR, Jr, Fujita S, Howard RJ. Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg 2004;239:712-9.
 
667 - Hendlisz A (2010)
Hendlisz A, Van den Eynde M, Peeters M, Maleux G, Lambert B, Vannoote J, et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy. J Clin Oncol. 2010 Aug 10;28(23):3687-94. doi: 10.1200/JCO.2010.28.5643. Epub 2010 Jun 21.
 
668 - Herfarth KK (2001)
Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001 Jan 1;19(1):164-70.
 
669 - Herfarth KK (2005)
Herfarth KK, Debus J. Stereotactic radiation therapy for liver metastases. Chirurg 2005 Jun;76(6):564-9.
 
670 - Hermanek P (2005)
Hermanek P, Junginger T. The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol 2005;9:193-9.
 
671 - Hewitt PM (1998)
Hewitt PM, Ip SM, Kwok SP, Somers SS, Li K, Leung KL et al. Laparoscopic-assisted vs. open surgery for colorectal cancer: comparative study of immune effects. Dis Colon Rectum 1998;41(7):901-9.
 
672 - Hind D (2005)
Hind D, Tappenden P, Tumur I, Eggington S, Sutcliffe P, Ryan A. The use of irinotecan, oxaliplatin and raltirexed for the treatment of avanced colorectal cancer: systematic review and economic valuation (review of guidance no. 33). NHS R&D HTA program, January 2005.
 
673 - Ho Y (1997)
Ho Y, Tan H, Tan M. Biofeedback therapy for bowel dysfunction following low anterior resection. Annals of the Academy of Medicine Singapore 1997 26(3): 299-302.
 
674 - Ho YH (2001)
Ho YH. Postanal sphincter repair for anterior resection anal sphincter injuries: report of three cases. Dis Colon Rectum 2001 44(8): 1218-1220.
 
675 - Ho KS (2012)
Ho KS, Quah HM, Lim JF, Tang CL, Eu KW. Endoscopic stenting and elective surgery versus emergency surgery for left-sided malignant colonic obstruction: a prospective randomized trial. Int J Colorectal Dis. 2012 Mar;27(3):355-62. doi: 10.1007/s00384-011-1331-4. Epub 2011 Oct 28.
 
676 - Hochster HS (2008)
Hochster HS, Hart LL, Ramanathan RK, Childs BH, Hainsworth JD, Cohn AL, et al. Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bevacizumab as first-line treatment of metastatic colorectal cancer: results of the TREE Study. J Clin Oncol. 2008 Jul 20;26(21):3523-9. doi: 10.1200/JCO.2007.15.4138.
 
677 - Hoff PM (2001)
Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J.Clin Oncol. 2001;19(8) :2282-92.
 
678 - Hohn DC (1989)
Hohn DC, Stagg RJ, Friedman MA, Hannigan JF Jr, Rayner A, Ignoffo RJ, et al. A randomised trial of continuous intravenous versus hepatic intraarterial fluoxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group Trial. J Clin Oncol 1989; 7:1646-54.
 
679 - Holm T (2001)
Holm T, Johansson H, Rutqvist LE, Cedermark B. Tumour location and the effects of preoperative radiotherapy in the treatment of rectal cancer. Br J Surg 2001; 88:839-43.
 
680 - Holzer B (2008)
Holzer B, Rosen HR, Zaglmaier W, Klug R, Beer B, Novi G, et al. Sacral nerve stimulation in patients after rectal resection--preliminary report. J Gastrointest Surg 2008 12(5): 921-5.
 
681 - Hoyer M (2006)
Hoyer M, Roed H, Traberg HA, Ohlhuis L, Petersen J, Nellemann H, et al. Phase II study on stereotactic body radiotherapy of colorectal metastases. Acta Oncol 2006;45(7):823-30.
 
682 - IKNL
http://www.iknl.nl
 
683 - Hung GU (2001)
Hung GU, Shiau YC, Tsai SC, Chao TH, Ho YJ, Kao CH. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer. Anticancer Res 2001;21:1375-8.
 
684 - Hunt T (1990)
Hunt T, Flowerdew A, Birch S, Williams JD, Mullee MA, Taylor I. Prospective randomized controlled trial of hepatic arterial embolization or infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastases. Br J Surg 1990;77:779-82.
 
685 - Hur H (2009)
Hur H, Ko YT, Min BS, Kim KS, Choi JS, Sohn SK, et al. Comparative study of resection and radiofrequency ablation in the treatment of solitary colorectal liver metastases. Am J Surg. 2009 Jun;197(6):728-36.
 
686 - Hurwitz H (2004)
Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med. 2004 Jun 3;350(23):2335-42.
 
687 - Hurwitz HI (2013)
Hurwitz HI, Tebbutt NC, Kabbinavar F, Giantonio BJ, Guan ZZ, Mitchell L, et al J.Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials. Oncologist 2013;18:1004-12
 
688 - Ike H (2002)
Ike H, Shimada H, Togo S, Yamaguchi S, Ichikawa Y, Tanaka K. Sequential resection of lung metastasis following partial hepatectomy for colorectal cancer. Br J Surg 2002; 89:1164-116.
 
689 - Imamura H (2000)
Imamura H, Kawasaki S, Miyagawa S, Ikegami T, Kitamura H, Shimada R. Aggressive surgical approach to recurrent tumors after hepatectomy for metastatic spread of colorectal cancer to the liver. Surgery 2000; 127:528-35.
 
690 - Imamura H (1999)
Imamura H, Shimada R, Kubota M, Matsuyama Y, Nakayama A, Miyagawa S, et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 1999 ;29:1099-105.
 
691 - IMPACT (1995)
Impact (no Authors listed). Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Lancet. 1995 Apr 15;345(8955):939-44.
 
692 - IMPACT-B2 (1999)
IMPACT-B2. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators. J Clin Oncol. 1999 May;17(5):1356-63.
 
693 - Ince WL (2005)
Ince WL, Jubb AM, Holden SN, Holmgren EB, Tobin P, Sridhar M, et al. Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab. J Natl Cancer Inst. 2005 Jul 6;97(13):981-9.
 
694 - Inoue H (1989)
Inoue H, Kobayashi H, Itoh Y, Shinohara S. Treatment of liver metastases by arterial injection of adriamycin/mitomycin C lipiodol suspension. Acta Radiol 1989;30:603-8.
 
695 - Inoue M (2004)
Inoue M, Ohta M, Iuchi K, Matsumura A, Ideguchi K, Yasumitsu T, et al. Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma. Ann Thorac Surg 2004;78:238-44.
 
696 - IGZ (2009)
Inspectie voor de Gezondheidszorg [IGZ]. (2009). Zorgketen voor kankerpatiënten moet verbeteren. Onderzoek naar de kwaliteit van de oncologische zorgketen voor patiënten die worden behandeld met radiotherapie. Op 1 april 2010 ontleend aan http://www.igz.nl/publicaties/rapporten/1772323/zorgketen-kankerpatienten
 
697 - IKA (2008)
Integraal kankercentrum Amsterdam (2008). Thema: Revalidatie en Nazorg, Vernieuwen nazorg & nacontrole.
 
698 - Irvine D (1991)
Irvine D, Brown B, Crooks D, Roberts J, Browne G. Psychosocial adjustment in women with breast cancer. Cancer 1991;67:1097-117.
 
699 - Isbister WH (1996)
Isbister WH, al-Sanea O. The utility of pre-operative abdominal computerized tomography scanning in colorectal surgery. J R Coll Surg Edinb. 1996 Aug;41(4):232-4.
 
700 - Issa N (2012)
Issa N, Murninkas A, Powsner E, Dreznick Z. Long-term outcome of local excision after complete pathological response to neoadjuvant chemoradiation therapy for rectal cancer. World J Surg. 2012 Oct;36(10):2481-7.
 
701 - Ito K (1996)
Ito K, Yamaguchi A, Miura K, Kato T, Baba S, Matsumoto S, et al. Oral adjuvant chemotherapy with carmofur (HCFU) for colorectal cancer: five-year followup. Tokai HCFU Study Group - third study on colorectal cancer. J Surg Oncol 1996;63:107-11.
 
702 - Iwashyna TJ (2002)
Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol. 2002 Oct 1;20(19):3992-8.
 
703 - Jacobs M (1991)
Jacobs M, Verdeja JC, Goldstein HS. Minimally invasive colon resection (laparoscopic colectomy). Surg Laparosc Endosc 1991;1:144-50.
 
704 - Jacobsen PB (2007)
Jacobsen PB, Ransom S. Implementation of NCCN Distress Management Guidelines by Member Institutions. J Natl Compr Canc Netw. 2007 Jan;5(1):99-103.
 
705 - Jaeck D (1997)
Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 1997;84:977-80.
 
706 - Jaeck D (2003)
Jaeck D, Bachellier P, Nakano H, Oussoultzoglou E, Weber JC, Wolf P, et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 2003;185:221-9.
 
707 - Jaeck D (2003)
Jaeck D. The significance of hepatic pedicle lymph nodes metastases in surgical management of colorectal liver metastases and of other liver malignancies. Ann Surg Oncol 2003;10:1007-11.
 
708 - Jamison RL (1997)
Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997; 132:505-10.
 
709 - Jansen SJT (2002)
Jansen SJT. Dokter, wat vindt u?, de patiënt helpen beslissen. Kanker bij de oudere patiënt: wat is er anders. Boerhaavecursus, 2002:21-36.
 
710 - Janssen MH (2012)
Janssen MH, Öllers MC, van Stiphout RG, Riedl RG, van den Bogaard J, Buijsen J, et al. PET-based treatment response evaluation in rectal cancer: prediction and validation. Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):871-6. doi: 0.1016/j.ijrobp.2010.11.038. Epub 2011 Mar 5.
 
711 - Jarnagin WR (2001)
Jarnagin WR, Conlon K, Bodniewicz J, Dougherty E, DeMatteo RP, Blumgart LH, et al. A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 2001;91:1121-8.
 
712 - Jarrett ME (2005)
Jarrett ME, Matzel KE, Stösser M, Christiansen J, Rosen H, Kamm MA. Sacral nerve stimulation for faecal incontinence following a rectosigmoid resection for colorectal cancer. Int J Colorectal Dis 2005;20(5): 446-51.
 
713 - Jatzko GR (1995)
Jatzko GR, Lisborg PH, Stettner HM, Klimpfinger MH. Hepatic resection for metastases from colorectal carcinoma--a survival analysis. Eur J Cancer 1995;31A:41-6.
 
714 - Jefferey M (2009)
Jefferey M, Hickey BE, Hider PN. Follow up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database of Systematic Reviews, Issue 1. Retrieved October 1, 2009 from: http://scripts.hro.nl/cgi-bin/nph-proxy.cgi/000000A/http/www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD002200/pdf_fs.html
 
715 - Jeffery GM (2003)
Jeffery GM, Hickey BE, Hider P: Follow-up strategies for patients treated for non-metastatic colorectal cancer (Cochrane review). The Cochrane Library Issue 1 Oxford; Update Software; 2003.
 
716 - Jehn CF (2012)
Jehn CF, Böning L, Kröning H, Possinger K, Lüftner D. Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancer. Br J Cancer 2012;106:274-8.
 
717 - Jenkins V (2001)
Jenkins V, Fallowfield L, Saul J. Information needs of patients with cancer: results from a large study in UK cancer centres. Br J Cancer 2001;84:48-51.
 
718 - Jensch S (2010)
Jensch S, Bipat S, Peringa J, de Vries AH, Heutinck A, Dekker E, et al. CT colonography with limited bowel preparation: prospective assessment of patient experience and preference in comparison to optical colonoscopy with cathartic bowel preparation. Eur Radiol. 2010 Jan;20(1):146-56. doi: 10.1007/s00330-009-1517-0. Epub 2009 Jul 23.
 
719 - Jeyarajah S (2011)
Jeyarajah S, Adams K, Higgins L, Ryan S, Leather A, Papagrigoriadis S. Prospective evaluation of a Colorectal Cancer Nurse Follow-up Clinic. Colorectal Dis. 2011 Jan;13(1):31-8. doi: 10.1111/j.1463-1318.2009.02027.x.
 
720 - Jiang HC (2002)
Jiang HC, Liu LX, Piao DX, Xu J, Zheng M, Zhu AL, et al. Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 2002;8:624-30.
 
721 - John TG (1994)
John TG, Greig JD, Crosbie JL, Miles WF, Garden OJ. Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg 1994;220:711-9.
 
722 - Johnson LB (1997)
Johnson LB, Krebs TL, Van Echo D, Plotkin JS, Njoku M, Wong JJ, et al. Cytoablative therapy with combined resection and cryosurgery for limited bilobar hepatic colorectal metastases. Am J Surg 1997;174:610-3.
 
723 - Johnson R (2004)
Johnson R, Marsh R, Corson J, Seymour K. A comparison of two methods of palliation of large bowel obstruction due to irremovable colon cancer. Ann R Coll Surg Engl. 2004 Mar;86(2):99-103.
 
724 - Jones RM (1998)
Jones RM, Moulton CE, Hardy KJ. Central venous pressure and its effect on blood loss during liver resection. Br J Surg 1998;85:1058-60.
 
725 - Jonker DJ (2000)
Jonker DJ, Maroun JA, Kocha W. Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials. Br J Cancer. 2000 82(11):1789-94.
 
726 - Joosten J (2005)
Joosten J, Jager G, Oyen W, Wobbes T, Ruers T. Cryosurgery and radiofrequency ablation for unresectable colorectal liver metastases. Eur J Surg Oncol. 2005 Dec;31(10):1152-9. Epub 2005 Aug 29. [link]
 
727 - Jouret-Mourin A (2004)
Jouret-Mourin A. Recommendations for pathological examination and reporting for colorectal cancer. Belgian consensus. Acta Gastroenterol Belg 2004;67:40-5.
 
728 - Kabbinavar F (2003)
Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, Lieberman G et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol. 2003 1;21(1):60-5.
 
729 - Kabbinavar F (2005)
Kabbinavar F, Schultz J, McLeod M, Patel T, Hamm JT, Hecht JR, et al. Addition of bevacizumab to bolus fluorouracil an leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol 2005;16:3697-705.
 
730 - Kabbinavar FF (2005)
Kabbinavar FF, Hambleton J, Mass RD, Hurwitz HI, Bergsland E, Sarkar S. Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer. J Clin Oncol. 2005 (B)23(16):3706-12.
 
731 - Kabbinavar FF (2009)
Kabbinavar FF, Hurwitz HI, Yi J, et al. Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials. J Clin Oncol 2009;27:199-205.
 
732 - Kahn KL (2010)
Kahn KL, Adams JL, Weeks JC, Chrischilles EA, Schrag D, Ayanian JZ, et al. Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. JAMA. 2010 Mar 17;303(11):1037-45.
 
733 - Kaiser AM (2004)
Kaiser AM, Kang JC, Chan LS, Vukasin P, Beart RW, Jr. Laparoscopic-assisted vs. open colectomy for colon cancer: a prospective randomized trial. J Laparoendosc Adv Surg Tech A 2004;14(6):329-34.
 
734 - Kalady MF (2009)
Kalady MF, Sanchez JA, Manilich E, Hammel J, Casey G, Church JM. Divergent oncogenic changes influence survival differences between colon and rectal adenocarcinomas. Dis Colon Rectum. 2009 Jun;52(6):1039-45. doi: 10.1007/DCR.0b013e31819edbd4.
 
735 - Kalofonos HP (2005)
Kalofonos HP, Aravantinos G, Kosmidis P, Papakostas P, Economopoulos T, Dimopoulos M et all. Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study. Ann Oncol. 2005 Jun;16(6):869-77. Epub 2005 Apr 26.
 
736 - Kamel IR (2004)
Kamel IR, Cohade C, Neyman E, Fishman EK, Wahl RL. Incremental value of CT in PET/CT of patients with colorectal carcinoma. Abdom Imaging 2004; 29:663-6.
 
737 - Kang SB (2010)
Kang SB, Park JW, Jeong SY, Nam BH, Choi HS, Kim DW et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010 Jul;11(7):637-45.
 
738 - Kantorová I (2003)
Kantorová I, Lipská L, Belohlávek O, Visokai V, Truba? M, Scheiderová M. Routine 18F-FDG-PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med 2003;44:1784-8.
 
739 - Kapiteijn E (2001)
Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
 
740 - Karapetis CS (2008)
Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med. 2008 Oct 23;359(17):1757-65. doi: 10.1056/NEJMoa0804385.
 
741 - Katz AW (2007)
Katz AW, Carey-Sampson M, Muhs AG, Milano MT, Schell MC, Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007 Mar 1;67(3):793-8.
 
742 - Kavanagh BD (2006)
Kavanagh BD, McGarry RC, Timmerman RD. Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases. Semin Radiat Oncol 2006 Apr;16(2):77-84.
 
743 - Keating J (2003)
Keating J, Lolohea S, Kenwright D. Pathology reporting of rectal cancer: a national audit. N Z Med J 2003;116:U514.
 
744 - Keeling AN (2010)
Keeling AN, Slattery MM, Leong S, McCarthy E, Susanto M, Lee MJ, et al. Limited-preparation CT colonography in frail elderly patients: a feasibility study. AJR Am J Roentgenol. 2010 May;194(5):1279-87. doi: 10.2214/AJR.09.2896.
 
745 - Keilholz L (1997)
Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis. 1997;12(1);19-23.
 
746 - Kelley RK (2011)
Kelley RK, Van Bebber SL, Phillips KA, Venook AP. Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw. 2011 Jan;9(1):13-25. Review.
 
747 - Kemeny N (1993)
Kemeny N, Cohen A, Seiter K, Conti JA, Sigurdson ER, Tao Y, et al: Randomized trial of hepatic arterial floxuridine, mitomycin and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 1993;11:330-5.
 
748 - Kemeny N (1987)
Kemeny N, Daly J, Reichmann B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxuridine in patients with liver metastasen from colorectal carcinoma. Ann Intern Med 1987;107:459-65.
 
749 - Kemeny N (2001)
Kemeny N, Gonen M, Sullivan D, Schwartz L, Benedetti F, Saltz L, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001; 19:2687-95
 
750 - Kemeny N (1999)
Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341:2039-48.
 
751 - Kennedy ED (2011)
Kennedy ED, Schmocker S, Victor C, Baxter NN, Kim J, Brierley J, McLeod RS. Do patients consider preoperative chemoradiation for primary rectal cancer worthwhile? Cancer. 2011 Jul 1;117(13):2853-62. doi: 10.1002/cncr.25842. Epub 2011 Jan 10.
 
752 - Kennelly RP (2012)
Kennelly RP, Heeney A, White A, Fennelly D, Sheahan K, Hyland JM, et al. A prospective analysis of patient outcome following treatment of T3 rectal cancer with neo-adjuvant chemoradiotherapy and transanal excision. Int J Colorectal Dis. 2012;27(6):759-64.
 
753 - Kerr D (2003)
Kerr D, McArdle C, Ledermann J, Taylor I, Sherlock DJ, Schlag PM, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicenter randomised trial. Lancet 2003;361:368-73.
 
754 - Kesmodel SB (2008)
Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, et al. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol. 2008 Nov 10;26(32):5254-60. doi: 10.1200/JCO.2008.17.7857. Epub 2008 Oct 14.
 
755 - Kessels RP (2003)
Kessels RP. Patients' memory for medical information. J R Soc Med 2003;96:219-22.
 
756 - Khot UP (2002)
Khot UP, Lang AW, Murali K, Parker MC. Systematic review of the efficacy and safety of colorectal stents. Br J Surg 2002;89(9):1096-1102.
 
757 - Kiesler DJ (2006)
Kiesler DJ, Auerbach SM. Optimal matches of patient preferences for information, decision-making and interpersonal behavior: evidence, models and interventions. Patient Educ Couns 2006;61:319-41.
 
758 - Kievit J (2002)
Kievit J. Follow-up of patients with colorectal cancer: numbers needed to test and treat. Eur J Cancer 2002;38(7):986-99.
 
759 - Kim E (2008)
Kim E, Hwang JM, Garcia-Aguilar J. Local excision for rectal carcinoma. Clin Colorectal Cancer. 2008 Nov;7(6):376-85. doi: 10.3816/CCC.2008.n.050.
 
760 - Kim JH (2004)
Kim JH, Beets GL, Kim MJ, Kessels AG, Beets-Tan RG. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol. 2004 Oct;52(1):78-83.
 
761 - Kim JH (2005)
Kim JH, Czernin J, len-Auerbach MS, Halpern BS, Fueger BJ, Hecht JR et al. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. J Nucl Med 2005; 46:587-95.
 
762 - Kim KH (2011)
Kim KH, Yoon YS, Yu CS, Kim TW, Kim HJ, Kim PN, et al. Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc. 2011 Jul;81(1):25-34.
 
763 - Kim KH (2011)
Kim KH, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC. Effectiveness of biofeedback therapy in the treatment of anterior resection syndrome after rectal cancer surgery. Dis Colon Rectum 2011;54(9): 1107-13.
 
764 - Kim MN (2011)
Kim MN, Kang JM, Yang JI, Kim BK, Im JP, Kim SG, et al. Clinical features and prognosis of early colorectal cancer treated by endoscopic mucosal resection. Journal of Gastroenterology & Hepatology. [Journal Article]. 2011 Nov 2011;26(11):1619-25.
 
765 - Kim MS (2009)
Kim MS, Kang JK, Cho CK, Choi CW, Seo YS, Hwang DY, et al. Three-fraction stereotactic body radiation therapy for isolated liver recurrence from colorectal cancer. Tumori 2009 Jul;95(4):449-54
 
766 - Kim SH (2009)
Kim SH, Lee JM, Hong SH, Kim GH, Lee JY, Han JK, Choi BI. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. Radiology. 2009 Oct;253(1):116-25. doi: 10.1148/radiol.2532090027.
 
767 - Kim SH (1997)
Kim SH, Milsom JW, Church JM, Ludwig KA, Garcia-Ruiz A, Okuda J, Fazio VW. Perioperative tumor localization for laparoscopic colorectal surgery. Surg Endosc. 1997 Oct;11(10):1013-6.
 
768 - Kim SH (1998)
Kim SH, Milsom JW, Gramlich TL, Toddy SM, Shore GI, Okuda J et al. Does laparoscopic vs. conventional surgery increase exfoliated cancer cells in the peritoneal cavity during resection of colorectal cancer? Dis Colon Rectum 1998;41(8):971-8.
 
769 - King PM
King PM. Open versus laparoscopic surgery for colorectal cancer: a randomised study embedded within an enhanced recovery programme (unpublished).
 
770 - Kinkel K (2002)
Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 2002;224:748-56.
 
771 - Kinoshita H (1986)
Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986;10:803-8.
 
772 - Kjeldsen BJ (1997)
Kjeldsen BJ, Kronborg O, Fenger C, Jřrgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997;84:666-9.
 
773 - Kjeldsen BJ (1999)
Kjeldsen BJ, Thorsen H, Whalley D, Kronborg O. Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol 1999;34(5):509-15.
 
774 - Klein Poelhuis EH (1997)
Klein Poelhuis EH, Schadé E, Kiezebrink ML, Pruyn JFA, Razenberg PPA, Wijnberg AES. Bewaakte overgangen; continuiteit in de zorg voor patiënten met kanker. Eindhoven: IKZ, 1997.
 
775 - Knaebel HP (2005)
Knaebel HP, Koch M, Feise T, Benner A, Kienle P. Diagnostics of rectal cancer: endorectal ultrasound. Recent Results Cancer Res. 2005;165:46-57.
 
776 - Knijn N (2011)
Knijn N, Mekenkamp LJ, Klomp M, Vink-Börger ME, Tol J, Teerenstra S, et al. KRAS mutation analysis: a comparison between primary tumours and matched liver metastases in 305 colorectal cancer patients. Br J Cancer. 2011 Mar 15;104(6):1020-6. doi: 10.1038/bjc.2011.26. Epub 2011 Mar 1
 
777 - Knijn N (2013)
Knijn N, de Ridder JA, Punt CJ, de Wilt JH, Nagtegaal ID. Histopathological evaluation of resected colorectal cancer liver metastases: what should be done? Histopathology. 2013 Aug;63(2):149-56. doi: 10.1111/his.12124. Epub 2013 Jun 13. [link]
 
778 - Kobayashi K (1999)
Kobayashi K, Kawamura M, Ishihara T. Surgical treatment for both pulmonary and hepatic metastases from colorectal cancer. J Thorac Cardiovasc Surg 1999; 118:1090-6.
 
779 - Koch SM (2009)
Koch SM, Rietveld MP, Govaert B, van Gemert WG, Baeten CG. Retrograde colonic irrigation for faecal incontinence after low anterior resection. Int J Colorectal Dis 2009;24(9):1019-22.
 
780 - Kocha W (2005)
Kocha W, Maroun J, Jonker D, Rumble RB, Zuraw L. Oral capecitabine in the first line treatment of metastasic colorectal cancer. 1. A clinical practice guideline & 2. a systematic review. Cancer Care Ontario, February 2005.
 
781 - Kodaira S (1997)
Kodaira S. Postoperative adjuvant chemotherapy with mitomycin C and UFT for rectal cancer. Oncology 1997;11:40-3.
 
782 - Köhne CH (2012)
Köhne CH. Current stages of adjuvant treatment of colon cancer. Ann Oncol. 2012 Sep;23 Suppl 10:x71-6.
 
783 - Kohne (2003)
Kohne, CH, Van Cutsem E, Wils JA et al Irinotecan improves the activity of the AIO regimen in metastatic colorectal cancer: Results of EORTC GI Group study 40986. Proc Am Soc Clin Oncol 2003; 22 254-Abstract 1018.
 
784 - Kok E de (2009)
Kok E de, Garssen B, Kuiper B , Visser A, Honing, C. Signaleringslijst helpt onderdiagnostiek van psychosociale problemen voorkomen. Oncologica, 2009: 4;36-9.
 
785 - Kokudo N (2002)
Kokudo N, Miki Y, Sugai S, Yanagisawa A, Kato Y, Sakamoto Y, et al. Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma: minimum surgical margins for successful resection. Arch Surg 2002;137:833-40.
 
786 - Kokudo N (2001)
Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, et al. Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 2001; 181:153-9.
 
787 - Kokudo N (2001)
Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M, et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34:267-72
 
788 - Kolfschoten NE (2013)
Kolfschoten NE, van Leersum NJ, Gooiker GA, Marang van de Mheen PJ, Eddes EH, Kievit J, et al. Successful and Safe Introduction of Laparoscopic Colorectal Cancer Surgery in Dutch hospitals. Ann Surg. 2013 May;257(5):916-21. doi: 10.1097/SLA.0b013e31825d0f37.
 
789 - Komborozos VA (2001)
Komborozos VA, Skrekas GJ, Pissiotis CA. The contribution of follow-up programs in the reduction of mortality of rectal cancer recurrences. Dig Surg 2001;18:403-8.
 
790 - Kondo H (2000)
Kondo H, Kanematsu M, Hoshi H, Murakami T, Kim T, Hori M, et al. Preoperative detection of malignant hepatic tumors: comparison of combined methods of MR imaging with combined methods of CT. AJR Am J Roentgenol 2000; 174:947-54
 
791 - Koopman M (2007)
Koopman M, Antonini NF, Douma J, Wals J, Honkooop AH, Erdkamp FL et al. Sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet 2007;370:135-42.
 
792 - Koopman M (2009)
Koopman M, Punt CJ. Chemotherapy, which drugs and when. Eur J Cancer 2009;45(suppl1):50-6
 
793 - Koopman M (2009)
Koopman M, Seymour MT, Punt CJ. The CAIRO and FOCUS studies: which lesson is to be learned? Oncologist. 2009 Feb;14(2):192-3; author reply 194-6. doi: 10.1634/theoncologist.2008-0247.
 
794 - Koopman M (2013)
Koopman M, Simkens LH, ten Tije AJ et al. Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer: the phase III CAIRO3 study of the Dutch Colorectal Cancer Group. Proc ASCO 2013;abstract 3502 [link]
 
795 - Koopman M (2009)
Koopman M, Venderbosch S, Nagtegaal ID, van Krieken JH, Punt CJ. A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned? Eur J Cancer. 2009 Jul;45(11):1935-49. doi: 10.1016/j.ejca.2009.04.023. Epub 2009 May 25.
 
796 - Koppenol-van Hooijdonk M (2002)
Koppenol-van Hooijdonk M, van Boxtel R. De bespreekbaarheid van ziekte en een naderende dood bij niet-westerse patiënten. Ned Tijdschr Palliat Zorg 2002;3:65-9.
 
797 - Körner H (2005)
Körner H, Soreide K, Stokkeland PJ, Soreide JA. Systematic follow-up after curative surgery for colorectal cancer in Norway: a population-based audit of effectiveness, costs, and compliance. J Gastrointest Surg 2005;9(3):320-8.
 
798 - Kornprat P (2007)
Kornprat P, Jarnagin WR, DeMatteo RP, Fong Y, Blumgart LH, D'Angelica M. Role of intraoperative thermoablation combined with resection in the treatment of hepatic metastasis from colorectal cancer. Arch Surg. 2007 Nov;142(11):1087-92.
 
799 - Kronawitter U (1999)
Kronawitter U, Kemeny NE, Heelan R, Fata F, Fong Y. Evaluation of chest computed tomography in the staging of patients with potentially resectable liver metastases from colorectal carcinoma. Cancer 1999;86:229-35.
 
800 - Kronborg O (1995)
Kronborg O. Acute obstruction from tumour in the left colon without spread. A randomized trial of emergency colostomy versus resection. Int J Colorectal Dis 1995;10(1):1-5.
 
801 - Kronborg O (2002)
Kronborg O. Emergency colorectal surgery in perforated sigmoid diverticulitis and obstructive carcinoma of the left colon. Seminars-in-Colon-and-Rectal-Surgery. 2002;13:1-95.
 
802 - Krook JE (1991)
Krook JE, Moertel CG, Gunderson LL, Wieand H, Collins R, Beart R, et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991;324:709-15.
 
803 - Kubota K (1997)
Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26:1176-18.
 
804 - Kuhry E (2008)
Kuhry E, Schwenk W, Gaupset R, Romild U, Bonjer J. Long-term outcome of laparoscopic surgery for colorectal cancer: a cochrane systematic review of randomised controlled trials. Cancer Treat Rev. 2008 Oct;34(6):498-504
 
805 - Kundel Y (2010)
Kundel Y, Brenner R, Purim O, Peled N, Idelevich E, Fenig E et al. Is local excision after complete pathological response to neoadjuvant chemoradiation for rectal cancer an acceptable treatment option? Dis Colon Rectum. 2010 Dec;53(12):1624-31
 
806 - Kuo LJ (2005)
Kuo LJ, Chern MC, Tsou MH, Liu MC, Jian JJ, Chen CM, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum. 2005 Jan;48(1):23-8.
 
807 - Kuvshinoff BW (2002)
Kuvshinoff BW, Ota DM. Radiofrequency ablation of liver tumors: influence of technique and tumor size. Surgery 2002;132:605-11.
 
808 - Kwok SP (1996)
Kwok SP, Lau WY, Leung KL, Liew CT, Li AK. Prospective analysis of the distal margin of clearance in anterior resection for rectal carcinoma. Br J Surg 1996;83:969-72.
 
809 - Labianca R (2011)
Labianca R, Sobrero A, Isa L, Cortesi E, Barni S, Nicolella D, et al. Intermittent versus continuous chemotherapy in advanced colorectal cancer: a randomised 'GISCAD' trial. Ann Oncol 2011;22:1236-42.
 
810 - Lacy AM (2002)
Lacy AM, Garcia-Valdecasas JC, Delgado S, Castells A, Taura P, Pique JM et al. Laparoscopyassisted colectomy versus open colectomy for treatment of non-metastatic colon cancer: a randomised trial. Lancet 2002;359(9325):2224-9.
 
811 - Laforest A (2012)
Laforest A, Bretagnol F, Mouazan AS, Maggiori L, Ferron M, Panis Y. Functional disorders after rectal cancer resection: Does a rehabilitation programme improve anal continence and quality of life? Colorectal Dis 2012;14(10):1231-7.
 
812 - Lahaye MJ (2009)
Lahaye MJ, Beets GL, Engelen SM, Kessels AG, de Bruďne AP, Kwee HW et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes? Radiology. 2009 Jul;252(1):81-91. doi: 10.1148/radiol.2521081364.
 
813 - Lahaye MJ (2005)
Lahaye MJ, Engelen SME, Nelemans PJ, Beets GL et al. Imaging for predicting the risk factors - the circumferential resection margin and nodal disease - of local recurrence in rectal cancer: a meta-analysis. Semin Ultrasound CT MRI 2005; 26:259-68.
 
814 - Lal R (2004)
Lal R, Dickson J, Cunningham D, Chau I, Norman AR, Ross PJ, et al. A randomized trial comparing defined-duration with continuous irinotecan until disease progression in fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer. J Clin Oncol 2004 Aug 1;22(15):3023-31
 
815 - Lambert LA (2000)
Lambert LA, Colacchio TA, Barth RJ, Jr. Interval hepatic resection of colorectal metastases improves patient selection. Arch Surg 2000; 135:473-9.
 
816 - Lambregts DM (2011)
Lambregts DM, Vandecaveye V, Barbaro B, Bakers FC, Lambrecht M, Maas M, et al. Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study. Ann Surg Oncol. 2011 Aug;18(8):2224-31. doi: 10.1245/s10434-011-1607-5. Epub 2011 Feb 23.
 
817 - Lange MM (2009) (2009)
Lange MM (2009). Long Term Outcome of Rectal Cancer Treatment. Universiteit Leiden, Proefschrift.
 
818 - Lange MM (2007)
Lange MM, Dulk M den, Bossema ER, Maas CP, Peeters KC, Rutten HJ, et al. Cooperative Clinical Investigators of the Dutch Total Mesorectal Excision Trial. Risk factors for faecal incontinence after rectal cancer treatment. Br J Surg. 2007 Oct;94(10):1278-84.
 
819 - Lange MM (2008)
Lange MM, Maas GP, Marijnen CAM, Wiggers T, Rutten HJ, Klein Kranenbarg E, et al. Urinary dysfunctioning after rectal cancer treatment is mainly cased by surgery. Br J Surg. 2008 Aug;95(8):1020-8. doi: 10.1002/bjs.6126.
 
820 - Lange MM (2009)
Lange MM, Marijnen CAM, Maas CP, Putter H, Rutten HJ, Stiggelhout AM, et al. Risk factors for sexual dysfunction after rectal cancer. Eur J Cancer. 2009 Jun;45(9):1578-88. doi: 10.1016/j.ejca.2008.12.014. Epub 2009 Jan 13.
 
821 - Lange MM (2008)
Lange MM, Van de Velde CJH. Faecal and urinary Incontinence after Multimodality Treatment of Rectal Cancer. Description of a case. Public library of Science 2008, (5), 1436-1438. Op 19 oktober 2009 ontleend aan http://plosjournal.deepdyve.com/search?author=Marilyne+M%2C+Lange
 
822 - Langenhoff BS (2002)
Langenhoff BS, Oyen WJ, Jager GJ, Strijk SP, Wobbes T, Corstens FH, Ruers TJ. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol. 2002 Nov 15;20(22):4453-8
 
823 - Langer C (2003)
Langer C, Liersch T, Suss M, Siemer A, Markus P, Ghadimi BM, et al. Surgical cure for early rectal carcinoma and large adenoma: transanal endoscopic microsurgery (using ultrasound or electrosurgery) compared to conventional local and radical resection. Int J Colorectal Dis 2003; 18:222-9.
 
824 - Lankshear S (2013)
Lankshear S, Srigley J, McGowan T, Yurcan M, Sawka C. Standardized synoptic cancer pathology reports - so what and who cares? A population-based satisfaction survey of 970 pathologists, surgeons, and oncologists. Arch Pathol Lab Med. 2013 Nov;137(11):1599-602. doi: 10.5858/arpa.2012-0656-OA. Epub 2013 Feb 21. [link]
 
825 - Law WL (2003)
Law WL, Choi HK, Chu KW. Comparison of stenting with emergency surgery as palliative treatment for obstructing primary left-sided colorectal cancer. Br J Surg 2003;90(11):1429-33.
 
826 - Law WL (2004)
Law WL, Choi HK, Lee YM, Chu KW. Palliation for Advanced Malignant Colorectal Obstruction by Self-Expanding Metallic Stents: Prospective Evaluation of Outcomes. Dis Colon Rectum 2004;47:1-43.
 
827 - Lax I (1994)
Lax I, Blomgren H, Naslund I, Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 1994;33(6):677-83
 
828 - Le Voyer TE (2003)
Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol. 2003 Aug 1;21(15):2912-9.
 
829 - Lee JH (2002)
Lee JH, Lee JH, Ahn JH, et al. Randomized trial of postoperative adjuvant therapy in stage II and III rectal cancer to define the optimal sequence of chemotherapy and radiotherapy: a preliminary report. J Clin Oncol 2002;20:1751-8.
 
830 - Lee JK (2012)
Lee JK, Delaney CP, Lipman JM. Current state of the art in laparoscopic colorectal surgery for cancer: Update on the multi-centric international trials. Ann Surg Innov Res. 2012 Jul 30;6(1):5. doi: 10.1186/1750-1164-6-5.
 
831 - Lee KC (1993)
Lee KC, Kinoshita H, Hirohashi K, Kubo S, Iwasa R. Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg 1993;17:109-15.
 
832 - Lee MT (2009)
Lee MT, Kim JJ, Dinniwell R, et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009 Apr 1;27(10):1585-91.
 
833 - Lee SD (2013)
Lee SD, Park SC, Park JW, Kim DY, Choi HS, Oh JH. Laparoscopic versus open surgery for stage I rectal cancer: long-term oncologic outcomes. World J Surg. 2013 Mar;37(3):646-51. doi: 10.1007/s00268-012-1846-z. [link]
 
834 - Lee SH (2005)
Lee SH, Hernandez-de-Anda E, Finne CO, Madoff RD, Garcia-Aguilar J. The effect of circumferential tumor location in clinical outcomes of rectal cancer patients treated with total mesorectal excision. Dis Colon Rectum 2005;48:2249-57.
 
835 - Lee W (2003)
Lee W, Lee D, Choi S et al. Transanal endoscopic microsurgery and radical surgery for T1 and T2 rectal cancer. Surg Endosc 2003; 17:1283-7.
 
836 - Lee WS (2008)
Lee WS, Yun SH, Chun HK, Lee WY, Kim SJ, Choi SH, et al. Clinical outcomes of hepatic resection and radiofrequency ablation in patients with solitary colorectal liver metastasis. J Clin Gastroenterol. 2008 Sep;42(8):945-9.
 
837 - Lehnert T (1999)
Lehnert T, Knaebel HP, Duck M, Bulzebruck H, Herfarth C. Sequential hepatic and pulmonary resections for metastatic colorectal cancer. Br J Surg 1999; 86:241-3.
 
838 - Lehnert T (2002)
Lehnert T, Methner M, Pollok A, Schaible A, Hinz U, Herfarth C. Multivisceral resection for locally advanced primary colon and rectal cancer: an analysis of prognostic factors in 201 patients. Ann Surg. 2002 Feb;235(2):217-25.
 
839 - Lembersky BC (2006)
Lembersky BC, Wieand HS, Petrelli NJ, O'Connell MJ, Colangelo LH, Smith RE et al. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. J Clin Oncol. 2006 May 1;24(13):2059-64.
 
840 - Lemmens VEPP (2006)
Lemmens VEPP, Coebergh JWW. Epidemiologie van colorectale tumoren. IKR Bulletin 2006; 30 (december):4-7.
 
841 - Lencioni R (1998)
Lencioni R, Donati F, Cioni D et al. Detection of colorectal liver metastases: prospective comparison of unenhanced and ferumoxides-enhanced magnetic resonance imaging at 1.5 T, dual-phase spiral CT, and spiral CT during arterial portography. MAGMA 1998;7:76-87.
 
842 - Lencioni R (1998)
Lencioni R, Goletti O, Armillotta N, Paolicchi A, Moretti M, Cioni D, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol 1998;8:1205-11.
 
843 - Lencioni R
Lencioni R. Lencioni R for the Tumor Radiofrequency Ablation Italian Network (TRAIN). Long-term results of percutaneous radiofrequency ablation of hepatic colorectal metastases. Radiology, in press.
 
844 - Leone F (2013)
Leone F, Artale S, Marino D, Cagnazzo C, Cascinu S, Pinto C, et al. Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases. The MetaPan study. Cancer. 2013 Oct 1;119(19):3429-35.
 
845 - Leung KL (2004)
Leung KL, Kwok SP, Lam SC, Lee JF, Yiu RY, Ng SS et al. Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial. Lancet 2004;363(9416):1187-92.
 
846 - Levy BF (2011)
Levy BF, Scott MJ, Fawcett W, Fry C, Rockall TA. Randomized clinical trial of epidural, spinal or patient-controlled analgesia for patients undergoing laparoscopic colorectal surgery. Br J Surg. 2011 Aug;98(8):1068-78. doi: 10.1002/bjs.7545. Epub 2011 May 17.
 
847 - Levy BF (2011)
Levy BF, Scott MJ, Fawcett WJ, Day A, Rockall TA. Optimizing patient outcomes in laparoscopic surgery. Colorectal Dis. 2011 Nov;13 Suppl 7:8-11. doi: 10.1111/j.1463-1318.2011.02770.x.
 
848 - Lezoche E (2012)
Lezoche E, Baldarelli M, Lezoche G, Paganini AM, Gesuita R, Guerrieri M. Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg. 2012 Sep;99(9):1211-8. doi: 10.1002/bjs.8821.
 
849 - Li L (2004)
Li L, Liu LZ, Xie ZM, Mo YX, Zheng L, Ruan CM, et al. Multi-phasic CT arterial portography and CT hepatic arteriography improving the accuracy of liver cancer detection. World J Gastroenterol 2004; 10:3118-21.
 
850 - Liedenbaum MH (2010)
Liedenbaum MH, de Vries AH, Gouw CI, van Rijn AF, Bipat S, Dekker E, et al. CT colonography with minimal bowel preparation: evaluation of tagging quality, patient acceptance and diagnostic accuracy in two iodine-based preparation schemes. Eur Radiol. 2010 Feb;20(2):367-76.
 
851 - Liersch T (2003)
Liersch T, Langer C, Jakob C, Muller D, Ghadimi BM, Siemer A, et al. Praoperative Diagnostik beim lokal fortgeschrittenen Rektumkarzinom (> or =T3 oder N+). Was leistet die Endosonographie gegenuber der Computertomographie im Staging und Restaging (nach neoadjuvanter Radio-/Chemotherapie)? [Preoperative diagnostic procedures in locally advanced rectal carcinoma (> or =T3 or N+). What does endoluminal ultrasound achieve at staging and restaging (after neoadjuvant radiochemotherapy) in contrast to computed tomography?]. Chirurg 2003;74[3], 224-34.
 
852 - Ličvre A (2006)
Ličvre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF, et al. KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res. 2006 Apr 15;66(8):3992-5.
 
853 - Lim JF (2005)
Lim JF, Tang CL, Seow-Choen F, Heah SM. Prospective, randomized trial comparing intraoperative colonic irrigation with manual decompression only for obstructed left-sided colorectal cancer. Dis Colon Rectum 2005;48(2):205-9.
 
854 - Lindner P (1999)
Lindner P, Fjalling M, Hafstrom L. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan. Eur J Surg Oncol 1999;25:179-85.
 
855 - Lindor NM (2002)
Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, Bapat B, Redston M, Thibodeau SN. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002 Feb 15;20(4):1043-8. [link]
 
856 - Lindsey I (2012)
Lindsey I, George B, et al. Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for erectile dysfunction after rectal excision for cancer and inflammatory bowel disease. Dis Colon Rectum 2012;45(6):727-32.
 
857 - Liu CL (2002)
Liu CL, Fan ST, Lo CM, Law WL, Ng IO, Wong J. Hepatic resection for colorectal liver metastases: prospective study. Hong Kong Med J 2002;8:329-33.
 
858 - LIMG (1997)
Liver Infusion Meta-analysis Group. Portal vein chemotherapy for colorectal cancer: a meta-analysis of 4000 patients in 10 studies. J.Natl.Cancer Inst. 1997; 89(7): 497-505.
 
859 - LiverMetSurvey
LiverMetSurvey: International registry of liver metastases of colorectal cancer. http://www.livermetsurvey.org.
 
860 - Livraghi T (2012)
Livraghi T, Meloni F, Solbiati L, Zanus G; Collaborative Italian Group using AMICA system. Complications of microwave ablation for liver tumors: results of a multicenter study. Cardiovasc Intervent Radiol. 2012 Aug;35(4):868-74.
 
861 - Livraghi T (1991)
Livraghi T, Vettori C, Lazzaroni S. Liver metastases ;results of percutaneous ethanol injection in 14 patients. Radiology 1991;179 :709-12.
 
862 - Lodge JP (2000)
Lodge JP, Ammori BJ, Prasad KR, Bellamy MC. Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg. 2000 Apr;231(4):471-9.
 
863 - Lorenz M (1992)
Lorenz M, Hottenrott C, Maier P, Reimann M, Inglis R, Encke A. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin. Semin Oncol 1992; 19:163-70.
 
864 - Lorenz M (2000)
Lorenz M, Muller HH for the German Cooperative Group on Liver Metastases. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000;18:243-54.
 
865 - Lorenz M (1999)
Lorenz M, Muller HH, Staib-Sebler E, et al. Relevance of neoadjuvant and adjuvant treatment for patients with resectable liver metastases of colorectal carcinoma. Langenbecks Arch Surg 1999;384:328-38.
 
866 - Loupakis F (2013)
Loupakis F, et al. FOLFOXIRI + bevacizumab versus FOLFIRI + bevacizumab as 1st line treatment of metastatic colorectal cancer: results of the phase III randomized TRIBE trial. Proc ASCO GI 2013 (abstract)
 
867 - Loupakis F (2013)
Loupakis F, Schirripa M, Caparello C, Funel N, Pollina L, Vasile E, et al. Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab. Br J Cancer 2013a;108:2549-56;
 
868 - Luglio G (2011)
Luglio G, Celentano V, Tarquini R, Sollazzo V, Giglio MC, Bucci L. Functional and oncological outcomes after transanal local excision for rectal cancer. A prospective study. European Journal of Surgical Oncology. 2011;37 (12):S4.
 
869 - Luna Pérez P (2003)
Luna Pérez P, Rodriguez RS, Alvarado I, Gutierrez-De-La BM, Labastida S. Prognostic significance of retrieved lymph nodes per specimenin resected rectal adenocarcinoma after preoperative chemoradiation therapy. Arch Med Research 2003;34:281-6.
 
870 - Luna-Perez P (2005)
Luna-Perez P, Bustos-Cholico E, Alvarado I, Maffuz A, Rodriguez-Ramirez S, Gutierrez-de-la-Barrera M, et al. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. J Surg Oncol 2005;90:20-5.
 
871 - Lyass S (2001)
Lyass S, Zamir G, Matot I, Goitein D, Eid A, Jurim O. Combined colon and hepatic resection for synchronous colorectal liver metastases.J Surg Oncol 2001; 78:17-21.
 
872 - Maas (2010)
Maas, M., et al., Selection of rectal cancer patients eligible for local excision with lymph node specific contrast-enhanced MRI. European Journal of Surgical Oncology, 2010. 36 (9): p. 817-818.
 
873 - Macari M (1999)
Macari M, Berman P, Dicker M, Milano A, Megibow AJ. Usefulness of CT colonography in patients with incomplete colonoscopy. AJR Am.J Roentgenol. 1999;173(3), 561-4.
 
874 - Mack MG (2001)
Mack MG, Straub R, Eichler K, Engelmann K, Zangos S, Roggan A, et al. Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. Abdom Imaging 2001; 26:369-74.
 
875 - Maeda K (2004)
Maeda K, Inoue T, Yashiro M, Nishihara T, Nishiguchi Y, Hirakawa K. Successful treatment using a self-expandable metallic stent in the palliation for unresectable malignant obstruction of the colon and rectum. Dig Endosc 2004;16:4-336.
 
876 - Maeda K (2002)
Maeda K, Maruta M, Sato H, Masumori K, Matsumoto M. Effect of oral diazepam on anal continence after low anterior resection: a preliminary study. Tech Coloproctol 2002; 6(1): 15-8.
 
877 - Mainenti PP (2010)
Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, et al. Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1.5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents. Abdom Imaging 2010;35(5):511-21.
 
878 - Makela JT (1995)
Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995;130:1062-7.
 
879 - Makuuchi M (1990)
Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990 May;107(5):521-7.
 
880 - Mamounas E (1999)
Mamounas E, Wieand S, Wolmark N, Bear HD, Atkins JN, Song K et al. Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04) J Clin Oncol. 1999 May;17(5):1349-55.
 
881 - Manes G (2011)
Manes G, de Bellis M, Fuccio L, Repici A, Masci E, Ardizzone S, et al. Endoscopic palliation in patients with incurable malignant colorectal obstruction by means of self-expanding metal stent: analysis of results and predictors of outcomes in a large multicenter series. Arch Surg. 2011 Oct;146(10):1157-62.
 
882 - Mansour EG (1991)
Mansour EG, Lefkopoulou M, Johnson R, Douglass H. A comparison of postoperative adjuvant chemotherapy, radiotherapy or combination therapy in potentially curable resectable rectal carcinoma. An ECOG study EST 4276 [abstract]. Proc Annu Meet Am Soc Clin Oncol 1991;10:154. Abstract 484.
 
883 - Marijnen CA (2003)
Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003;55:1311-20.
 
884 - Marijnen CAM (2005)
Marijnen CAM, Velde CJH, van de Putter H, Brink M, van den Maas CP, Martijn H, et al. Impact of Short-Term Preoperative Radiotherapy on Health-Related Quality of Life and Sexual Functioning in Primary Rectal Cancer: Report of a Mulitcenter Randomized Trial. J Clin Oncol. 2005 Mar 20;23(9):1847-58.
 
885 - Marinelli A (1996)
Marinelli A, de Brauw LM, Beerman H, Keizer HJ, van Bockel JH, Tjaden URl. Isolated liver perfusion with mitomycin C in the treatment of colorectal cancer metastases confined to the liver. Jpn J Clin Oncol 1996;26:341-50.
 
886 - Marinelli A (1991)
Marinelli A, van Dierendonck JH, van Brakel GM, Irth H, Kuppen PJ, Tjaden UR, van de Velde CJ. Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion. Br J Cancer 1991;64:1069-75.
 
887 - Marsoni S (2001)
Marsoni S; International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Efficacy of adjuvant fluorouracil and leucovorin in stage B2 and C colon cancer. International Multicenter Pooled Analysis of Colon Cancer Trials Investigators. Semin Oncol. 2001 Feb;28(1 Suppl 1):14-9.
 
888 - Martenson JA Jr (2004)
Martenson JA Jr, Willett CG, Sargent DJ, Mailliard JA, Donohue JH, Gunderson LL et al. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. J Clin Oncol. 2004;22(16):3277-83.
 
889 - Martin JK JR (1990)
Martin JK JR, O'Connell MJ, Wieand HS, Fitzgibbons RJ Jr, Mailliard JA, Rubin J, et al: Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990;125:1022-7.
 
890 - Martinez F (2005)
Martinez F, Kondylis P, Reilly J. Limitations of barium enema performed as an adjunct to incomplete colonoscopy. Dis.Colon Rectum 2005;48(10):1951-4.
 
891 - Marusch F (2002)
Marusch F, KochA, Schmidt U, Zippel R. Kuhn R, Wolff S, et al. Routine use of transrectal ultrasound in rectal carcinoma: results of a prospetive multicenter study. Endoscopy. 2002 May;34(5):385-90.
 
892 - Masaki T (2003)
Masaki T, Matsuoka H, Sugiyama M, Abe N, Mori T, Atomi Y, et al. Budding as a useful determinant of the optimal treatment for T1 rectal carcinomas. Hepato-gastroenterology. 2003 Mar-Apr;50(50):388-91.
 
893 - Masi G (2009)
Masi G, Loupakis F, Pollina L, Vasile E, Cupini S, Ricci S, et al. Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases. Ann Surg. 2009 Mar;249(3):420-5. doi: 10.1097/SLA.0b013e31819a0486
 
894 - Masi G (2011)
Masi G, Vasile E, Loupakis F, Cupini S, Fornaro L, Baldi G, et al. Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis. J Natl Cancer Inst. 2011 Jan 5;103(1):21-30. doi: 10.1093/jnci/djq456. Epub 2010 Dec 1.
 
895 - Matsuda T (1991)
Matsuda T, Yasutomi M, Kikuchi K, Kasai Y, Abe O, Kondo T et all. [Cooperative study of surgical adjuvant chemotherapy for colorectal cancer (third report): five-year results. Cooperative Study Group of Surgical Adjuvant Chemotherapy for Colorectal Cancer in Japan] Gan To Kagaku Ryoho.1991 Mar;18(3):461-9.
 
896 - Matsuo M (2001)
Matsuo M, Kanematsu M, Inaba Y, Matsueda K, Yamagami T, Kondo H, et al. Pre-operative detection of malignant hepatic tumours: value of combined helical CT during arterial portography and biphasic CT during hepatic arteriography. Clin Radiol 2001; 56:138-45
 
897 - Matsuo M (2001)
Matsuo M, Kanematsu M, Itoh K, Ito K, Maetani Y, Kondo H, et al. Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging. AJR Am J Roentgenol 2001;177:637-43.
 
898 - Matsuoka H (2003)
Matsuoka H, Nakamura A, Masaki T, Sugiyama M, Takahara T, Hachiya J, et al. Comparison between endorectal coil and pelvic phased-array coil magnetic resonance imaging in patients with anorectal tumor. Am J Surg. 2003 Apr; 185(4):328-32.
 
899 - Matzel KE (2002)
Matzel KE, Stadelmaier U, Bittorf B, Hohenfellner M, Hohenberger W. Bilateral sacral spinal nerve stimulation for fecal incontinence after low anterior rectum resection. Int J Colorectal Dis 2002;17(6):430-4.
 
900 - Maughan TS (2011)
Maughan TS, Adams RA, Smith CG, Meade AM, Seymour MT, Wilson RH et al. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial. Lancet. 2011 Jun 18;377(9783):2103-14. doi: 10.1016/S0140-6736(11)60613-2. Epub 2011 Jun 5.
 
901 - Maughan TS (2002)
Maughan TS, James RD, Kerr DJ, Ledermann JA, McArdle C, Seymour MT et al. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: A multicentre randomised trial. Lancet 2002;359:1555-63.
 
902 - Mawdsley S (2005)
Mawdsley S, Glynne-Jones R, Grainger J, Richman P, Makris A, Harrison M, et al. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 2005;63:745-52.
 
903 - McAndrew MR (1999)
McAndrew MR, Saba AK. Efficacy of routine preoperative computed tomography scans in colon cancer. Am.Surg. 1999;65(3):205-8.
 
904 - McCloskey CA (2007)
McCloskey CA, Wilson MA, Hughes SJ, Eid GM. Laparoscopic colorectal surgery is safe in the high-risk patient: a NSQIP risk-adjusted analysis. Surgery. 2007 Oct;142(4):594-7; discussion 597.e1-2.
 
905 - McGahan JP (1990)
McGahan JP, Browning PD, Brock JM, Tesluk H. Hepatic ablation using radiofrequency electrocautery. Invest Radiol 1990;25:267-70.
 
906 - McGinn CJ (1998)
McGinn CJ, Ten Haken RK, Ensminger WD, Walker S, Wang S, Lawrence TS. Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model. J Clin Oncol 1998 Jun;16(6):2246-52.
 
907 - McKay A (2009)
McKay A, Fradette K, Lipschitz J. Long-term outcomes following hepatic resection and radiofrequency ablation of colorectal liver metastases. HPB Surg. 2009;2009:346863.
 
908 - McLarty AJ (1997)
McLarty AJ, Deschamps C, Trastek VF, Allen MS, Pairolero PC, Harmsen WS. Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg 1997;63:1568-72.
 
909 - Meadows K (2006)
Meadows K, Morris CG, Rout WR, Zlotecki RA, Hochwald SN, Marsh RD, et al. Preoperative radiotherapy alone or combined with chemotherapy followed by transanal excision for rectal adenocarcinoma. Am J Clin Oncol. 2006 Oct;29(5):430-4.
 
910 - Meining A (2011)
Meining A, von Delius S, Eames TM, Popp B, Seib HJ, Schmitt W. Risk factors for unfavorable outcomes after endoscopic removal of submucosal invasive colorectal tumors. Clinical Gastroenterology & Hepatology. [Journal Article]. 2011 Jul 2011;9(7):590-4.
 
911 - Meisner S (2004)
Meisner S, Hensler M, Knop FK, West F, Wille-Jorgensen P. Self-expanding metal stents for colonic obstruction: experiences from 104 procedures in a single center. Dis Colon Rectum 2004;47(4):444-50.
 
912 - Melendez JA (1998)
Melendez JA, Arslan V, Fischer ME, Wuest D, Jarnagin WR, Fong Y, et al. Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 1998;187:620-5.
 
913 - Mellgren A (2000)
Mellgren A, Sirivongs P, Rothenberger DA, Madoff RD, García-Aguilar J. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum 2000; 43:1064-71.
 
914 - Mendez Romero A (2006)
Mendez Romero A, Wunderink W, Hussain SM, De Pooter JA, Heijmen BJ, Nowak PC, et al. Stereotactic body radiation therapy for primary and metastatic liver tumors: A single institution phase i-ii study. Acta Oncol 2006;45(7):831-7.
 
915 - Mendez Romero A (2008)
Mendez Romero A, Wunderink W, van Os RM, Nowak PJ, Heijmen BJ, Nuyttens JJ, et al. Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys 2008 Apr 1;70(5):1447-52.
 
916 - Mentges B (1997)
Mentges B, Buess G, Effinger G, Manncke K, Becker HD. Indications and results of local treatment of rectal cancer. Br J Surg. 1997 Mar;84(3):348-51.
 
917 - MERCURY Study Group (2006)
MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006 Oct 14;333(7572):779-82.
 
918 - Meric F (2000)
Meric F, Patt YZ, Curley SA, Chase J, Roh MS, Vauthey JN, et al. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 2000; 7:490-5.
 
919 - Mescoli C (2012)
Mescoli C, Albertoni L, Pucciarelli S, Giacomelli L, Russo VM, Fassan M, et al. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer. J Clin Oncol. 2012 Mar 20;30(9):965-71. doi: 10.1200/JCO.2011.35.9539. Epub 2012 Feb 21.
 
920 - MGC (2001)
Meta-analysis Group in Cancer. Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancer. Br J Cancer 2001;84:611-620.
 
921 - MGC (1998)
Meta-analysis Group In Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J.Clin.Oncol. 1998;16(1):301-8.
 
922 - MGC (1996)
Meta-Analysis Group In Cancer. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. Meta-Analysis Group in Cancer. J Natl Cancer Inst 1996;88:252-8.
 
923 - Metcalfe MS (2004)
Metcalfe MS, Bridgewater FH, Mullin EJ, Maddern GJ. Useless and dangerous--fine needle aspiration of hepatic colorectal metastases. BMJ 2004;328:507-8.
 
924 - Metcalfe MS (2003)
Metcalfe MS, Close JS, Iswariah H, Morrison C, Wemyss-Holden SA, Maddern GJ. The value of laparoscopic staging for patients with colorectal metastases. Arch Surg 2003;138:770-2.
 
925 - Metcalfe MS (2004)
Metcalfe MS, Mullin EJ, Maddern GJ. Choice of surveillance after hepatectomy for colorectal metastases. Arch Surg 2004; 139:749-54.
 
926 - Metser U (2010)
Metser U, You J, McSweeney S, Freeman M, Hendler A. Assessment of tumor recurrence in patients with colorectal cancer and elevated carcino-embryonic antigen level: FDG PET-CT versus contrast enhanced 64-MDCT of the chest and abdomen. AJR Am J Roentgenol. 2010 Mar;194(3):766-71
 
927 - Meyer TJ (1995)
Meyer TJ, Mark MM. Effects of psychosocial interventions with adult cancer patients: a meta-analysis of randomized experiments. Health Psychol 1995;14:101-8.
 
928 - Meyerhardt JA (2003)
Meyerhardt JA, Mayer RJ. Follow-up strategies after curative resection of colorectal cancer. Semin Oncol 2003;30:3-360.
 
929 - Middleton PF (2005)
Middleton PF, Sutherland LM, Maddern GJ. Transanal endoscopic microsurgery: a systematic review. Dis Colon Rectum 2005; 48:270-84.
 
930 - Milsom JW (1998)
Milsom JW, Bohm B, Hammerhofer KA, Fazio V, Steiger E, Elson P. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report. J Am Coll Surg 1998;187(1):46-54.
 
931 - Mineo TC (2003)
Mineo TC, Ambrogi V, Tonini G, Bollero P, Roselli M, Mineo D, et al. Longterm results after resection of simultaneous and sequential lung and liver metastases from colorectal carcinoma. J Am Coll Surg 2003;197:386-91
 
932 - Ministry of Health (2004)
Ministry of Health. Colorectal cancer. MOH Clinical Practise Guidelines 2/2004. Ministry of Health, Singapore; 2004.
 
933 - Mitry E (2008)
Mitry E, Fields AL, Bleiberg H, Labianca R, Portier G, Tu D, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008;26:4906-11.
 
934 - Mittal BR (2011)
Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh B, Kapoor R, et al. 18-FDG PET-CT in the evaluation of postoperative colorectal cancer patients with rising CEA. Nucl Med Comm 2011; 32(9):789-93.
 
935 - Mock V (2003)
Mock V, Olsen M. Current management of fatigue and anemia in patients with cancer. Semin Oncol Nurs 2003;19(4 suppl 2):36-41.
 
936 - Moertel CG (1990)
Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Goodman PJ, et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990 Feb 8;322(6):352-8.
 
937 - Mohiuddin M (1994)
Mohiuddin M, Marks G, Bannon J. High-dose preoperative radiation and full thickness local excision: a new option for selected T3 distal rectal cancers. Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):845-9.
 
938 - Mol L (2013)
Mol L, Koopman M, van Gils CWM, Ottevanger PB, Punt CJ. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands. Acta Oncol. 2013 Jun;52(5):950-5.
 
939 - Monges G (1998)
Monges G, Piard F. Recommandations pour la redaction des comptes rendus anatomopathologiques des cancers colorectaux. [Recommendations for editing pathology reports of colorectal cancer]. Ann Pathol 1998;18:444-9.
 
940 - Moore HG (2003)
Moore HG, Riedel E, Minsky BD, Saltz L, Paty P, Wong D, et al. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 2003;10:80-5.
 
941 - Moore JS (2008)
Moore JS, Cataldo PA, Osler T, Hyman NH. Transanal endoscopic microsurgery is more effective than traditional transanal excision for resection of rectal masses. Dis Colon Rectum. 2008 Jul;51(7):1026-30; discussion 1030-1. doi: 10.1007/s10350-008-9337-x. Epub 2008 May 15
 
942 - Moosmann N (2011)
Moosmann N, von Weikersthal LF, Vehling-Kaiser U, Stauch M, Hass HG, Dietzfelbinger H, et al. Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group. J Clin Oncol. 2011 Mar 10;29(8):1050-8. doi: 10.1200/JCO.2010.31.1936. Epub 2011 Feb 7.
 
943 - Morino M (2011)
Morino M, Allaix ME, Caldart M, Scozzari G, Arezzo A. Risk factors for recurrence after transanal endoscopic microsurgery for rectal malignant neoplasm. Surg Endosc 2011 25(11): 3683-90.
 
944 - Morrin MM (1999)
Morrin MM, Kruskal JB, Farrell RJ, Goldberg SN, McGee JB, Raptopoulos V. Endoluminal CT colonography after an incomplete endoscopic colonoscopy. AJR Am.J Roentgenol. 1999;172(4) :913-8.
 
945 - Moulton C (2011)
Moulton C, Levine N, Law R, et al. An Ontario Clinical Oncology Group (OCOG) randomized controlled trial (RCT) assessing FDG PET/CT in resectable liver colorectal adenocarcinoma metastases (CAM). J Clin Oncol 2011(29): suppl;abstr. 3520.
 
946 - Moya P (2012)
Moya P, Arroyo A, Soriano-Irigaray L, Frangi A, Candela Polo F, Calpena Rico R. Sacral nerve stimulation in patients with severe fecal incontinence after rectal resection. Tech Coloproctol. 2012 Jun;16(3):263-4
 
947 - Mulhall BP (2005)
Mulhall BP, Veerappan GR, Jackson JL. Meta-analysis: computed tomographic colonography. Ann Intern Med. 2005 Apr 19;142(8):635-50.
 
948 - Mulier S (2002)
Mulier S, Mulier P, Ni Y, Miao Y, Dupas B, Marchal G, t al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002;89:1206-22.
 
949 - Müller H (2001)
Müller H, Nakchbandi W, Chatzissavvidis I, Valek V. Intra-arterial infusion of 5-fluorouracil plus granulocyte-macrophage colony-stimulating factor (GM-CSF) and chemoembolization with melphalan in the treatment of disseminated colorectal liver metastases. Eur J Surg Oncol. 2001 Nov;27(7):652-61.
 
950 - Muller-Engelmann M (2011)
Muller-Engelmann M, Keller H, Donner-Banzhoff N, Krones T. Shared decision making in medicine: the influence of situational treatment factors. Patient Educ Couns 2011;82:240-6.
 
951 - MSRS (2011)
Multicenter Study Research Support Non-U S Gov't]. 2011 Apr 2011;23(2):190-4.
 
952 - Muratore A (2001)
Muratore A, Polastri R, Bouzari H, Vergara V, Ferrero A, Capussotti L. Repeat hepatectomy for colorectal liver metastases: A worthwhile operation? J Surg Oncol 2001; 76:127-32.
 
953 - Murphy KM
Murphy KM, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR.
 
954 - Murpphy KM (2006)
Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn. 2006 Jul;8(3):305-11. [link]
 
955 - Murray A (2006)
Murray A, Lourenco T, de Verteuil R, Hernandez R, Fraser C, McKinley A, et al. Systematic review of the clinical effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer,. Health Technol Assess. 2006 Nov;10(45):1-141, iii-iv.
 
956 - Mutsaerts EL (2003)
Mutsaerts EL, Van CF, Krause R, Borel Rinkes IH, Strobbe LJ, Prevoo W, et al. Initial experience with radiofrequency ablation for hepatic tumours in the Netherlands. Eur J Surg Oncol 2003;29:731-4.
 
957 - Nagakura S (2002)
Nagakura S, Shirai Y, Suda T, Hatakeyama K. Multiple repeat resections of intra- and extrahepatic recurrences in patients undergoing initial hepatectomy for colorectal carcinoma metastases. World J Surg 2002; 26:141-7.
 
958 - Nagtegaal ID (2002)
Nagtegaal ID, Marijnen CA, Kranenbarg EK, van deVelde CJ, van Krieken JH. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350-7.
 
959 - Nagtegaal ID (2005)
Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23(36):9257-64.
 
960 - Nagtegaal ID (2002)
Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729-34.
 
961 - Nair RM (2008)
Nair RM, Siegel EM, Chen DT, Fulp WJ, Yeatman TJ, Malafa MP, et al. Long-term results of transanal excision after neoadjuvant chemoradiation for T2 and T3 adenocarcinomas of the rectum. J Gastrointest Surg. 2008;12(10):1797-805; discussion 805-6.
 
962 - Nakafusa Y (2004)
Nakafusa Y, Tanaka T, Tanaka M, Kitajima Y, Sato S, Miyazaki K. Comparison of multivisceral resection and standard operation for locally advanced colorectal cancer: analysis of prognostic factors for short-term and long-term outcome. Dis Colon Rectum. 2004 Dec;47(12):2055-63
 
963 - Naredi P (2003)
Naredi P, Oman M, Blind P, Lindnér P, Gustavsson B, Hafström L. A comparison between hepatic artery ligation and portal 5-FU infusion versus 5-FU intra arterial infusion for colorectal liver metastases. Eur J Surg Oncol. 2003 Jun;29(5):459-66.
 
964 - Nascimbeni R (2002)
Nascimbeni R, Burgart LJ, Nivatvongs S, Larson DR. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum. Dis Colon Rectum 2002; 45:200-6.
 
965 - Nascimbeni R (2004)
Nascimbeni R, Nivatvongs S, Larson DR, Burgart LJ. Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum 2004; 47:1773-9.
 
966 - Nash GM (2009)
Nash GM, Weiser MR, Guillem JG, Temple LK, Shia J, Gonen M, et al. Long-term survival after transanal excision of T1 rectal cancer. Dis Colon Rectum. 2009 Apr;52(4):577-82. doi: 10.1007/DCR.0b013e3181a0adbd.
 
967 - NPK (2004)
Nationaal Programma Kankerbestrijding [NPK] (2004). Deel I. Visie en samenvatting NPK 2005-2010. Leens: Grafische Industrie De Marne.
 
968 - NVMDL (2013)
Nederlandse Vereniging voor Maag-Darm-Leverartsen. Nederlandse richtlijn coloscopie surveillance 2013.
 
969 - Neri E (2002)
Neri E, Giusti P, Battolla L, Vagli P, Boraschi P, Lencioni R, et al. Colorectal cancer: role of CT colonography in preoperative evaluation after incomplete colonoscopy. Radiology 2002;223(3):615-9.
 
970 - Nesbakken A (2002)
Nesbakken A, Nygaard K, Westerheim O, Lunde OC, Mala T. Audit of intraoperative and early postoperative complications after introduction of mesorectal excision for rectal cancer. Eur J Surg 2002;168:229-35.
 
971 - Neudecker J (2003)
Neudecker J, Junghans T, Ziemer S, Raue W, Schwenk W. Prospective randomized trial to determine the influence of laparoscopic and conventional colorectal resection on intravasal fibrinolytic capacity. Surg Endosc 2003;17(1):73-7.
 
972 - NICE (2004)
NICE. Guidance for Commissioning Cancer Services. Improving Outcomes in Colorectal Cancers. Research Evidence for the Manual Update. NICE 2004.
 
973 - NICE (2005)
NICE. Overview. The use of irinotecan, oxaliplatin and raltitrexed for the treatment of dvanced colorectal cancer. February 2005.
 
974 - Niekel MC (2010)
Niekel MC, Bipat S, Stoker J. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology. 2010;257:674-84
 
975 - Nielsen K (2013)
Nielsen K, van Tilborg AA, Scheffer HJ, Meijerink MR, de Lange-de Klerk ES, Meijer S, Comans EF, van den Tol MP. PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation. Eur J Radiol. 2013 Dec;82(12):2169-75
 
976 - NGTATG (1992)
Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Expectancy of primary chemotherapy in patients with advanced asymptomatic colorectal cancer: a randomized trial. J Clin Oncol 1992;10:904-11.
 
977 - Nordlinger B (1996)
Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254-62.
 
978 - Nordlinger B (2008)
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008:371:1007-16.
 
979 - Nordlinger B
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T; for the EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und–tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD).
 
980 - Nordlinger B (2012)
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. EORTC liver metastases intergroup randomized phase III study40983: long-term survival results. Proc Am Soc Clin Oncol 2012; abstract 3508
 
981 - Nordlinger B (1994)
Nordlinger B, Vaillant JC, Guiguet M, Balladur P, Paris F, Bachellier P, et al. Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Francaise de Chirurgie. J Clin Oncol 1994; 12:1491-6
 
982 - Norum J (1997)
Norum J, Olsen JA. A cost-effectiveness approach to the Norwegian follow-up programme in colorectal cancer. Ann Oncol. 1997;8(11):1081-7.
 
983 - Noter SL (2004)
Noter SL, Rothbarth J, Pijl ME, Keunen JE, Hartgrink HH, Tijl FG, et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of uveal melanoma metastases confined to the liver. Melanoma Res. 2004;14:67-72.
 
984 - Nymann T (1995)
Nymann T, Jess P, Christiansen J. Rate and treatment of pelvic recurrence after abdominoperineal resection and low anterior resection for rectal cancer. Dis Colon Rectum. 1995 Aug;38(8):799-802.
 
985 - O'Connell JB (2004)
O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004 Oct 6;96(19):1420-5.
 
986 - O'Connell MJ (1997)
O'Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ et al. Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol. 1997 Jan;15(1):246-50.
 
987 - O'Connell MJ (1994)
O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, et al. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 1994;331(8):502-7.
 
988 - O'Connor AM (1995)
O'Connor AM. Validation of a decisional conflict scale. Med Decis Making 1995;15:25-30.
 
989 - Ohlsson B (1995)
Ohlsson B, Breland U, Ekberg H, Graffner H, Trannberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum 1995,38:619-26.
 
990 - Ohlsson B (2002)
Ohlsson B, Nilsson J, Stenram U, Akerman M, Tranberg KG. Percutaneous fine-needle aspiration cytology in the diagnosis and management of liver tumours. Br J Surg. 2002 ;89:757-62.
 
991 - Ohlsson B (2003)
Ohlsson B, Pĺlsson B. Follow-up after colorectal cancer surgery. Acta Oncol 2003;42(8):816-26.
 
992 - Ohlsson B (1993)
Ohlsson B, Tranberg KG, Lundstedt C, Ekberg H, Hederstrom E. Detection of hepatic metastases in colorectal cancer: a prospective study of laboratory and imaging methods. Eur J Surg 1993;159:275-281.
 
993 - Oka S (2011)
Oka S, Tanaka S, Kanao H, Ishikawa H, Watanabe T, Igarashi M, et al. Mid-term prognosis after endoscopic resection for submucosal colorectal carcinoma: summary of a multicenter questionnaire survey conducted by the colorectal endoscopic resection standardization implementation working group in Japanese Society for Cancer of the Colon and Rectum. Dig Endosc. 2011 Apr;23(2):190-4.
 
994 - Okabe S (2004)
Okabe S, Shia J, Nash G, Wong WD, Guillem JG, Weiser MR, et al. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum. J Gastrointest Surg. 2004 Dec;8(8):1032-9; discussion 9-40.
 
995 - Oldhafer KJ (1998)
Oldhafer KJ, Lang H, Frerker M, Moreno L, Chavan A, Flemming P, et al. First experience and technical aspects of isolated liver perfusion for extensive liver metastasis. Surgery 1998;123:622-31.
 
996 - Ong LJM (1999)
Ong LJM, Hoos AM, Laarhoven FJ van, Molenaar S, Visser MRM. De arts als boodschapper. In: Haes JC de, Hoos AM, Everdingen JJ van (eds). Communiceren met patiënten. Maarssen: Elsevier/Bunge, 1999:49-62.
 
997 - Onbekend (1997)
Ontwikkeling van een informatieprotocol, 1997.
 
998 - Ortega M (2012)
Ortega M, et al. Sacral nerve stimulation for the treatment of faecal incontinence after anterior resection. Colorectal Disease 2012;14: 29.
 
999 - Oshowo A (2003)
Oshowo A, Gillams A, Harrison E, Lees WR, Taylor I. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003 Oct;90(10):1240-3.
 
1000 - Otchy D (2004)
Otchy D, Hyman NH, Simmang C, Anthony T, Buie WD, Cataldo P et al. Practice parameters for colon cancer. Dis Colon Rectum. 2004;47:1269-84.
 
1001 - Oudkerk M (1997)
Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PI, Borel Rinkes IH, Wiggers T. Hepatic lesions: detection with ferumoxide-enhanced T1-weighted MR imaging. Radiology 1997;203:449-56.
 
1002 - Ozkam E (2012)
Ozkam E, Soydal C, Araz M, Kir KM, Ibis E. The role of (18)F PET-CT in detecting colorectal cancer recurrence in patients with elevated CEA level. Nucl Med Comm 2012; 33(4): 395-402.
 
1003 - Pachler J (2005)
Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. 2005 Apr 18;(2):CD004323.
 
1004 - Pahlman L (2013)
Pahlman L, Bujko K, Rutkowski A, Michalski W. Altering the therapeutic paradigm towards a distal bowel margin of less than 1 cm in patients with low-lying rectal cancer: a systematic review and commentary. Colorectal Dis 2013 Jan 19. doi: 10.1111/codi.12120. [Epub ahead of print]
 
1005 - Pahlman L (1990)
Pahlman L, Glimelius B. Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial. Ann Surg. 1990 Feb;211(2):187-95.
 
1006 - Palermo JA (2000)
Palermo JA, Richards F, Lohman KK, Lovelace JV, Atkinson J, Case LD, et al. Phase II trial of adjuvant radiation and intraperitoneal 5-fluorouracil for locally advanced colon cancer: results with 10-year follow-up. Int J Radiat Oncol Biol Phys 2000;47(3):725-33.
 
1007 - Palma P (2009)
Palma P, Horisberger K, Joos A, Rothenhoefer S, Willeke F, Post S. Local excision of early rectal cancer: is transanal endoscopic microsurgery an alternative to radical surgery? Rev Esp Enferm Dig. 2009 Mar;101(3):172-8.
 
1008 - Pandor A (2006)
Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliff P. The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation. Health Technol Assess. 2006 Nov;10(41):iii-iv, xi-xiv,1-185.
 
1009 - Panzironi G (2004)
Panzironi G, De Vargas Macciucca M, Manganaro L, Ballesio L, Ricci F, Casale A, Campagnano D. Preoperative locoregional staging of rectal carcinoma: comparison of MR, TRUS and Multislice CT. Personal experience. Radiol Med. 2004 Apr;107(4):344-55. [link]
 
1010 - Park IJ (2008)
Park IJ, Kim HC, Yu CS, Kim PN, Won HJ, Kim JC. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol. 2008 Jan;15(1):227-32.
 
1011 - Park JS (2007)
Park JS, Kang SB, Kim DW, Namgung HW, Kim HL. The efficacy and adverse effects of topical phenylephrine for anal incontinence after low anterior resection in patients with rectal cancer. Int J Colorectal Dis 2007: 22(11):1319-24.
 
1012 - Park JW (2008)
Park JW, Sohn DK, Hong CW, Han KS, Choi DH, Chang HJ, et al. The usefulness of preoperative colonoscopic tattooing using a saline test injection method with prepackaged sterile India ink for localization in laparoscopic colorectal surgery. Surg Endosc. 2008 Feb;22(2):501-5. Epub 2007 Aug 17
 
1013 - Park SH (2012)
Park SH, Lee JH,Lee SS, Kim JC, Yu CS, Kim HC, et al. CT colonography for detection and characterisation of synchronous proximal colonic lesions in patients with stenosing colorectal cancer. Gut 2012;61:1716–22.
 
1014 - Patel S (2011)
Patel S, McCall M, Ohinmaa A, Bigam D, Dryden DM. Positron emission tomography/computed tomographic scans compared to computed tomographic scans for detecting colorectal liver metastases: a systematic review. Ann Surg 2011 Apr;253(4):666-71.
 
1015 - Pathak S (2011)
Pathak S, Jones R, Tang JM, Parmar C, Fenwick S, Malik H, Poston G. Ablative therapies for colorectal liver metastases: a systematic review. Colorectal Dis. 2011 Sep;13(9):e252-65.
 
1016 - Paty PB (2002)
Paty PB, Nash GM, Baron P, Zakowski M, Minsky BD, Blumberg D, et al. Long-term results of local excision for rectal cancer. Ann Surg 2002;236:522-9.
 
1017 - Pawlik TM (2005)
Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C, et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005;241:715-22,discussion
 
1018 - Pazdur R (1997)
Pazdur R, Vincent M. Raltitrexed (Tomudex) versus 5-fluorouracil and leucovorin (5FU+LV) in patients with advanced colorectal cancer (ACC): results of a randomized, multicenter, North American trial. Proc Am Soc Clin Oncol 1997; 16 228a-Abstr 801.
 
1019 - Pearson AS (1999)
Pearson AS, Izzo F, Fleming RY, Ellis LM, Delrio P, Roh MS, et al.Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg 1999;178:592-9.
 
1020 - Peeters KC (2005)
Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK et all. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients--a Dutch colorectal cancer group study. J Clin Oncol 2005 Sep 1;23(25):6199-206.
 
1021 - Peeters M (2010)
Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y et al. Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer. J Clin Oncol. 2010 Nov 1;28(31):4706-13. doi: 10.1200/JCO.2009.27.6055. Epub 2010 Oct 4
 
1022 - Peng J (2011)
Peng J, Chen W, Sheng W, Xu Y, Cai G, Huang D, Cai S. Oncological outcome of T1 rectal cancer undergoing standard resection and local excision. Colorectal Dis. 2011 Feb;13(2):e14-9. doi: 10.1111/j.1463-1318.2010.02424.x.
 
1023 - Peng J (2011)
Peng J, Chen W, Venook AP, Sheng W, Xu Y, Guan Z, et al., Long-term outcome of early-stage rectal cancer undergoing standard resection and local excision. Clin Colorectal Cancer. 2011 Mar 1;10(1):37-41.
 
1024 - Peng (2010)
Peng, J., et al., Outcome of T1N0 rectal cancer undergoing standard resection and local excision. Diseases of the Colon and Rectum, 2010. 53 (4): p. 638.
 
1025 - Penna C (2002)
Penna C, Nordlinger B. Surgery of liver metastases from colorectal cancer: new promises. Br Med Bull 2002;64:127-40.
 
1026 - Perez RO (2013)
Perez RO, Habr-Gama A, Lynn PB, Săo Juliăo GP, Bianchi R, Proscurshim I, et al. Transanal Endoscopic Microsurgery for Residual Rectal Cancer (ypT0-2) Following Neoadjuvant Chemoradiation Therapy: Another Word of Caution. Dis Colon Rectum. 2013 Jan;56(1):6-13
 
1027 - Perez RO (2011)
Perez RO, Habr-Gama A, Săo Juliăo GP, Proscurshim I, Scanavini Neto A, Gama-Rodrigues J. Transanal endoscopic microsurgery for residual rectal cancer after neoadjuvant chemoradiation therapy is associated with significant immediate pain and hospital readmission rates. Dis Colon Rectum. 2011 May;54(5):545-51. doi: 10.1007/DCR.0b013e3182083b84.
 
1028 - Nordlinger B (2013)
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol 2013; Oct 10 [Epub ahead of print]
 
1029 - Peschaud F (2005)
Peschaud F, Cuenod CA, Benoist S, Julie C, Beauchet A, Siauve N, et al. Accuracy of magnetic resonance imaging in rectal cancer depends on location of the tumor. Dis Colon Rectum. 2005 Aug;48(8):1603-9.
 
1030 - Peterson MS (1996)
Peterson MS, Baron RL, Murakami T. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging. Radiology. 1996;201:337-45.
 
1031 - Petrowsky H (2002)
Petrowsky H, Gonen M, Jarnagin W, Lorenz M, DeMatteo R, Heinrich S, et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 2002; 235:863-71
 
1032 - Pettersson D (2010)
Pettersson D, Cedermark B, Holm T, Radu C, Pĺhlman L, Glimelius B, Martling A. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg. 2010 Apr;97(4):580-7. doi: 10.1002/bjs.6914.
 
1033 - Pettersson D (2012)
Pettersson D, Holm T, Iversen H, Blomqvist L, Glimelius B, Martling A. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg. 2012 Apr;99(4):577-83. doi: 10.1002/bjs.7796. Epub 2012 Jan 12.
 
1034 - Peulen JJ (2010)
Peulen JJ, de Witte MT, Friederich P, Dirix HL, de Visser DC, van Langen H, et al. CT-colografie als eerstelijnsdiagnosticum bij patiënten met darmklachten. Ned Tijdschr Geneeskd 2010;154:A1681
 
1035 - Phillips RK (1992)
Phillips RK. Adequate distal margin of resection for adenocarcinoma of the rectum. World J Surg 1992;16:463-6.
 
1036 - Pickhardt PJ (2011)
Pickhardt PJ, Hassan C, Halligan S, Marmo R. Colorectal cancer: CT colonography and colonoscopy for detection--systematic review and meta-analysis. Radiology 2011;259:393-405
 
1037 - Pieterse AH (2011)
Pieterse AH, Stalmeier PF, Kroep JR, Stiggelbout AM. [Adjuvant cancer treatment: what benefit does the patient consider worthwhile?]. Ned Tijdschr Geneeskd 2011;155:A3905.
 
1038 - Pieterse AH (2007)
Pieterse AH, Stiggelbout AM, Baas-Thijssen MC, van de Velde CJ, Marijnen CA. Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences. Br J Cancer 2007;97:717-724.
 
1039 - Pietra N (1998)
Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer. Dis Colon Rectum 1998;41:1127-33.
 
1040 - Pijl ME (2003)
Pijl ME, Wasser MN, Joekes EC, van De Velde CJ, Bloem JL. Metastases of Colorectal Carcinoma: Comparison of soft and hard copy helical CT interpretation. Radiology 2003;227:747-51.
 
1041 - Pijl ME (1998)
Pijl ME, Wasser MN, van Persijn van Meerten EL, Gratama JW, van de Velde CJ, Hermans J, et al. Comparison of inversion-recovery grad. Radiology 1998;209:427-34.
 
1042 - Pińol V (2005)
Pińol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Rodríguez-Moranta F, Payá A, Jover R, Bessa X; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA. 2005 Apr 27;293(16):1986-94.
 
1043 - Pirlet IA (2011)
Pirlet IA, Slim K, Kwiatkowski F, Michot F, Millat BL. Emergency preoperative stenting versus surgery for acute left-sided malignant colonic obstruction: a multicenter randomized controlled trial. Surg Endosc. 2011 Jun;25(6):1814-21. doi: 10.1007/s00464-010-1471-6. Epub 2010 Dec 18.
 
1044 - Piscatelli N (2005)
Piscatelli N, Hyman N, Osler T. Localizing colorectal cancer by colonoscopy. Arch Surg. 2005 Oct;140(10):932-5.
 
1045 - Pohl H (2013)
Pohl H, Srivastava A, Bensen SP, Anderson P, Rothstein RI, Gordon SR, et al. Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology. 2013 Jan;144(1):74-80 e1.
 
1046 - Poon FW (2005)
Poon FW, McDonald A, Anderson JH, Duthie F, Rodger C, McCurrach G, et al. Accuracy of thin section magnetic resonance using phased-array pelvic coil in predicting the T-staging of rectal cancer. Eur.J.Radiol. 2005 Feb;53(2):256-62.
 
1047 - Poon RT (2004)
Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg 2004;240:698-708.
 
1048 - Popovici V (2012)
Popovici V, Budinska E, Tejpar S, Weinrich S, Estrella H, Hodgson G, et al. Identification of a poor-prognosis BRAF-mutant-like population of patients with colon cancer. J Clin Oncol. 2012 Apr 20;30(12):1288-95.
 
1049 - Povoski SP (1998)
Povoski SP, Fong Y, Sgouros SC, Kemeney NE, Downey RJ, Blumgart LH. Role of chest CT in patients with negative chest x-rays referred for hepatic colorectal metastases. Ann Surg Oncol 1998;5:9-15.
 
1050 - Power DG (2010)
Power DG, Kemeny NE. Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol 2010;28:2300-9.
 
1051 - Price T (2013)
Price T, et al. A randomised, multicentre, open-label, phase 3 study of panitumumab versus cetuximab for previously treated wild-type KRAS metastatic colorectal cancer. ECCO 2013; LBA18
 
1052 - Pucciani F (2008)
Pucciani F, Ringressi MN, Redditi S, Masi A, Giani I. Rehabilitation of fecal incontinence after sphincter-saving surgery for rectal cancer: encouraging results. Dis Colon Rectum 2008; 51(10):1552-8.
 
1053 - Pucciarelli S (2004)
Pucciarelli S, Toppan P, Friso ML, Russo V, Pasetto L, Urso E, et al. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum 2004;47:1798-1807.
 
1054 - Punt CJ (2008)
Punt CJ, Koopman M. Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer. J Clin Oncol. 2008 Apr 10;26(11):1907-8; author reply 1908-9. doi: 10.1200/JCO.2007.15.9640.
 
1055 - Punt CJ (2005)
Punt CJ. Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer? Ann Oncol. 2005 Jun;16(6):845-6. Epub 2005 May 12.
 
1056 - Punt CJ (2004)
Punt CJ. New options and old dilemmas in the treatment of patients with advanced colorectal cancer. Ann Oncol 2004; 15:1453-9.
 
1057 - Punt CJ (2007)
Punt CJ, Buyse M, Köhne CH, Hohenberger P, Labianca R, Schmoll HJ, Pĺhlman L, Sobrero A, Douillard JY. Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials. J Natl Cancer Inst. 2007 Jul 4;99(13):998-1003. Epub 2007 Jun 27.
 
1058 - Purkayastha S (2005)
Purkayastha S, Tekkis PP, Athanasiou T, Aziz O, Negus R, Gedroyc W et al. Magnetic resonance colonography versus colonoscopy as a diagnostic investigation for colorectal cancer: a meta-analysis. Clin Radiol 2005;60:980–9.
 
1059 - QUASAR (2000)
QUASAR Collaborative Group. Comparison of flourouracil with additional levamisole, higher-dose folinic acid, or both, as adjuvant chemotherapy for colorectal cancer: a randomised trial. Lancet. 2000 May 6;355(9215):1588-96.
 
1060 - Quirke P (1986)
Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 1986 Nov 1;2(8514):996-9.
 
1061 - Radu C (2008)
Radu C, Berglund A, Pĺhlman L, Glimelius B . Short-course preoperative radiotherapy with delayed surgery in rectal cancer - a retrospective study. Radiother Oncol. 2008 Jun;87(3):343-9. Epub 2008 Feb 21.
 
1062 - Rahbari NN (2012)
Rahbari NN, Bork U, Motschall E, Thorlund K, Büchler MW, Koch M, et al. Molecular detection of tumor cells in regional lymph nodes is associated with disease recurrence and poor survival in node-negative colorectal cancer: a systematic review and meta-analysis. J Clin Oncol. 2012 Jan 1;30(1):60-70. doi: 10.1200/JCO.2011.36.9504. Epub 2011 Nov 28.
 
1063 - Rahusen FD (1999)
Rahusen FD, Cuesta MA, Borgstein PJ, Bleichrodt RP, Barkhof F, Doesburg T, et al. Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg 1999;230:31-7.
 
1064 - Ramirez JM (2011)
Ramirez JM, Aguilella V, Valencia J, Ortego J, Gracia JA, Escudero P, et al. Transanal endoscopic microsurgery for rectal cancer. Long-term oncologic results. Int J Colorectal Dis 2011. 26(4): 437-43.
 
1065 - Ramos E (2008)
Ramos E, Martínez L, Gámez C, Torras J, Valls C, Rafecas A, Lladó L, Jorba R, Ruiz S, Serrano T, Fabregat J. [Use of PET-CT in pre-surgical staging of colorectal cancer hepatic metastases]. Cir Esp. 2008 Aug;84(2):71-7. [link]
 
1066 - Rappeport ED (2007)
Rappeport ED, Loft A, Berthelsen AK, von der Recke P, Larsen PN, Mogensen AM, Wettergren A, Rasmussen A, Hillingsoe J, Kirkegaard P, Thomsen C.Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol. 2007 May;48(4):369-78.
 
1067 - Ratto C (2005)
Ratto C, Grillo E, Petrolino M, Costamagna G, Doglietto GB. Sacral neuromodulation in treatment of fecal incontinence following anterior resection and chemoradiation for rectal cancer. Dis Colon Rectum 2005; 48(5):1027-36.
 
1068 - Ratto C (2012)
Ratto C, Parello A, et al. Sacral nerve stimulation as therapeutic option in patients with faecal incontinence following rectal cancer treatment. Colorectal Dis. 2012 Jun;14(6):297-304.
 
1069 - Ratto C (2002)
Ratto C, Ricci R, Rossi C, Morelli U, Vecchio FM, Doglietto GB. Mesorectal microfoci adversely affect the prognosis of patients with rectal cancer. Dis Colon Rectum 2002;45:733-42.
 
1070 - Read TE (2004)
Read TE, Andujar JE, Caushaj PF, Johnston DR, Dietz DW, Myerson RJ, et al. Neoadjuvant therapy for rectal cancer: histologic response of the primary tumor predicts nodal status. Dis Colon Rectum 2004;47:825-31.
 
1071 - Reddy RH (2004)
Reddy RH, Kumar B, Shah R, Mirsadraee S, Papagiannopoulos K, Lodge ,P et al. Staged pulmonary and hepatic metastasectomy in colorectal cancer--is it worth it? Eur J Cardiothorac Surg 2004;25:151-4.
 
1072 - Reggiani Bonetti L (2011)
Reggiani Bonetti L, Di Gregorio C, De Gaetani C, Pezzi A, Barresi G, Barresi V, et al. Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma. Scand J Gastroenterol. 2011 Jul;46(7-8):881-6. doi: 10.3109/00365521.2011.571708. Epub 2011 Apr 15.
 
1073 - Beets-Tan RGH (2012)
Beets-Tan RGH; et al Magnetic resonance imaging for the clinical management of rectal cancer patients: recommendations from the 2012 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting. European radiology 2013, in press 
 
1074 - Regnard JF (1998)
Regnard JF, Grunenwald D, Spaggiari L, Girard P, Elias D, Ducreux M, et al. Surgical treatment of hepatic and pulmonary metastases from colorectal cancers. Ann Thorac Surg 1998; 66:214-8.
 
1075 - Ren L (2012)
Ren L, Zhu D, Wei Y, Pan X, Liang L, Xu J, et al. Enhanced Recovery After Surgery (ERAS) program attenuates stress and accelerates recovery in patients after radical resection for colorectal cancer: a prospective randomized controlled trial. World J Surg. 2012 Feb;36(2):407-14. doi: 10.1007/s00268-011-1348-4.
 
1076 - Renehan AG (2002)
Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002;324:813.
 
1077 - Renehan AG (2004)
Renehan AG, O'Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ 2004;328:81.
 
1078 - Reuter NP (2009)
Reuter NP, Woodall CE, Scoggins CR, McMasters KM, Martin RC. Radiofrequency ablation vs. resection for hepatic colorectal metastasis: therapeutically equivalent? J Gastrointest Surg. 2009 Mar;13(3):486-91.
 
1079 - Rex DK (2006)
Rex DK, Kahi CJ, Levin B, Smith RA, Bond JH, Brooks D et al. American Cancer Society; US Multi-Society Task Force on Colorectal Cancer. Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterol 2006;130:1865-71.
 
1080 - Reza MM (2006)
Reza MM, Blasco JA, Andradas E, Cantero R, Mayol J. Systematic review of laparoscopic versus open surgery for colorectal cancer. Br J Surg. 2006 Jul 17;93(8):921-8.
 
1081 - Ribero D (2007)
Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C, et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer 2007 Dec 15;110(12):2761-7.
 
1082 - Ricciardi R (2006)
Ricciardi R, Madoff RD, Rothenberger DA, Baxter NN. Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol 2006;4(12):1522-7.
 
1083 - Richman SD (2009)
Richman SD, Seymour MT, Chambers P, Elliott F, Daly CL, Meade AM, et al. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. J Clin Oncol. 2009 Dec 10;27(35):5931-7. doi: 10.1200/JCO.2009.22.4295. Epub 2009 Nov 2.
 
1084 - Rigby K (1999)
Rigby K, Brown SR, Lakin G, Balsitis M, Hosie KB. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl 1999;81:401-3.
 
1085 - RIVM
Rijksinstituut voor Volksgezondheid en Milieu, Uitvoeringstoets bevolkingsonderzoek naar darmkanker.
 
1086 - Rivoire M (2002)
Rivoire M, De Cian F, Meeus P, Negrier S, Sebban H, Kaemmerlen P. Combination of neoadjuvant chemotherapy with cryotherapy and surgical resection for the treatment of unresectable liver metastases from colorectal carcinoma.Cancer 2002; 95:2283-92.
 
1087 - Robinson HM (2007)
Robinson HM, Black EJ, Brown R, Gillespie DA. DNA mismatch repair and Chk1-dependent centrosome amplification in response to DNA alkylation damage. Cell Cycle. 2007 Apr 15;6(8):982-92. Epub 2007 Apr 5.
 
1088 - Rodel C (2005)
Rodel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-96.
 
1089 - Rodgers MS (2000)
Rodgers MS, McCall JL. Surgery for colorectal liver metastases with hepatic lymph node involvement: a systematic review. Br J Surg 2000; 87:1142-55.
 
1090 - Rodriguez-Moranta F (2006)
Rodriguez-Moranta F, Salo J, Arcusa A, Boadas J, Pinol V, Bessa X et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006;24(3):386-93.
 
1091 - Rohren EM (2002)
Rohren EM, Paulson EK, Hagge R, Wong TZ, Killius J, Clavien PA, et al. The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. Clin Nucl Med 2002;27:550-5.
 
1092 - Rosen M (1998)
Rosen M, Chan L, Beart RW Jr, Vukasin P, Anthone G. Follow-up of colorectal cancer: a meta-analysis. Dis Colon Rectum 1998;41:1116-26.
 
1093 - Rothbarth J (2003)
Rothbarth J, Pijl ME, Vahrmeijer AL, Hartgrink HH, Tijl FG, Kuppen PJ, et al. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver. Br J Surg 2003;90:1391-7.
 
1094 - Rothbarth J (2002)
Rothbarth J, Vahrmeijer AL, Mulder GJ. Modulation of cytostatic efficacy of melphalan by glutathione: mechanisms and efficacy. Chem Biol Interact 2002;140:93-107.
 
1095 - Rothenberg ML (2001)
Rothenberg ML, Meropol NJ, Poplin EA, Van Cutsem E, Wadler S. Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panel. J Clin Oncol. 2001 Sep 15;19(18):3801-7
 
1096 - Rothenberg ML (2003)
Rothenberg ML, Oza AM, Bigelow RH, Berlin JD, Marshall JL, Ramanathan RK et al. Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: interim results of a phase III trial. J Clin Oncol. 2003;21(11):2059-69.
 
1097 - Rougier P (1992)
Rougier P, Laplanche A, Huguier M, Hay JM, Ollivier JM, Escat J, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long term results of a prospective randomised trial. J Clin Oncol 1992;10:1112-8.
 
1098 - Rougier P (1998)
Rougier P, van Cutsem E, Bajetta E, Niederle N, Possinger K, Labianca R et al. Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer.[erratum appears in Lancet 1998;352(9140):1634]. Lancet 1998;352:1407-12.
 
1099 - Rozmovits L (2004)
Rozmovits L, Rose P, Ziebland S. In the absence of evidence, who choose? A qualitative study of patients’ needs after treatment for colorectal cancer. J Health Serv Res Policy. 2004 Jul;9(3):159-64.
 
1100 - Ruers T (2002)
Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38:1023-33.
 
1101 - Ruers T (2012)
Ruers T, Punt C, Van Coevorden F, Pierie JP, Borel-Rinkes I, Ledermann JA, et al; EORTC Gastro-Intestinal Tract Cancer Group, Arbeitsgruppe Lebermetastasen und—tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) and the National Cancer Research Institute Colorectal Clinical Study Group (NCRI CCSG). Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. 2012 Oct;23(10):2619-26.
 
1102 - Ruers TJ (2001)
Ruers TJ, Joosten J, Jager GJ, Wobbes T. Long-term results of treating hepatic colorectal metastases with cryosurgery. Br J Surg 2001;88:844-9.
 
1103 - Ruers TJ (2002)
Ruers TJ, Langenhoff BS, Neeleman N, et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 2002;20:388-395.
 
1104 - Ruers TJM (2009)
Ruers TJM, Wiering B, Van Der Sijp J, Roumen RM, De Jong K, Comans EFI, et al. Improved selection of patients for hepatic surgery of colorectal liver metastases with 18F-FDG PET: A randomized study. J Nucl Med 2009;50(7):1036-1041.
 
1105 - Rule W (2010)
Rule W, Timmerman R, Tong L, Abdulrahman R, Meyer J, Boike T, et al. Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy in Patients With Hepatic Metastases. Ann Surg Oncol 2010 Nov 3.
 
1106 - Rullier A (2005)
Rullier A, Laurent C, Vendrely V, Le-Bail B, Bioulac-Sage P, Rullier E. Impact of colloid response on survival after preoperative radiotherapy in locally advanced rectal carcinoma. Am J Surg Pathol 2005;29:602-6.
 
1107 - Rullier E (2005)
Rullier E, Laurent C, Bretagnol F, Rullier A, Vendrely V, Zerbib F. Sphincter-saving resection for all rectal carcinomas: the end of the 2-cm distal rule. Ann Surg 2005;241:465-9.
 
1108 - Rullier E (1997)
Rullier E, Laurent C, Carles J, Saric J, Michel P, Parneix M. Local recurrence of low rectal cancer after abdominoperineal and anterior resection. Br J Surg. 1997 Apr;84(4):525-8.
 
1109 - Rusthoven KE (2009)
Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009 Apr 1;27(10):1572-8.
 
1110 - Ryan R (2005)
Ryan R, Gibbons D, Hyland JMP, Treanor D, White A, Mulcahy HE, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-6.
 
1111 - Rydzewski B (2002)
Rydzewski B, Dehdashti F, Gordon BA, Teefey SA, Strasberg SM, Siegel BA. Usefulness of intraoperative sonography for revealing hepatic metastases from colorectal cancer in patients selected for surgery after undergoing FDG PET. AJR Am J Roentgenol 2002;178:353-8.
 
1112 - Sabbagh C (2013)
Sabbagh C, Browet F, Diouf M, Cosse C, Brehant O, Bartoli E, et al. Is stenting as "a bridge to surgery" an oncologically safe strategy for the management of acute, left-sided, malignant, colonic obstruction? A comparative study with a propensity score analysis. Ann Surg. 2013 Jul;258(1):107-15.
 
1113 - Safi F (1989)
Safi F, Bittner R, Roscher R, Schuhmacher K, Gaus W, Beger GH. Regional chemotherapy for hepatic metastases of colorectal carcinoma (continuous intraarterial versus continuous intraarterial/intravenous therapy). Cancer 1989; 64:379-87.
 
1114 - Safi F (1993)
Safi F, Link KH, Beger HG. Is follow-up of colorectal cancer patients worthwhile? Dis Colon Rectum 1993;36:636-43.
 
1115 - Sagar PM (1986)
Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1986 Mar;83(3):293-304.
 
1116 - Sahay TB (2000)
Sahay TB, Gray RE, Fitch M. A qualitative study of patient perspectives on colorectal cancer. Cancer Pract. 2000 Jan-Feb;8(1):38-44.
 
1117 - Saif MW (2009)
Saif MW. Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer. World J Gastroenterol 2009 Aug 21;15(31):3855-64.
 
1118 - Sakamoto J (1999)
Sakamoto J, Hamada C, Kodaira S, Nakazato H, Ohashi Y. Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials. Jpn J Clin Oncol. 1999;29(2):78-86.
 
1119 - Saltz L (2012)
Saltz L, Badarinath S, Dakhil S, et al. Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer. Clin Colorectal Cancer 2012;11:101-11.
 
1120 - Saltz LB (2008)
Saltz LB, Clarke S, Díaz-Rubio E, Scheithauer W, Figer A, Wong R, et al. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study. J Clin Oncol. 2008 Apr 20;26(12):2013-9. doi: 10.1200/JCO.2007.14.9930.
 
1121 - Saltz LB (2000)
Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343:905-14.
 
1122 - Sammour T (2010)
Sammour T, Zargar-Shoshtari K, Bhat A, Kahokehr A, Hill AG. A programme of Enhanced Recovery After Surgery (ERAS) is a cost-effective intervention in elective colonic surgery. N Z Med J. 2010 Jul 30;123(1319):61-70.
 
1123 - Sankararajah D (2005)
Sankararajah D, Forshaw MJ, Aggrawal A, Stewart M, Kirk J. Images of interest. Gastrointestinal: colonic intussusception in adults. J Gastroenterol Hepatol. 2005 Aug;20(8):1300.
 
1124 - Sanoff HK (2012)
Sanoff HK, Carpenter WR, Stürmer T, Goldberg RM, Martin CF, Fine JP, et al. Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years. J Clin Oncol. 2012 Jul 20;30(21):2624-34.
 
1125 - Sargent DJ (2001)
Sargent DJ, Goldberg RM, Jacobson SD, Macdonald JS, Labianca R, Haller DG, Shepherd LE, Seitz JF, Francini G. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001 Oct 11;345(15):1091-7
 
1126 - Sargent D (2010)
Sargent D, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, et al. Defective mismatch repair as a predictive marker for lack of efficacy of FU-based adjuvant therapy in colon cancer. J Clin Oncol. 2010 Jul 10;28(20):3219-26.
 
1127 - Sargent D (2011)
Sargent D, Shi Q, Yothers G, Van Cutsem E, Cassidy J, Saltz L, et al; Adjuvant Colon Cancer End-points (ACCENT) Group. Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803. Eur J Cancer. 2011 May;47(7):990-6.
 
1128 - Sargent DJ (2007)
Sargent DJ, Patiyil S, Yothers G, Haller DG, Gray R, Benedetti J, et al; ACCENT Group. End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol. 2007 Oct 10;25(29):4569-74. Epub 2007 Sep 17.
 
1129 - Sastre J (2005)
Sastre J, Marcuello E, Masutti B, Navarro M, Gil S, Anton A, et al. Cooperative Group for the Treatment of Digestive Tumors. Irinotecan in combination with fluorouracil in a 48-hour continuous infusion as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors study. J Clin Oncol. 2005 May 20;23(15):3545-51.
 
1130 - Sauer R (2004)
Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004;351:1731-40.
 
1131 - Schefter TE (2005)
Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005 Aug 1;62(5):1371-8.
 
1132 - Schell SR (2002)
Schell SR, Zlotecki RA, Mendenhall WM, Marsh RW, Vauthey JN, Copeland EM 3rd. Transanal excision of locally advanced rectal cancers downstaged using neoadjuvant chemoradiotherapy. J Am Coll Surg. 2002 May;194(5):584-90; discussion 590-1.
 
1133 - Schiffman SC (2010)
Schiffman SC, Bower M, Brown RE, Martin RC, McMasters KM, Scoggins CR. Hepatectomy is superior to thermal ablation for patients with a solitary colorectal liver metastasis. J Gastrointest Surg. 2010 Dec;14(12):1881-6.
 
1134 - Schild SE (1997)
Schild SE, Gunderson LL, Haddock MG, Wong WW, Nelson H. The treatment of locally advanced colon cancer. Int J Radiat Oncol Biol Phys 1997;37(1):51-8.
 
1135 - Schmidt J (2000)
Schmidt J, Strotzer M, Fraunhofer S, Boedeker H, Zirngibl H. Intraoperative ultrasonography versus helical computed tomography and computed tomography with arterioportography in diagnosing colorectal liver metastases: lesion-by-lesion analysis. World J Surg 2000;24:43-47.
 
1136 - Schmoll HJ (2012)
Schmoll HJ, Cunningham D, Sobrero A, et al. Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III). J Clin Oncol 2012;30:3588-95.
 
1137 - Schmoll HJ (2005)
Schmoll HJ. Improving longevity in advanced intestinal cancer]. Krankenpfl J. 2005;43(1-3):48
 
1138 - Schneider PD (2004)
Schneider PD. Preoperative assessment of liver function. Surg Clin North Am 2004;84:355-73.
 
1139 - Schoemaker D (1998)
Schoemaker D, Black R, Giles L. Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998;114:7-14.
 
1140 - Schrameijer F (1992)
Schrameijer F, Brunenberg W. Psychosciale zorg bij kankerpatiënten en hulpverleners over problemen en hulpaanbod. Utrecht: Nederlands Centrum Geestelijke Volksgezondheid, 1992. 614 -Nisso X. Verlost van kanker, nog altijd vermoeid. Tijdschr Kanker 2002;26:32-3.
 
1141 - Schreuder-Cats (2012)
Schreuder-Cats,M. (2012). Blauwdruk vaste contactpersoon in de oncologische keten. Oncologica…
 
1142 - Schussler-Fiorenza CM (2004)
Schussler-Fiorenza CM, Mahvi DM, Niederhuber J, Rikkers LF, Weber SM. Clinical risk score correlates with yield of of PET scan in patients with colorectal hepatic metastases. J Gastrointest Surg 2004;8(2):150-7; discussion 157-8.
 
1143 - Schwartz AL (2004)
Schwartz AL. Physical activity after a cancer diagnosis: psychosocial outcomes. Cancer Invest 2004;22:82-92.
 
1144 - Schwartzberg L (2013)
Schwartzberg L et al. Proc ASCO Gastrointestinal Cancers Symp 2013; (abstract 446)
 
1145 - Schwartzberg LS (2013)
Schwartzberg LS et al. Analysis of KRAS/NRAS mutations in PEAK: A randomized phase II study of FOLFOX6 plus panitumumab (pmab) or bevacizumab (bev) as first-line treatment (tx) for wild type (WT) KRAS (exon 2) metastatic colorectal cancer (mCRC). Proc ASCO 2013;abstract [link]
 
1146 - Schwemmle K (1987)
Schwemmle K, Link KH, Rieck B. Rationale and indications for perfusion in liver tumors: current data. World J Surg 1987;11:534-40.
 
1147 - Schwenk W (1998)
Schwenk W, Bohm B, Haase O, Junghans T, Muller JM. Laparoscopic versus conventional colorectal resection: a prospective randomised study of postoperative ileus and early postoperative feeding. Langenbecks Arch Surg 1998;383(1):49-55.
 
1148 - Scott DJ (2001)
Scott DJ, Guthrie JA, Arnold P, Ward J, Atchley J, Wilson D, et al. Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings. Clin Radiol 2001;56:235-42.
 
1149 - SIGN
Scottish Intercollegiate Guidelines Netwerk. Management of Colorectal Cancer. A national clinical guideline. Scottish Intercollegiate Guidelines Netwerk, Scotland.
 
1150 - Sebag-Montefiore D (2006)
Sebag-Montefiore D. for the NCRI colorectal cancer study group. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. J Clin Oncol 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 3511.
 
1151 - Sebastian S (2004)
Sebastian S, Johnston S, Geoghegan T, Torreggiani W, Buckley M. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004;99(10):2051-7.
 
1152 - Secco GB (2002)
Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G et al. Efficacy and cost of risk-adapted followup in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002;28(4):418-23.
 
1153 - Seifert JK (1998)
Seifert JK, Morris DL. Prognostic factors after cryotherapy for hepatic metastases from colorectal cancer. Ann Surg 1998; 228:201-8.
 
1154 - Selzner M (2004)
Selzner M, Hany TF, Wildbrett P, McCormack L, Kadry Z, Clavien PA. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg 2004; 240:1027-34.
 
1155 - Semelka RC (1999)
Semelka RC, Cance WG, Marcos HB, Mauro MA. Liver metastases: comparison of current MR techniques and spiral CT during arterial portography for detection in 20 surgically staged cases. Radiology 1999;213:86-91.
 
1156 - Serra-Aracil X (2008)
Serra-Aracil X, Vallverdú H, Bombardó-Junca J, Pericay-Pijaume C, Urgellés-Bosch J, Navarro-Soto S. Long-term follow-up of local rectal cancer surgery by transanal endoscopic microsurgery. World J Surg. 2008 Jun;32(6):1162-7.
 
1157 - Seymour MT (2013)
Seymour MT, Brown SR, Middleton G, Maughan T, Richman S, Gwyther S, Lowe C, et al. Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. Lancet Oncol 2013; 14:749–59
 
1158 - Seymour MT (2007)
Seymour MT, Maughan TS, Ledermann JA, topham C, James R, Swyther SJ et al. FOCUS Trial Investigators: National Cancer Research Institute Colorectal Clinical Studies Group. Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised trial. Lancet 2007:370:143-52.
 
1159 - Seymour MT (2011)
Seymour MT, Thompson LC, Wasan HS, et al. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Lancet 2011;377:1749-59.
 
1160 - Shaha M (2008)
Shaha M, Cox CL, Talman K, Kelly D. Uncertainty in breast, prostate, and colorectal cancer: implications for supportive care. J Nurs Scholarsh. 2008;40(1):60-7.
 
1161 - Shia J (2004)
Shia J, Guillem JG, Moore HG, Tickoo SK, Qin J, Ruo L, et al. Patterns of morphologic alteration in residual rectal carcinoma following preoperative chemoradiation and their association with long-term outcome. Am J Surg Pathol 2004;28:215-23.
 
1162 - Shia J (2008)
Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry. J Mol Diagn. 2008 Jul;10(4):293-300. doi: 10.2353/jmoldx.2008.080031. Epub 2008 Jun 13.
 
1163 - Shibata T (2000)
Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer 2000 Jul 15;89(2):276-84
 
1164 - Shimamura T (1997)
Shimamura T, Nakajima Y, Une Y, Namieno T, Ogasawara K, Yamashita K, et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study. Surgery 1997;121:135-41.
 
1165 - Shindoh J (2012)
Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol. 2012 Dec 20;30(36):4566-72. doi: 10.1200/JCO.2012.45.2854. Epub 2012 Nov 13.
 
1166 - Shirouzu K (1995)
Shirouzu K, Isomoto H, Kakegawa T. Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer 1995;76:388-92.
 
1167 - Simmonds PC (2000)
Simmonds PC. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group. BMJ 2000;321(7260):531-5.
 
1168 - Simon CJ (2005)
Simon CJ, Dupuy DE, Mayo-Smith WW. Microwave ablation: principles and applications. Radiographics. 2005 Oct;25 Suppl 1:S69-83.
 
1169 - Simon D (2001)
Simon D. Das Rektumkarzinom--die onkologisch adaquate Resektion. [Rectal carcinoma--oncologically adequate resection]. Schweiz Rundsch Med Prax 2001;90:575-80.
 
1170 - Simons PC (2012)
Simons PC, Van Steenbergen LN, De Witte MT, Janssen-Heijnen ML. Miss rate of colorectal cancer at CT colonography in average-risk symptomatic patients. Eur Radiol. 2012 Oct 20. [Epub ahead of print]. PMID: 23085864.
 
1171 - Sinicrope FA (2011)
Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, et al. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst. 2011 Jun 8;103(11):863-75. doi: 10.1093/jnci/djr153. Epub 2011 May 19. Erratum in: J Natl Cancer Inst. 2011 Nov 2;103(21):1639. Kim, George P [added]. PubMed PMID: 21597022; PubMed Central PMCID: PMC3110173.
 
1172 - Sinicrope FA (2012)
Sinicrope FA, Foster NR, Yoon HH, Smyrk TC, Kim GP, Allegra CJ, et al. Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials. J Clin Oncol. 2012 Feb 1;30(4):406-12. doi: 10.1200/JCO.2011.39.2563. Epub 2011 Dec 27. PubMed PMID: 22203756; PubMed Central PMCID: PMC3269966.
 
1173 - Sinicrope FA (2012)
Sinicrope FA, Sargent DJ. Molecular pathways: microsatellite instability in colorectal cancer: prognostic, predictive, and therapeutic implications. Clin Cancer Res. 2012 Mar 15;18(6):1506-12. doi: 10.1158/1078-0432.CCR-11-1469. Epub 2012 Feb 2. PubMed PMID: 22302899; PubMed Central PMCID: PMC3306518.
 
1174 - Sinicrope FA (2012)
Sinicrope FA, Shi Q. Combining molecular markers with the TNM staging system to improve prognostication in stage II and III colon cancer: are we ready yet? J Natl Cancer Inst. 2012 Nov 7;104(21):1616-8. doi: 10.1093/jnci/djs441. Epub 2012 Oct 25. PubMed PMID: 23104213.
 
1175 - Skibba JL (1986)
Skibba JL, Quebbeman EJ. Tumoricidal effects and patient survival after hyperthermic liver perfusion. Arch Surg 1986;121:1266-71.
 
1176 - Slater A (2012)
Slater A, North M, Hart M, Ferrett C. Gas insufflation of minimal preparation CT of the colon reduces false-positives. Br J Radiol. 2012 Apr;85(1012):346-50. doi: 10.1259/bjr/20678489. Epub 2011 Jan 11.
 
1177 - Sloothaak DA (2012)
Sloothaak DA, Buskens CJ, Bemelman WA, Tanis PJ. Treatment of chronic presacral sinus after low anterior resection. Colorectal Dis. 2012 Dec 5. doi: 10.1111/codi.12094. [Epub ahead of print
 
1178 - Sloothaak DA (2013)
Sloothaak DA, Geijsen DE, van Leersum NJ, Punt CJ, Buskens CJ, Bemelman WA, et al; Dutch Surgical Colorectal Audit. Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancer. Br J Surg. 2013 Jun;100(7):933-9. doi: 10.1002/bjs.9112. Epub 2013 Mar 27.
 
1179 - Smalley SR (2006)
Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006; 24: 3542-7.
 
1180 - Smidt ML (2003)
Smidt ML, Wegdam JA, Bremers AJ, Bleichrodt RP. Missing evidence for the adequacy of a 1-cm distal margin in resected rectal cancer. Ann Surg Oncol 2003;10:823-24.
 
1181 - Smyrniotis V (2004)
Smyrniotis V, Kostopanagiotou G, Theodoraki K, Tsantoulas D, Contis JC. The role of central venous pressure and type of vascular control in blood loss during major liver resections.Am J Surg 2004;187:398-402.
 
1182 - Snoeren N (2010)
Snoeren N, Voest EE, Bergman AM, Dalesio O, Verheul HM, Tollenaar RA, et al. A randomized two arm phase III study in patients post radical resection of liver metastases of colorectal cancer to investigate bevacizumab in combination with capecitabine plus oxaliplatin (CAPOX) vs CAPOX alone as adjuvant treatment. BMC Cancer. 2010 Oct 11;10:545. doi: 10.1186/1471-2407-10-545.
 
1183 - Sobin LH (1997)
Sobin LH, Fleming ID. TNM Classification of Malignant Tumors, fifth edition (1997). TNM Prognostic Factors Project, International Union Against Cancer, Washington, DC, USA.
 
1184 - Sobin LH (2002)
Sobin LH, Wittekind CH (Eds). TNM Classification of Malignant Tumours, 6th Edition. International Union Against Cancer, Washington, DC, USA, 2002.
 
1185 - Solbiati L (1997)
Solbiati L, Ierace T, Goldberg SN, Sironi S, Livraghi T, Fiocca R, et al. Percutaneous US-guided radio-frequency tissue ablation of liver metastases: treatment and follow-up in 16 patients. Radiology 1997;202:195-203.
 
1186 - Solbiati L (2001)
Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases.Eur J Ultrasound 2001;13:149-158.
 
1187 - Solbiati L (2003)
Solbiati L, Ierace T, Tonolini M. Long-term survival of patients treated with radiofrequency ablation for liver colorectal metastases: improved outcome with increasing experience. Radiology 2003 S;229,:411.
 
1188 - Solbiati L (2001)
Solbiati L, Livraghi T, Goldberg SN, Ierace T, Meloni F, Dellanoce M, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001;221:159-166.
 
1189 - Sosna J (2003)
Sosna J, Morrin MM, Kruskal JB, Lavin PT, Rosen MP, Raptopoulos V. CT colonography of colorectal polyps: a metaanalysis. Am J Roentgenol. 2003;181(6):1593-8.
 
1190 - Sosna J (2008)
Sosna J, Sella T, Sy O, Lavin PT, Eliahou R, Fraifeld S, Libson E. Critical analysis of the performance of double-contrast barium enema for detecting colorectal polyps > or = 6 mm in the era of CT colonography. AJR Am J Roentgenol. 2008 Feb;190(2):374-85. doi: 10.2214/AJR.07.2099.
 
1191 - Souglakos J (2006)
Souglakos J, Androulakis N, Syrigos K, Polyzos A, Ziras N, Athanasiadis A, et al. FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG). Br J Cancer 2006;94:798-805.
 
1192 - Souglakos J (2012)
Souglakos J, Ziras N, Kakolyris S, Boukovinas I, Kentepozidis N, Makrantonakis P, et al. Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC). Br J Cancer. 2012 Jan 31;106(3):453-9. doi: 10.1038/bjc.2011.594. Epub 2012 Jan 12.
 
1193 - Souličres D (2010)
Souličres D, Greer W, Magliocco AM, Huntsman D, Young S, Tsao MS, Kamel-Reid S. KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies. Curr Oncol. 2010 Jul;17 Suppl 1:S31-40.
 
1194 - Soyer P (1993)
Soyer P, Laissy JP, Sibert A, Azencot M, Vissuzaine C, Marmuse JP, et al. Hepatic metastases: detection with multisection FLASH MR imaging during gadolinium chelate-enhanced arterial portography. Radiology 1993;189:401-405.
 
1195 - Soyer P (1994)
Soyer P, Laissy JP, Sibert A, Blanc F, Belghiti J, Marmuse JP, et al. Focal hepatic masses: comparison of detection during arterial portography with MR imaging and CT. Radiology 1994;190:737-40.
 
1196 - Soyer P (1993)
Soyer P, Levesque M, Caudron C et al. MRI of liver metastases from colorectal cancer vs. CT during arterial portography.J Comput Assist Tomogr 1993;17:67-74.
 
1197 - Sprangers MA (2002)
Sprangers MA. Quality-of-life assessment in oncology. Achievements and challenges. Acta Oncol 2002;41:229-37.
 
1198 - Stage JG (1997)
Stage JG, Schulze S, Moller P, Overgaard H, Andersen M, Rebsdorf-Pedersen VB et al. Prospective randomized study of laparoscopic versus open colonic resection for adenocarcinoma. Br J Surg 1997;84(3):391-6.
 
1199 - Staib L (2000)
Staib L, Link KH, Beger HG. Follow-up in colorectal cancer: cost-effectiveness analysis of established and novel concepts. Langenbecks Arch Surg 2000;385:412-20.
 
1200 - Steele GD Jr. (1999)
Steele GD Jr., Herndon JE, Bleday R, Russell A, Benson A 3rd, Hussain M, et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol 1999; 6:433-41.
 
1201 - Stelzner S (2011)
Stelzner S, Holm T, Moran BJ, Heald RJ, Witzigmann H, Zorenkov D, Wedel T. Deep pelvic anatomy revisited for a description of crucial steps in extralevator abdominoperineal excision for rectal cancer. Dis Colon Rectum. 2011 Aug;54(8):947-57. doi: 10.1097/DCR.0b013e31821c4bac
 
1202 - Sterk P (2005)
Sterk P, Shekarriz B, Günter S, Nolde J, Keller R, Bruch HP, et al. Voiding and sexual dysfunction after deep rectal resection and total mesorectal excision: prospective study on 52 patients. Int J Colorectal Dis. 2005 Sep;20(5):423-7. Epub 2005 Apr 22.
 
1203 - Stewart MA (1995)
Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ 1995;152:1423-33.
 
1204 - SONCOS (2012)
Stichting Oncologische Samenwerking. Multidisciplinaire normeringrapport oncologie, 12/12/2012. Op 27 februari 2013 ontleend aan: http://www.soncos.org/Basis.aspx?Tid=2&Sid=156&Hmi=156&Smi=156
 
1205 - Stiggelbout AM (1997)
Stiggelbout AM, de Haes JC, Vree R, van de Velde CJ, Bruijninckx CM, van Groningen K, Kievit J. Follow-up of colorectal cancer patients: quality of life and attitudes towards follow-up. Br J Cancer 1997; 75(6): 914-20.
 
1206 - Stiggelbout AM (2012)
Stiggelbout AM, van der Weijden T, De Wit MP, Frosch D, Légaré F, Montori VM, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ 2012;344:e256.
 
1207 - Stintzing S (2010)
Stintzing S, Hoffmann RT, Heinemann V, Kufeld M, Muacevic A, et al. Frameless single-session robotic radiosurgery of liver metastases in colorectal cancer patients. Eur J Cancer 2010 Apr;46(6):1026-32.
 
1208 - Stocchi L (2001)
Stocchi L, Nelson H, Sargent DJ, O'Connell MJ, Tepper JE, Krook JE, et al. Impact of surgical and pathologic variables in rectal cancer: a United States community and cooperative group report. J Clin Oncol 2001;19:3895-902.
 
1209 - Stoker J (2013)
Stoker J, Dekker E. CT-colografie in de dagelijkse praktijk. Ned Tijdschr Geneeskd. 2013;157:A6477
 
1210 - Strotzer M (1997)
Strotzer M, Gmeinwieser J, Schmidt J, Fellner C, Seitz J, Albrich H, et al. Diagnosis of liver metastases from colorectal adenocarcinoma. Comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol 1997;38:986-92.
 
1211 - Suzuki S (2001)
Suzuki S, Sakaguchi T, Yokoi Y, Kurachi K, Okamoto K, Okumura T, et al. Impact of repeat hepatectomy on recurrent colorectal liver metastases. Surgery 2001;129:421-8
 
1212 - Swanson RS (2003)
Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003;10:65-71.
 
1213 - Swedish Rectal Cancer Trial (1997)
Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997;336:980-7.
 
1214 - Sweed MR (2002)
Sweed MR, Schiech L, Barsevick A, Babb JS, Goldberg M. Quality of life after esophagectomy for cancer. Oncol Nurs Forum 2002;29:1127-31.
 
1215 - Taal BG (2001)
Taal BG, Tinteren H, Zoetmulder FA, NACCP group¨. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Br J Cancer 2001 Nov 16;85(10):1437-43
 
1216 - Takahashi S (2003)
Takahashi S, Inoue K, Konishi M, Nakagouri T, Kinoshita T. Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases.Surgery 2003;133:627-34
 
1217 - Tang CL (2001)
Tang CL, Eu KW, Tai BC, Soh JGS, MacHin D, Seow-Choen F. Randomized clinical trial of the effect of open versus laparoscopically assisted colectomy on systemic immunity in patients with colorectal cancer. Br J Surg 2001;88(6):801-7.
 
1218 - Tanimoto A (2005)
Tanimoto A, Wakabayashi G, Shinmoto H, Nakatsuka S, Okuda S, Kuribayashi S. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography. J Gastroenterol 2005; 40:371-80.
 
1219 - Tanis PJ (2013)
Tanis PJ, Doeksen A, van Lanschot JJ. Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg. 2013 Apr;56(2):135-44. doi: 10.1503/cjs.025911.
 
1220 - Tappenden P (2006)
Tappenden P, Jones R, Paisley S, Carroll C. The use of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. NHS R&D HTA program, February 2006.
 
1221 - Targownik LE (2004)
Targownik LE, Spiegel BM, Sack J, Hines OJ, Dulai GS, Gralnek IM et al. Colonic stent vs. emergency surgery for management of acute left-sided malignant colonic obstruction: A decision analysis. Gastrointest.Endosc. 2004;60:6-874.
 
1222 - Tattersall MH (2002)
Tattersall MH, Butow PN, Clayton JM. Insights from cancer patient communication research. Hematol Oncol Clin North Am 2002;16:731-43.
 
1223 - Taylor C (2008)
Taylor C. Reviewing the follow up care of colorectal cancer patients. Gastrointestinal Nursing,2008; (6), 29-34.
 
1224 - Taylor FG (2011)
Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. MERCURY study group. One millimetre is the safe cut-off for magnetic resonance imaging prediction of surgical margin status in rectal cancer. Br J Surg. 2011 Jun;98(6):872-9. doi: 10.1002/bjs.7458. Epub 2011 Apr 8.
 
1225 - Taylor FG (2011)
Taylor FG, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. MERCURY study group. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone: a prospective, multicenter, European study. Ann Surg. 2011 Apr;253(4):711-9. doi: 10.1097/SLA.0b013e31820b8d52.
 
1226 - Taylor WE (2002)
Taylor WE, Donohue JH, Gunderson LL, Nelson H, Nagorney DM, Devine RM et al. The Mayo Clinic experience with multimodality treatment of locally advanced or recurrent colon cancer. Ann.Surg.Oncol. 2002;9(2):177-85.
 
1227 - Tebbutt NC (2010)
Tebbutt NC, Wilson K, Gebski VJ, Cummins MM, Zannino D, van Hazel GA, et al. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. J Clin Oncol. 2010 Jul 1;28(19):3191-8. doi: 10.1200/JCO.2009.27.7723. Epub 2010 Jun 1.
 
1228 - Tejpar S (2012)
Tejpar S, Celik I, Schlichting M, Sartorius U, Bokemeyer C, Van Cutsem E. Association of KRAS G13D tumor mutations with outcome in patients with metastatic colorectal cancer treated with first-line chemotherapy with or without cetuximab. J Clin Oncol. 2012 Oct 10;30(29):3570-7. doi: 10.1200/JCO.2012.42.2592. Epub 2012 Jun 25.
 
1229 - Tekkis PP (2005)
Tekkis PP, Senagore AJ, Delaney CP, Fazio VW. Evaluation of the Learning Curve in Laparoscopic Colorectal Surgery: Comparison of Right-Sided and Left-Sided Resections. Ann Surg. 2005 Jul;242(1):83-91.
 
1230 - Tennyson N (2012)
Tennyson N, Mendenhall WM, Morris CG, Huang EH, Zlotecki RA. Transanal excision with radiation therapy for rectal adenocarcinoma. Clin Med Res. 2012;10(4):224-9.
 
1231 - Tepper JE (1997)
Tepper JE, O'Connell MJ, Petroni GR, Hollis D, Cooke E, Benson AB, et al. Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of Intergroup 0114. J Clin Oncol 1997;15:2030-9.
 
1232 - Termuhlen PM (2002)
Termuhlen PM, Kemeny MM. Surgery in the older patient. Oncology (Williston Park) 2002; 16:183-9
 
1233 - CCA (2005)
The Cancer Council Australia, Australian Cancer Network. Clinical practise guidelines for the prevention, early detection and management of colorectal cancer. Australian Cancer Netwerk, Australia; 2005.
 
1234 - SCOTIA (1995)
The SCOTIA Study Group. Single-stage treatment for malignant left-sided colonic obstruction: a prospective randomized clinical trial comparing subtotal colectomy with segmental resection following intraoperative irrigation. Subtotal Colectomy versus On-table Irrigation and Anastomosis. Br J Surg 1995;82(12):1622-7.
 
1235 - Theodoropoulos G (2002)
Theodoropoulos G, Wise WE, Padmanabhan A, Kerner BA, Taylor CW, Aguilar PS, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002;45:895-903.
 
1236 - Thirion P (2004)
Thirion P, Michiels S, Pignon JP, Buyse M, Braud AC, Carlson RW et al. Meta-Analysis Group in Cancer. Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: an updated meta-analysis. J Clin Oncol. 2004;22(18):3766-75.
 
1237 - Thirion P (1999)
Thirion P, Wolmark N, Haddad E,Buyse M, Piedbois P. Survival impact of chemotherapy in patients with colorectal cancer confined to the liver: a re-analysis of 1458 non-operable patients randomised in 22 trials and 4 meta-analyses. Ann Oncol 1999;10:1317-20.
 
1238 - Thomas PR (1988)
Thomas PR, Lindblad AS. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol. 1988 Dec;13(4):245-52.
 
1239 - Tilney HS (2007)
Tilney HS, Lovegrove RE, Purkayastha S, Sains PS, Weston-Petrides GK, Darzi AW, et al. Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg Endosc. 2007 Feb;21(2):225-33. Epub 2006 Dec 9.
 
1240 - Tjandra JJ (2007)
Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum. 2007 Nov;50(11):1783-99.
 
1241 - Tjandra JJ (2005)
Tjandra JJ, Kilkenny JW, Buie WD, Hyman N, Simmang C, Anthony T, et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2005; 48:411-23.
 
1242 - Tol J (2009)
Tol J, Koopman M, Cats A, Rodenburg CJ, Creemers GJ, Schrama JG, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med. 2009 Feb 5;360(6):563-72. doi: 10.1056/NEJMoa0808268.
 
1243 - Tol J (2009)
Tol J, Nagtegaal ID, Punt CJ. BRAF mutation in metastatic colorectal cancer. N Engl J Med. 2009 Jul 2;361(1):98-9. doi: 10.1056/NEJMc0904160.
 
1244 - Tono T (2000)
Tono T, Hasuike Y, Ohzato H, Takatsuka Y, Kikkawa N. Limited but definite efficacy of prophylactic hepatic arterial infusion chemotherapy after curative resection of colorectal liver metastases: A randomized study. Cancer 2000;88:1549-1556.
 
1245 - Tournigand C (2004)
Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol, 2004;22:229-37.
 
1246 - Tournigand C (2012)
Tournigand C, André T, Bonnetain F, Chibaudel B, Lledo G, Hickish T, et al. Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients (between ages 70 and 75 years) with colon cancer: subgroup analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer trial. J Clin Oncol. 2012 Sep 20;30(27):3353-60.
 
1247 - Tournigand C (2006)
Tournigand C, Cervantes A, Figer A, Lledo G, Flesch M, Buyse M et al. OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study. J Clin Oncol. 2006;24(3):394-400.
 
1248 - Trapé J (2011)
Trapé J, Filella X, Alsina-Donadeu M, Juan-Pereira L, Bosch-Ferrer Á, Rigo-Bonnin R; et al. Increased plasma concentrations of tumour markers in the absence of neoplasia. Clin Chem Lab Med 2011;49:1605-20
 
1249 - Trijsburg RW (1992)
Trijsburg RW, Knippenberg FC van, Rijpma SE. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 1992;54:489-517.
 
1250 - Tsavaris N (2004)
Tsavaris N, Gennatas K, Kosmas C, Skopelitis HM, Gouveris P, Dimitrakopoulis A, et al. Leucovorin and fluoroyracil vs levamisole and fluorouracil as adjuvant chemotherapy in rectal cancer. Oncol Rep. 2004 Oct;12(4):927-32.
 
1251 - Tschmelitsch J (1995)
Tschmelitsch J, Kronberger P, Prommegger R, Reibenegger G, Glaser K, Bodner E. Survival and local recurrence after anterior resection and abdominoperineal excision for rectal cancer. Eur J Surg Oncol. 1995 Dec;21(6):640-3.
 
1252 - Tsioulias GJ (2001)
Tsioulias GJ, Wood TF, Chung MH, Morton DL, Bilchik A. Diagnostic laparoscopy and laparoscopic ultrasonography optimize the staging and resectability of intraabdominal neoplasms. Surg Endosc 2001;15:1016-1019.
 
1253 - Tuinman MA (2008)
Tuinman MA, Gazendam-Donodfrio SM, Hoekstra-Weebers JE. Screening and Referral For Psychosocial Distress in Oncologic Practice. Use of the Distress Thermometer. Cancer. 2008 Aug 15;113(4):870-8.
 
1254 - Tveit KM (1997)
Tveit KM, Guldvog I, Hagen S, Trondsen E, Harbitz T, Nygaard K, et al. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 1997; 84: 1130-5.
 
1255 - Tveit KM (2012)
Tveit KM, Guren T, Glimelius B, Pfeiffer P, Sorbye H, Pyrhonen S, et al. Phase III trial of cetuximab with continuous or intermittent fluorouracil, leucovorin, and oxaliplatin (Nordic FLOX) versus FLOX alone in first-line treatment of metastatic colorectal cancer: the NORDIC-VII study. J Clin Oncol. 2012 May 20;30(15):1755-62. doi: 10.1200/JCO.2011.38.0915. Epub 2012 Apr 2
 
1256 - Twelves C (2005)
Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005 Jun 30;352(26):2696-704.
 
1257 - Twelves C (2002)
Twelves C, Xeloda Colorectal Cancer Group. Capecitabine as first-line treatment in colorectal cancer: Pooled data from two large, phase III trials. Eur J Cancer. 2002; 38(suppl. 2):15-20.
 
1258 - Uemura T (2000)
Uemura T, Miyazaki M, Hirai R, Matsumoto H, Ota T, Ohashi R, et al. Different expression of positive and negative regulators of hepatocyte growth in growing and shrinking hepatic lobes after portal vein branch ligation in rats. Int J Mol Med 2000;5:173-179.
 
1259 - Ueno H (2004)
Ueno H, Mochizuki H, Hashiguchi Y, Ishikawa K, Fujimoto H, Shinto E, et al. Preoperative parameters expanding the indication of sphincter preserving surgery in patients with advanced low rectal cancer. Ann Surg 2004;239:34-42.
 
1260 - Ueno H (2004)
Ueno H, Mochizuki H, Hashiguchi Y, Shimazaki H, Aida S, Hase K, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127(2):385-94.
 
1261 - Ueno H (1998)
Ueno H, Mochizuki H, Tamakuma S. Prognostic significance of extranodal microscopic foci discontinuous with primary lesion in rectal cancer. Dis Colon Rectum 1998;41:55-61.
 
1262 - Vahrmeijer AL (2000)
Vahrmeijer AL, Van Dierendonck JH, Keizer HJ, Beijnen JH, Tollenaar RA, Pijl ME, et al. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver. Br JCancer 2000;82:1539-46.
 
1263 - Vaid S (2012)
Vaid S, Tucker J, Bell T, Grim R, Ahuja V. Cost analysis of laparoscopic versus open colectomy in patients with colon cancer: results from a large nationwide population database. Am Surg. 2012 Jun;78(6):635-41.
 
1264 - Vale CL (2012)
Vale CL, Tierney JF, Fisher D, Adams RA, Kaplan R, Maughan TS, et al. Does anti-EGFR therapy improve outcome in advanced colorectal cancer? A systematic review and meta-analysis. Cancer Treat Rev 2012;38:618-25.
 
1265 - Valls C (2001)
Valls C, Andia E, Sanchez A, Gumŕ A, Figueras J, Torras J, et al. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology 2001;218:55-60.
 
1266 - Valls C (1998)
Valls C, Lopez E, Guma A, Gil M, Sanchez A, Andía E, et al. Helical CT versus CT arterial portography in the detection of hepatic metastasis of colorectal carcinoma. AJR Am J Roentgenol 1998;170:1341-7.
 
1267 - van Bree SH (2011)
van Bree SH, Vlug MS, Bemelman WA, Hollmann MW, Ubbink DT, Zwinderman AH, et al. Faster recovery of gastrointestinal transit after laparoscopy and fast-track care in patients undergoing colonic surgery. Gastroenterology. 2011 Sep;141(3):872-880.e1-4. doi: 10.1053/j.gastro.2011.05.034. Epub 2011 May 26.
 
1268 - Van Cutsem E (2009)
Van Cutsem E, Köhne CH, Hitre E, Zaluski J, Chang Chien CR, Makhson A, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med. 2009 Apr 2;360(14):1408-17. doi: 10.1056/NEJMoa0805019.
 
1269 - Van Cutsem E (2011)
Van Cutsem E, Köhne CH, Láng I, Folprecht G, Nowacki MP, Cascinu S, et al. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status. J Clin Oncol 2011;20:2011-9
 
1270 - Van Cutsem E (2009)
Van Cutsem E, Labianca R, Bodoky G, Barone C, Aranda E, Nordlinger B, et al. Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3. J Clin Oncol. 2009 Jul 1;27(19):3117-25. doi: 10.1200/JCO.2008.21.6663. Epub 2009 May 18.
 
1271 - Van Cutsem E (2012)
Van Cutsem E, Tabernero J, Lakomy R, Prenen H, Prausová J, Macarulla T, Ruff P et al. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen. J Clin Oncol. 2012 Oct 1;30(28):3499-506. Epub 2012 Sep 4.
 
1272 - Van Cutsem E (2001)
Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, et al. Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study. J.Clin.Oncol. 2001;19[21] :4097-106.
 
1273 - Van den Brink M (2004)
Van den Brink M, Stiggelbout AM, Van den Hout WB, Kievit J, Klein Kranenbarg E, Marijnen CA, et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 2004;22:3958-64.
 
1274 - van der Paardt MP (2013)
van der Paardt MP, Zagers MB, Beets-Tan RG, et al. Patients who undergo preoperative chemoradiotherapy for locally advanced rectal cancer restaged by using diagnostic MR imaging: a systematic review and meta-analysis. Radiology. 2013 Oct;269(1):101-12. doi: 10.1148/radiol.13122833. Epub 2013 Jun 25.
 
1275 - van der Pool AE (2010)
van der Pool AE, Lalmahomed ZS, Ozbay Y, Wilt JH, Eggermont AM, Jzermans JN, et al. "Staged" liver resection in synchronous and metachronous colorectal hepatic metastases; differences in clinicopathological features and outcome. Colorectal Dis. 2010 Oct;12(10 Online):e229-35
 
1276 - van der Pool AE (2010)
van der Pool AE, Mendez RA, Wunderink W, Heijmen BJ, Levendag PC, Verhoef C, et al. Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 2010 Mar;97(3):377-82.
 
1277 - van der Zee J (1997)
van der Zee J, Kroon BB, Nieweg OE, van de Merwe SA, Kampinga HH.Rationale for different approaches to combined melphalan and hyperthermia in regional isolated perfusion. Eur J Cancer 1997;33:1546-50.
 
1278 - van Gelder RE (2004)
van Gelder RE, Birnie E, Florie J, Schutter MP, Bartelsman JF, Snel P, et al. CT colonography and colonoscopy: assessment of patient preference in a 5-week follow-up study. Radiology. 2004 Nov;233(2):328-37. Epub 2004 Sep 9.
 
1279 - van Harten WH (1998)
van Harten WH, van Noort O, Warmerdam R, Hendricks H, Seidel E. Assessment of rehabilitation needs in cancer patients. Int J Rehabil Res 1998;21:247-57.
 
1280 - Van Hazel G (2004)
Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, et al. Randomised Phase 2 Trial of SIR-Spheres1 Plus Fluorouracil/Leucovorin Chemotherapy Versus Fluorouracil/Leucovorin Chemotherapy Alone in Advanced Colorectal Cancer. J Surg Oncol. 2004 Nov 1;88(2):78-85.
 
1281 - van Hooft JE (2011)
van Hooft JE, Bemelman WA, Oldenburg B, Marinelli AW, Holzik MF, Grubben MJ, et al.; collaborative Dutch Stent-In study group. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial. Lancet Oncol. 2011 Apr;12(4):344-52. doi: 10.1016/S1470-2045(11)70035-3.
 
1282 - van Hooft JE (2008)
van Hooft JE, Fockens P, Marinelli AW, Timmer R, van Berkel AM, Bossuyt PM, et al.; Dutch Colorectal Stent Group. Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy. 2008 Mar;40(3):184-91. doi: 10.1055/s-2007-995426.
 
1283 - Van Lier MG (2012)
Van Lier MG, Leenen CH, Wagner A, Ramsoekh D, Dubbink HJ, van den Ouweland AM, et al. LIMO Study Group. Yield of routine molecular analyses in colorectal cancer patients ?70 years to detect underlying Lynch syndrome. J Pathol. 2012 Apr;226(5):764-74. doi: 10.1002/path.3963. Epub 2012 Jan 17. PMID 22081473
 
1284 - van Puijenbroek M (2008)
van Puijenbroek M, Nielsen M, Tops CM, Halfwerk H, Vasen HF, Weiss MM, et al. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res. 2008 Jan 1;14(1):139-42. doi: 10.1158/1078-0432.CCR-07-1705. PMID: 18172263.
 
1285 - van Tol-Geerdink JJ (2006)
van Tol-Geerdink JJ, Stalmeier PF, van Lin EN, Schimmel EC, Huizenga H, van Daal WA, et al. Do prostate cancer patients want to choose their own radiation treatment? Int J Radiat Oncol Biol Phys 2006;66:1105-11.
 
1286 - Vardulaki K (2000)
Vardulaki K, Bennett-Lloyd BD, Parfitt J, Normond C, Paisley S, Darzi A et al. A systematic review of the effectiveness and cost-effectiveness of laparoscopic surgery for colorectal cancer. July 2000:http://www.nice.org.uk/pdf/HTAreportonlapsurgcoloreccanc. pdf [1 October 2005].
 
1287 - Vautravers-Dewas C (2011)
Vautravers-Dewas C, Dewas S, Bonodeau F, Adenis A, Lacornerie T, Penel N, et al. Image-guided robotic stereotactic body radiation therapy for liver metastases: is there a dose response relationship? Int J Radiat Oncol Biol Phys 2011 Nov 1;81(3):39-47.
 
1288 - Vecchio FM (2005)
Vecchio FM, Valentini V, Minsky BD, Padula GD, Venkatraman ES, Balducci M, et al. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:752-60.
 
1289 - Veenhof AA (2012)
Veenhof AA, Vlug MS, van der Pas MH, Sietses C, van der Peet DL, de Lange-de Klerk ES, et al. Surgical stress response and postoperative immune function after laparoscopy or open surgery with fast track or standard perioperative care: a randomized trial. Ann Surg. 2012 Feb;255(2):216-21. doi: 10.1097/SLA.0b013e31824336e2.
 
1290 - Veldkamp R (2005)
Veldkamp R, Kuhry E, Hop WC, Jeekel J, Kazemier G, Bonjer HJ et al. COLOR 2005 - Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial. Lancet Oncol 2005;6(7):477-84.
 
1291 - Venderbosch S (2012)
Venderbosch S, Doornebal J, Teerenstra S, Lemmens W, Punt CJ, Koopman M. Outcome of first line systemic treatment in elderly compared to younger patients with metastatic colorectal cancer: a retrospective analysis of the CAIRO and CAIRO2 studies of the Dutch Colorectal Cancer Group (DCCG). Acta Oncol 2012;51:831-9.
 
1292 - Verberne CJ (2012)
Verberne CJ, Nijboer CH, de Bock GH, Grossmann I, Wiggers T, Havenga K. Evaluation of the use of decision-support software in carcino-embryonic antigen (CEA)-based follow-up of patients with colorectal cancer. BMC Med Inform Decis Mak. 2012 Mar 5;12:14. doi: 10.1186/1472-6947-12-14.
 
1293 - VIKC (2010)
Vereniging Integrale Kankercentra [VIKC]. (2010). Landelijke Evidence- Based Richtlijn “Detecteren behoefte psychosociale zorg”. VIKC: Utrecht.
 
1294 - Vermorken JB (1999)
Vermorken JB, Claessen AM, van Tinteren H, Gall HE, Ezinga R, Meijer S et al. Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet. 1999 Jan 30;353(9150):345-50.
 
1295 - Verwaal VJ (2003)
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003 Oct 15;21(20):3737-43.
 
1296 - Vignali A (2004)
Vignali A, Braga M, Zuliani W, Frasson M, Radaelli G, Di C, V. Laparoscopic colorectal surgery modifies risk factors for postoperative morbidity. Dis Colon Rectum 2004;47(10):1686-93.
 
1297 - Vignati P (1994)
Vignati P, Welch JP, Cohen JL. Endoscopic localization of colon cancers. Surg Endosc. 1994 Sep;8(9):1085-7.
 
1298 - Villar JM (2005)
Villar JM, Martinez AP, Villegas MT, Muffak K, Mansilla A, Garrote D et al. Surgical options for malignant left-sided colonic obstruction. Surg Today. 2005;35(4):275-81.
 
1299 - Virgo KS (1995)
Virgo KS, Vernava AM, Longo WE, McKirgan LW, Johnson FE. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 1995;273:1837-41.
 
1300 - Vitola JV (1996)
Vitola JV, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright JK, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21-6.
 
1301 - Vliegen RF (2008)
Vliegen RF, Beets GL, Lammering G, Dresen RC, Rutten HJ, Kessels AG, et al. Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction. Radiology 2008;246:454-62.
 
1302 - Vlug MS (2011)
Vlug MS, Wind J, Hollmann MW, Ubbink DT, Cense HA, Engel AF et al. LAFA study group. Laparoscopy in combination with fast track multimodal management is the best perioperative strategy in patients undergoing colonic surgery: a randomized clinical trial (LAFA-study). Ann Surg. 2011 Dec;254(6):868-75. doi: 10.1097/SLA.0b013e31821fd1ce
 
1303 - Vogl TJ (1999)
Vogl TJ, Muller PK, Mack MG, Straub R, Engelmann K, Neuhaus P. Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 1999;9:675-84.
 
1304 - Vogl TJ (2003)
Vogl TJ, Schwarz W, Blume S, Pietsch M, Shamsi K, Franz M, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 2003; 13:262-72
 
1305 - Vogl TJ (2002)
Vogl TJ, Straub R, Eichler K, Woitaschek D, Mack MG. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions).Radiology 2002;225:367-77.
 
1306 - Vogt P (1991)
Vogt P, Raab R, Ringe B, Pichlmayr R. Resection of synchronous liver metastases from colorectal cancer. World J Surg 1991 Jan-Feb;15(1):62-7.
 
1307 - von Schulhess GK (2006)
von Schulhess GK, Steinert HC, Hanny TF. Integrated PET/CT: Current Applications and Future Directions. Radiology 2006;238:405-22
 
1308 - von Wagner C (2012)
von Wagner C, Ghanouni A, Halligan S,Smith S, Dadswell E, Lilford RJ, et al. SIGGAR Investigators. Patient acceptability and psychologic consequences of CT colonography compared with those of colonoscopy: results from a multicenter randomized controlled trial of symptomatic patients. Radiology. 2012;263:723-31.
 
1309 - Vyslouzil K (2009)
Vyslouzil K, Klementa I, Starý L, Zboril P, Skalický P, Dlouhý M, Cwiertka K, Duda M. [Radiofrequency ablation of colorectal liver metastases]. Zentralbl Chir. 2009 Apr;134(2):145-8
 
1310 - Wagman LD (1990)
Wagman LD, Kemeny MM, Leong LL, et al: A prospective evaluation of the treatment of colorectal cancer metastatic to the liver. J Clin Oncol 1990;8:1885-93.
 
1311 - Wakabayashi H (1997)
Wakabayashi H, Okada S, Maeba T, Maeta H. Effect of preoperative portal vein embolization on major hepatectomy for advanced-stage hepatocellular carcinomas in injured livers: a preliminary report. Surg Today 1997;27:403-10.
 
1312 - Wang C (2005)
Wang C, Zhou Z, Wang Z, Zheng Y, Zhao G, Yu Y, et al. Patterns of neoplastic foci and lymph node micrometastasis within the mesorectum. Langenbecks Arch Surg 2005;390:312-8.
 
1313 - Wang G1 (2012)
Wang G1, Jiang Z, Zhao K, Li G, Liu F, Pan H, Li J. Immunologic response after laparoscopic colon cancer operation within an enhanced recovery program. J Gastrointest Surg. 2012 Jul;16(7):1379-88. doi: 10.1007/s11605-012-1880-z. Epub 2012 May 15.
 
1314 - Wang Q1 (2012)
Wang Q1, Suo J, Jiang J, Wang C, Zhao YQ, Cao X. Effectiveness of fast-track rehabilitation vs conventional care in laparoscopic colorectal resection for elderly patients: a randomized trial. Colorectal Dis. 2012 Aug;14(8):1009-13. doi: 10.1111/j.1463-1318.2011.02855.x. [link]
 
1315 - Ward J (2000)
Ward J, Chen F, Guthrie JA, Wilson D, Lodge JP, Wyatt JI, et al. Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis. Radiology 2000;214:159-66.
 
1316 - Ward J (2003)
Ward J, Guthrie JA, Wilson D, Arnold P, Lodge JP, Toogood GJ, et al. Colorectal Hepatic Metastases: Detection with SPIO-enhanced Breath-hold MR Imaging--Comparison of Optimized Sequences. Radiology 2003 Sep;228(3):709-18. Epub 2003 Jul 29.
 
1317 - Ward J (1999)
Ward J, Naik KS, Guthrie JA, Wilson D, Robinson PJ. Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT by using alternative-free response receiver operating characteristic analysis. Radiology 1999;210:459-66.
 
1318 - Ward S (2002)
Ward S, Kaltenthaler E, Cowan J, Brewer N. A review of the evidence for the clinical and cost-effectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer. NHS R&D HTA program, September 2002.
 
1319 - Warner GC (2003)
Warner GC, Cox GJ. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. J Otolaryngol 2003;32:107-109.
 
1320 - Watt AM (2007)
Watt AM, Faragher IG, Griffin TT, Rieger NA, Maddern GJ. Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg 2007 Jul;246(1):24-30. Review.
 
1321 - Watt E (2003)
Watt E, Whyte F. The experience of dysphagia and its effect on the quality of life of patients with oesophageal cancer. Eur J Cancer Care (Engl) 2003;12:183-93.
 
1322 - Wei JT (2004)
Wei JT, Miller EA, Woosley JT, Martin CF, Sandler RS. Quality of colon carcinoma pathology reporting: a process of care study. Cancer 2004;100:1262-7.
 
1323 - Wein A (2001)
Wein A, Riedel C, Kockerling F, Martus P, Baum U, Brueckl WM,, et al. Impact of surgery on survival in palliative patients with metastatic colorectal cancer after first line treatment with weekly 24-hour infusion of high-dose 5-fluorouracil and folinic acid. Ann Oncol 2001;12:1721-7.
 
1324 - Welch S (2005)
Welch S, Kocha W, Rumble RB, Spithoff K, Aroun J. The role of bevacizumab combined with chemotherapy in the treatment of patient with advianced colorectal cancer. part 1. A clinical practice guideline & part 2. A systematic review. Cancer Care Ontario 2005.
 
1325 - Welch S (2010)
Welch S, Spithoff K, Rumble RB, Maroun J; Gastrointestinal Cancer Disease Site Group. Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review. Ann Oncol. 2010;21:1152-62
 
1326 - Weng M (2012)
Weng M, Zhang Y, Zhou D, Yang Y, Tang Z, Zhao M, et al. Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One. 2012;7(9):e45493.
 
1327 - Wernecke K (1991)
Wernecke K, Rummeny E, Bongartz G, Vassallo P, Kivelitz D, Wiesmann W, et al. Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR Am J Roentgenol 1991;157:731-9.
 
1328 - Wheeler JM (2004)
Wheeler JM, Dodds E, Warren BF, Cunningham C, George BD, Jones AC, et al. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade. Dis Colon Rectum 2004;47:2025-31.
 
1329 - Whistance RN (2009)
Whistance RN, Conroy T, Chie W, Constantini A, Sezer O, Koller M, et al. Clinical and psychometric validation of the EORTC QOL-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer. 2009 Nov;45(17):3017-26. doi: 10.1016/j.ejca.2009.08.014. Epub 2009 Sep 16.
 
1330 - White RR (2007)
White RR, Avital I, Sofocleous CT, Brown KT, Brody LA, Covey A, et al. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg. 2007 Mar;11(3):256-63.
 
1331 - White TJ (2004)
White TJ, Roy-Choudhury SH, Breen DJ, Cast J, Maraveyas A, Smyth EF, et al. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. Dig Surg 2004;21:314-20.
 
1332 - Whiteford MH (2000)
Whiteford MH, Whiteford HM, Yee LF, Ogunbiyi OA, Dehdashti F, Siegel BA,et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000;43:759-67.
 
1333 - Wiering B (2005)
Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ. The impact of FDG-PET in the management of colorectal liver metastases: a systematic review and (meta)-analysis. Cancer 2005;104:2658-70.
 
1334 - Wilkinson NW (2010)
Wilkinson NW, Yothers G, Lopa S, Costantino JP, Petrelli NJ, Wolmark N. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol. 2010 Apr;17(4):959-66.
 
1335 - Willett CG (1993)
Willett CG, Fung CY, Kaufman DS, Efird J, Shellito PC. Postoperative radiation therapy for high-risk colon carcinoma. J Clin Oncol 1993;11:1112-7.
 
1336 - Willett CG (1999)
Willett CG, Goldberg S, Shellito PC, Grossbard M, Clark J, Fung C et al. Does postoperative irradiation play a role in the adjuvant therapy of stage T4 colon cancer? Cancer J Sci Am 1999;5(4):242-7.
 
1337 - Winawer SJ (1993)
Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993; 329(27):1977-81.
 
1338 - Winde G (1996)
Winde G, Nottberg H, Keller R, Schmid KW, Bünte H. Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum 1996; 39:969-76.
 
1339 - Wolmark N (2000)
Wolmark N, Wieand HS, Hyams DM, Colangelo L, Dimitrov NV, Romond EH, et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000; 92: 388-96.
 
1340 - Wong J (2012)
Wong J, Szumacher E. Patients' decision-making in radiation oncology. Expert Rev Pharmacoecon Outcomes Res 2012;12:95-104.
 
1341 - Wulf J (2006)
Wulf J, Guckenberger M, Haedinger U, Oppitz U, Mueller G, Baier K, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006;45(7):838-47
 
1342 - Wulf J (2001)
Wulf J, Hadinger U, Oppitz U, Thiele W, Ness-Dourdoumas R, Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001 Dec;177(12):645-55.
 
1343 - Xinopoulos D (2004)
Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, Tsamakidis K, Bitsakou G, Plataniotis G et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysis. Surg Endosc. 2004;18(3):421-6.
 
1344 - Xinopoulos D (2011)
Xinopoulos D, Kypreos D, Bassioukas SP, Korkolis D, Mavridis K, Scorilas A, et al. Comparative study of balloon and metal olive dilators for endoscopic management of benign anastomotic rectal strictures: clinical and cost-effectiveness outcomes. Surg Endosc. 2011 Mar;25(3):756-63. doi: 10.1007/s00464-010-1247-z. Epub 2010 Oct 7. 
 
1345 - Yamamoto J (1999)
Yamamoto J, Shimada K, Kosuge T, Yamasaki S, Sakamoto M, Fukuda H. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg 1999;86:332-7.
 
1346 - Yang DH (2010)
Yang DH, Byeon JS, Lee KH, Yoon SM, Kim KJ, Ye BD, et al. Is endoscopic closure with clips effective for both diagnostic and therapeutic colonoscopy-associated bowel perforation? Surg Endosc. 2010 May;24(5):1177-85.
 
1347 - Yang HY (2012)
Yang HY, Wu CC, Jao SW, Hsu KF, Mai CM, Hsiao KC. Two-stage resection for malignant colonic obstructions: the timing of early resection and possible predictive factors. World J Gastroenterol. 2012 Jul 7;18(25):3267-71
 
1348 - Yasuda S (1998)
Yasuda S, Makuuchi Y, Sadahiro S, Mukai M, Tokunaga N, Tajima T, et al. Colorectal cancer recurrence in the liver: detection by PET. Tokai J Exp Clin Med 1998;23:167-71.
 
1349 - Ye LC (2013)
Ye LC, Liu TS, Ren L, Wei Y, Zhu DX, Zai SY, et al. Randomized Controlled Trial of Cetuximab Plus Chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. J Clin Oncol. 2013 Jun 1;31(16):1931-8.
 
1350 - Yeo SG (2010)
Yeo SG, Kim DY, Kim TH, Kim SY, Chang HJ, Park JW, et al. Local excision following pre-operative chemoradiotherapy-induced downstaging for selected cT3 distal rectal cancer. Jpn J Clin Oncol. 2010;40(8):754-60.
 
1351 - Yeung JM (2009)
Yeung JM, Maxwell-Armstrong C, Acheson AG. Colonic tattooing in laparoscopic surgery - making the mark? Colorectal Dis. 2009 Jun;11(5):527-30. doi: 10.1111/j.1463-1318.2008.01706.x. Epub 2008 Oct 10
 
1352 - Yoshimatsu K (2005)
Yoshimatsu K, Ishibashi K, Umehara A, Yokomizo H, Yoshida K, Fujimoto T et al. How many lymph nodes should be examined in Dukes\' B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology 2005;52:1703-6.
 
1353 - Yothers G (2011)
Yothers G, O'Connell MJ, Allegra CJ, Kuebler JP, Colangelo LH, Petrelli NJ, et al. Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses. J Clin Oncol 2011 Oct 1;29(28):3768-74.
 
1354 - You YN (2007)
You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified?: a nationwide cohort study from the National Cancer Database. Ann Surg. 2007 May;245(5):726-33.
 
1355 - Yucel C (2008)
Yucel C, Lev-Toaff AS, Moussa N, Durrani H. CT colonography for incomplete or contraindicated optical colonoscopy in older patients. AJR Am J Roentgenol. 2008 Jan;190(1):145-50.
 
1356 - Zaniboni A (2004)
Zaniboni A, Labianca R; Gruppo Italiano per lo Studio e la Cura dei Tumori del Digerente. Adjuvant therapy for stage II colon cancer: an elephant in the living room? Ann Oncol 2004;15:1310-8.
 
1357 - Zhang L (2008)
Zhang L. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing. J Mol Diagn. 2008 Jul;10(4):301-7. doi: 10.2353/jmoldx.2008.080062. Epub 2008 Jun 13. [link]
 
1358 - Zhao GP (2005)
Zhao GP, Zhou ZG, Lei WZ, Yu YY, Wang C, Wang Z, et al. Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin. World J Gastroenterol 2005;11:319-22.
 
1359 - Zhou ZG (2004)
Zhou ZG, Hu M, Li Y, Lei WZ, Yu YY, Cheng Z et al. Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc 2004;18(8):1211-5.
 
1360 - Zijta FM (2010)
Zijta FM, Bipat S, Stoker J. Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies. Eur Radiol 2010;20:1031-46.
 
1361 - Zoetmulder FAN (1999)
Zoetmulder FAN, Taal BG, Van Tinteren H for the NACCP. Adjuvant 5FU plus levamisole improves survival in stage II and III colonic cancer, but not in rectal cancer. Interim analysis of the Netherlands Adjuvant Colorectal Cancer Project (NACCP) [abstract]. Proc Annu meet Am Soc Clin Oncol 1999;18:266a. Abstract 1021.
 
1362 - Rauch P
Rauch P, Miny J, Conroy T, et al. Quality of life among disease-free survivors of rectal cancer. J Clin Oncol. 2004 Jan 15;22(2):354-60.
 
1363 - Wille-Jorgensen P
Wille-Jørgensen P, Laurberg S, Påhlman L, Carriquiry L, Lundqvist N, Smedh K, Svanfeldt M, Bengtson J. An interim analysis of recruitment to the COLOFOL trial. Colorectal Dis. 2009;11(7):756-758.
 
1364 - Lemmens VE 2011

Lemmens VE, Klaver YL, Verwaal VJ, et al. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study. Int J Cancer. 2011 Jun 1;128(11):2717-25. doi: 10.1002/ijc.25596. Epub 2010 Oct 13.

 
1365 - Segelman J 2012
Segelman J, Granath F, Holm T, et al. Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2012 May;99(5):699-705. doi: 10.1002/bjs.8679. Epub 2012 Jan 27.
 
1366 - Assersohn L 1999

Assersohn L, Norman A, Cunningham D, et al. Influence of metastatic site as an additional predictor for response and outcome in advanced colorectal carcinoma. Br J Cancer. 1999 Apr;79(11-12):1800-5.

 
1367 - Bloemendaal AL 2005
Bloemendaal AL, Verwaal VJ, van Ruth S, et al. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol. 2005 Dec;31(10):1145-51. Epub 2005 Aug 3.
 
1368 - Chu DZ 1989
Chu DZ, Lang NP, Thompson C, et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989 Jan 15;63(2):364-7.
 
1369 - Elias D 2009
Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009 Feb 10;27(5):681-5. doi: 10.1200/JCO.2008.19.7160. Epub 2008 Dec 22.
 
1370 - Folprecht G 2007
Folprecht G, Köhne CH, Lutz MP. Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Cancer Treat Res. 2007;134:425-40.
 
1371 - Jayne DG 2002

Jayne DG, Fook S, Loi C, Seow-Choen F.Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002 Dec;89(12):1545-50.

 
1372 - Kecmanovic DM 2005
Kecmanovic DM, Pavlov MJ, Ceranic MS, et al. Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. Eur J Surg Oncol. 2005 Mar;31(2):147-52.
 
1373 - Klaver YL 2011
Klaver YL, Lemmens VE, Creemers GJ, et al. Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy. Ann Oncol. 2011 Oct;22(10):2250-6. doi: 10.1093/annonc/mdq762. Epub 2011 Feb 23.
 
1374 - Koh JL 2009
Koh JL, Yan TD, Glenn D, et al. Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2009 Feb;16(2):327-33. doi: 10.1245/s10434-008-0234-2. Epub 2008 Dec 3.
 
1375 - Kohne CH 2002.
Köhne CH, Cunningham D, Di Costanzo F, et al. Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients. Ann Oncol. 2002 Feb;13(2):308-17.
 
1376 - Pelz JO 2010
Pelz JO, Chua TC, Esquivel J, et al. Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin. BMC Cancer. 2010 Dec 22;10:689. doi: 10.1186/1471-2407-10-689.
 
1377 - Pilati P 2003
Pilati P, Mocellin S, Rossi CR, et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol. 2003 Jun;10(5):508-13.
 
1378 - Piso P 2007
Piso P, Dahlke MH, Ghali N, et al. Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies. Int J Colorectal Dis. 2007 Nov;22(11):1295-300. Epub 2007 Apr 26.
 
1379 - Sadeghi B 2000
Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000 Jan 15;88(2):358-63.
 
1380 - Schneebaum S 1996
Schneebaum S, Arnold MW, Staubus A, et al. Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol. 1996 Jan;3(1):44-50.
 
1381 - Shen P 2004

Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol. 2004 Feb;11(2):178-86.

 
1382 - Verwaaal VJ 2003
Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003 Oct 15;21(20):3737-43.
 
1383 - Verwaal VJ 2005
Verwaal VJ, van Ruth S, Witkamp A, et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2005 Jan;12(1):65-71. Epub 2004 Dec 27.
 
1384 - Verwaal VJ 2004
Verwaal VJ, Boot H, Aleman BM, et al. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol. 2004 Apr;11(4):375-9. Epub 2004 Mar 15.
 
1385 - Verwaal VJ 2008
Verwaal VJ, Bruin S, Boot H, et al. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.
 
1386 - Zauber 2012

Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012 Feb 23;366(8):687-96. doi: 10.1056/NEJMoa1100370.

 
1387 - Zijta 2010
Zijta FM, Bipat S, Stoker J. Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies. Eur Radiol. 2010 May;20(5):1031-46.
 
1388 - Schefter TE 2005
Schefter TE, Kavanagh BD, Timmerman RD, et al. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005 Aug 1;62(5):1371-8.
 
1389 - Verhoef C 2008
Verhoef C, de Wilt JH, Brunstein F, et al. Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion. Ann Surg Oncol. 2008 May;15(5):1367-74. doi: 10.1245/s10434-007-9714-z. Epub 2008 Feb 1.
 
1390 - Van iersel LB 2010

van Iersel LB, Koopman M, van de Velde CJ, et al. Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy. Ann Oncol. 2010 Aug;21(8):1662-7. doi: 10.1093/annonc/mdp589. Epub 2010 Jan 28.

 
1391 - Fiorentini G 2012
Fiorentini G, Aliberti C, Tilli M, et al. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res. 2012 Apr;32(4):1387-95.
 
1392 - Kanas GP
Kanas GP, Taylor A, Primrose JN, et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301. doi: 10.2147/CLEP.S34285. Epub 2012 Nov 7.
 
1393 - Bilchik AJ
Bilchik AJ, Poston G, Adam R, et al. Prognostic variables for resection of colorectal cancer hepatic metastases: an evolving paradigm. J Clin Oncol. 2008 Nov 20;26(33):5320-1. doi: 10.1200/JCO.2008.18.3152. Epub 2008 Oct 20.
 
1394 - Kopetz S
Kopetz S, Chang GJ, Overman MJ, et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009 Aug 1;27(22):3677-83. doi: 10.1200/JCO.2008.20.5278. Epub 2009 May 26.
 
1395 - Poston GJ
Poston GJ, Figueras J, Giuliante F, et al. Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol. 2008 Oct 10;26(29):4828-33. doi: 10.1200/JCO.2008.17.6453. Epub 2008 Aug 18.
 
1396 - Abdalla EK 2006
Abdalla EK, Eng C, Madary A, et al; Southwest Oncology Group 0408. Southwest Oncology Group 0408: Phase II trial of neoadjuvant capecitabine/oxaliplatin/bevacizumab for resectable colorectal metastases in the liver. Clin Colorectal Cancer. 2006 Mar;5(6):436-9.
 
1397 - Van Lienden KP 2013
van Lienden KP, van den Esschert JW, de Graaf W, et al. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013 Feb;36(1):25-34. doi: 10.1007/s00270-012-0440-y. Epub 2012 Jul 18.
 
1398 - De Graaf W 2010
de Graaf W, van Lienden KP, Dinant S, et al. Assessment of future remnant liver function using hepatobiliary scintigraphy in patients undergoing major liver resection. J Gastrointest Surg. 2010 Feb;14(2):369-78. doi: 10.1007/s11605-009-1085-2.
 
1399 - Van den Esschert JW 2011
van den Esschert JW, van Lienden KP, de Graaf W, et al. Portal vein embolization induces more liver regeneration than portal vein ligation in a standardized rabbit model. Surgery. 2011 Mar;149(3):378-85. doi:10.1016/j.surg.2010.07.045.
 
1400 - Schnitzbauer AA 2012
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012 Mar;255(3):405-14. doi: 10.1097/SLA.0b013e31824856f5.
 
1401 - Ayez N 2013
Ayez N, Burger JW, van der Pool AE, et al. Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum. 2013 Mar;56(3):281-7. doi: 10.1097/DCR.0b013e318279b743
 
1402 - Andreou A 2013
Andreou A, Aloia TA, Brouquet A, et al. Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg. 2013 Jun;257(6):1079-88. doi: 10.1097/SLA.0b013e318283a4d1.
 
1403 - Benoist S 2006
Benoist S, Brouquet A, Penna C, et al, Nordlinger B. Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol. 2006 Aug 20;24(24):3939-45.
 
1404 - Chua TC 2012
Chua TC, Saxena A, Liauw W, et al. Hepatectomy and resection of concmitant extrahepatic disease for colorectal liver metastases--a systematic review. Eur J Cancer. 2012 Aug;48(12):1757-65. doi: 10.1016/j.ejca.2011.10.034. Epub 2011 Dec 5.
 
1405 - Adam R 2010
Adam R, Frilling A, Elias D, et al; LiverMetSurvey Centres. Liver resection of colorectal metastases in elderly patients. Br J Surg. 2010 Mar;97(3):366-76. doi: 10.1002/bjs.6889.
 
1406 - Yin Z 2013
Yin Z, Liu C, Chen Y, Bai Y, et al. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed? Hepatology. 2013 Jun;57(6):2346-57. doi: 10.1002/hep.26283.
 
1407 - Li ZQ 2013
Li ZQ, Liu K, Duan JC, et al. Meta-analysis of simultaneous versus staged resection for synchronous colorectal liver metastases. Hepatol Res. 2013 Jan;43(1):72-83. doi: 10.1111/j.1872-034X.2012.01050.x. Epub 2012 Sep 13.
 
1408 - Slesser AA 2013
Slesser AA, Simillis C, Goldin R, et al. A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases. Surg Oncol. 2013 Mar;22(1):36-47. doi: 10.1016/j.suronc.2012.11.002. Epub 2012 Dec 14
 
1409 - Lyass S 2001
Lyass S, Zamir G, Matot I, Goitein D, Eid A, Jurim O. Combined colon and hepatic resection for synchronous colorectal liver metastases. J Surg Oncol 2001; 78:17-21.
 
1410 - Vogt P 1991
Vogt P, Raab R, Ringe B, Pichlmayr R. Resection of synchronous liver metastases from colorectal cancer. World J Surg 1991 Jan-Feb;15(1):62-7.
 
1411 - Fujita S 2000
Fujita S, Akasu T, Moriya Y. Resection of synchronous liver metastases from colorectal cancer. Jpn J Clin Oncol 2000; 30:7-11.
 
1412 - Lam VW 2013
Lam VW, Laurence JM, Pang T, et al. A systematic review of a liver-first approach in patients with colorectal cancer and synchronous colorectal liver metastases. HPB (Oxford). 2014 Feb;16(2):101-8. doi: 10.1111/hpb.12083. Epub 2013 Mar 19.
 
1413 - Ayez N 2013
Ayez N, Burger JW, van der Pool AE, et al. Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastases. Dis Colon Rectum. 2013 Mar;56(3):281-7. doi: 10.1097/DCR.0b013e318279b743
 
1414 - Van Dijk TH 2013
Van Dijk TH, Tamas K, Beukema JC, et al. Evaluation of short-course radiotherapy followed by neoadjuvant bevacizumab, capecitabine, and oxaliplatin and subsequent radical surgical treatment in primary stage IV rectal cancer. Ann Oncol. 2013 Jul;24(7):1762-9. doi: 10.1093/annonc/mdt124. Epub 2013 Mar 22.
 
1415 - Figueras J 2007
Figueras J, Llado L, Miro M, Ramos E, Torras J, Fabregat J, Serrano T. Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg. 2007 Apr;245(4):536-42.
 
1416 - de Boer MT
de Boer MT, Klaase J, Verhoef C, van Dam RM, van Gulik TM, Molenaar IQ, de Jong CHC, Porte RJ. Fibrin sealant for prevention of resection surface-related complications after liver resection: a randomized controlled trial. Ann Surg 2012;256(2):229-34 (IF 8.9)
 
1417 - Wicherts DA 2013
Wicherts DA, de Haas RJ, Salloum C, Andreani P, Pascal G, Sotirov D, Adam R, Castaing D, Azoulay D. Repeat hepatectomy for recurrent colorectal metastases. Br J Surg. 2013 May;100(6):808-18. doi: 10.1002/bjs.9088. Epub 2013 Mar 12.
 
1418 - van der Pool AE 2009
van der Pool AE, Lalmahomed ZS, de Wilt JH, et al. Local treatment for recurrent colorectal hepatic metastases after partial hepatectomy. J Gastrointest Surg. 2009 May;13(5):890-5. doi: 10.1007/s11605-008-0794-2. Epub 2009 Jan 9.
 
1419 - Den Dulk M 2009
den Dulk M, Putter H, Collette L, et a;. The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer. 2009 May;45(7):1175-83. doi: 10.1016/j.ejca.2008.11.039. Epub 2009 Jan 6.
 
1420 - Peeters KC 2007
Peeters KC, Marijnen CA, Nagtegaal ID, et al; Dutch Colorectal Cancer Group.The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007 Nov;246(5):693-701.
 
1421 - Van Gijn W 2011

van Gijn W, Marijnen CA, Nagtegaal ID, et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol. 2011 Jun;12(6):575-82. doi: 10.1016/S1470-2045(11)70097-3. Epub 2011 May 17.

 
1422 - Stephens RJ 2010
Stephens RJ, Thompson LC, Quirke P, et al. Impact of short-course preoperative radiotherapy for rectal cancer on patients' quality of life: data from the Medical Research Council CR07/National Cancer Institute of Canada Clinical Trials Group C016 randomized clinical trial. J Clin Oncol. 2010 Sep 20;28(27):4233-9. doi: 10.1200/JCO.2009.26.5264. Epub 2010 Jun 28.
 
1423 - Sauer R 2012
Sauer R, Liersch T, Merkel S, et al. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012 Jun 1;30(16):1926-33. doi: 10.1200/JCO.2011.40.1836. Epub 2012 Apr 23.
 
1424 - Kacar S 2008
Kaçar S, Varilsüha C, Gürkan A, et al. Pre-operative radiochemotherapy for rectal cancer. A prospective randomized trial comparing pre-operative vs. postoperative radiochemotherapy in rectal cancer patients. Acta Chir Belg. 2008 Sep-Oct;108(5):518-23.
 
1425 - Park MJ 2011

Park MJ, Kim SH, Lee SJ, et al. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology. 2011 Sep;260(3):771-80. doi: 10.1148/radiol.11102135

 
1426 - Wang G 2011
Wang G, Jiang ZW, Xu J, et al. Fast-track rehabilitation program vs conventional care after colorectal resection: a randomized clinical trial. World J Gastroenterol, 2011;17:671-6.
 
1427 - Holdhoff M 2011
Holdhoff M, Schmidt K, Diehl F, et al. Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res. 2011 Jun 1;17(11):3551-7. doi: 10.1158/1078-0432.CCR-10-3087. Epub 2011 Apr 29.
 
1428 - Nagtegaal ID 2008
Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008 Jan 10;26(2):303-12. doi: 10.1200/JCO.2007.12.7027. Review. PubMed PMID: 18182672.
 
1429 - Bosch SL 2012

Bosch SL, Nagtegaal ID. The Importance of the Pathologist's Role in Assessment of the Quality of the Mesorectum. Curr Colorectal Cancer Rep. 2012 Jun;8(2):90-98. Epub 2012 Mar 27. PubMed PMID: 22611342; PubMed Central PMCID: PMC3343235.

 
1430 - West NP 2012
West NP, Kobayashi H, Takahashi K, et al. Understanding optimal colonic cancer surgery: comparison of Japanese D3 resection and European complete mesocolic excision with central vascular ligation. J Clin Oncol. 2012 May 20;30(15):1763-9. doi: 10.1200/JCO.2011.38.3992. Epub 2012 Apr 2. PubMed PMID: 22473170.
 
1431 - West NP 2010

West NP, Hohenberger W, Weber K, et al. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol. 2010 Jan 10;28(2):272-8. doi: 10.1200/JCO.2009.24.1448. Epub 2009 Nov 30. PubMed PMID: 19949013.

 
1432 - West NP 2008
West NP, Morris EJ, Rotimi O, et al. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008 Sep;9(9):857-65. doi: 10.1016/S1470-2045(08)70181-5. Epub 2008 Jul 28. PubMed PMID: 18667357.
 
1433 - Nagtegaal ID 2011

Nagtegaal ID, Tot T, Jayne DG, McShane P, Nihlberg A, Marshall HC, PÃ¥hlman L, Brown JM, Guillou PJ, Quirke P. Lymph nodes, tumor deposits, and TNM: are we getting better? J Clin Oncol. 2011 Jun 20;29(18):2487-92. doi: 10.1200/JCO.2011.34.6429. Epub 2011 May 9. PubMed PMID: 21555695.

 
1434 - Mekenkamp LJ 2009

Mekenkamp LJ, van Krieken JH, Marijnen CA, et al; Pathology Review Committee and the Co-operative Clinical Investigators. Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol. 2009 Oct;33(10):1547-53. doi: 10.1097/PAS.0b013e3181b2e01f.

 
1435 - Chang GJ 2007

Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J NatlCancer Inst. 2007 Mar 21;99(6):433-41. Review. PubMed PMID: 17374833.

 
1436 - King PM 2004

King PM, Blazeby JM, Gupta J, et al. Upper gastrointestinal cancer pathology reporting: a regional audit to compare standards with minimum datasets. J Clin Pathol. 2004 Jul;57(7):702-5. PubMed PMID: 15220361; PubMed Central PMCID: PMC1770360.

 
1437 - Mandard AM 1994

Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994 Jun 1;73(11):2680-6.

 
1438 - Abraham A (2013)

Abraham A, Habermann EB, Rothenberger DA, et al. Adjuvant chemotherapy for stadium III colon cancer in the oldest old: results beyond clinical guidelines. Cancer. 2013;119(2):395-403. # http://www.ncbi.nlm.nih.gov/pubmed/22806931

 
1439 - Audisio RA (2003)

Audisio RA, Gennari R, Sunouchi K, Nair HR, Sestini A, Pope D et al. Preoperative assessment of cancer in elderly patients: a pilot study. Support Cancer Ther 2003; 1(1):55-60. # http://www.ncbi.nlm.nih.gov/pubmed/18628132

 
1440 - Broek van den CB (2013)

Broek van den CB, Bastiaannet E, Dekker JW, et al. Time trends in chemotherapy (administration and costs) and relative survival in stage III colon cancer patients - a large population-based study from 1990 to 2008. Acta Oncol. 2013 Jun;52(5):941-9. doi: 10.3109/0284186X.2012.739730. Epub 2012 Nov 12. # http://www.ncbi.nlm.nih.gov/pubmed/23145507

 
1441 - Broek van den CB (2011)

Broek van den CB, Dekker JW, Bastiaannet E, et al. The survival gap between middle-aged and elderly colon cancer patients. Time trends in treatment and survival. Eur J Surg Oncol. 2011 Oct;37(10):904-12. doi: 10.1016/j.ejso.2011.06.013. Epub 2011 Jul 23. # http://www.ncbi.nlm.nih.gov/pubmed/21784608

 
1442 - den Dulk M (1990)

den Dulk M, Krijnen P, Marijnen CAM, et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer 2008;44(12):1710-6. # http://www.ncbi.nlm.nih.gov/pubmed/18573654

 
1443 - Gooiker GA (2012)

Gooiker GA, Dekker JW, Bastiaannet E, et al. Risk factors for excess mortality in the first year after curative surgery for colorectal cancer. Ann Surg Oncol. 2012 Aug;19(8):2428-34. doi: 10.1245/s10434-012-2294-6. Epub 2012 Mar 7. # http://www.ncbi.nlm.nih.gov/pubmed/22396000

 
1444 - Gross CP (2007)

Gross CP, McAvay GJ, Guo Z, et al. The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer. 2007;109(12):2410-9. # http://www.ncbi.nlm.nih.gov/pubmed/17510973

 
1445 - Hamaker ME (2014)

Hamaker ME, Schiphorst AH, Ten Bokkel Huinink D, Schaar C, van Munster BC. The effect of a geriatric evaluation on treatment decisions for older cancer patients - a systematic review. Acta Oncol. 2014 Mar;53(3):289-96. # http://www.ncbi.nlm.nih.gov/pubmed/24134505

 
1446 - Hamaker ME (2012)

Hamaker ME, Vos AG, Smorenburg CH, de Rooij SE, van Munster BC. The value of geriatric assessments in predicting treatment tolerance and all-cause mortality in older cancer patients. The Oncologist 2012;17:1439-49. # http://www.ncbi.nlm.nih.gov/pubmed/22941970

 
1447 - Hu CY (2011)

Hu CY, Delclos GL, Chan W, et al. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stadium-III colon cancer. Med Oncol. 2011;28(4):1062-74. # http://www.ncbi.nlm.nih.gov/pubmed/20714945

 
1448 - Jessup JM (2005)

Jessup JM, Stewart A, Greene FL, et al. Adjuvant chemotherapy for stadium III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294(21):2703-11. # http://www.ncbi.nlm.nih.gov/pubmed/16333005

 
1449 - Kahn KL (2010)

Kahn KL, Adams JL, Weeks JC, et al. Adjuvant chemotherapy use and adverse events among older patients with stadium III colon cancer. JAMA. 2010;303(11):1037-45. # http://www.ncbi.nlm.nih.gov/pubmed/20233821

 
1450 - Kristjansson SR (2010)
Kristjansson SR, J. Geriatr. Oncol 2010, 1(2)57-65.
 
1451 - Kristjansson SR (2010)

Kristjansson SR, Nesbakken A, Jordh›y MS, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol. 2010b Dec;76(3):208-17. doi: 10.1016/j.critrevonc.2009.11.002. Epub 2009 Dec 14. # http://www.ncbi.nlm.nih.gov/pubmed/20005123

 
1452 - Leersum van NJ (2013)

Leersum van NJ, Janssen-Heijnen ML, Wouters MW, et al. Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 1995-2010. Int J Cancer. 2013 May 1;132(9):2157-63. doi: 10.1002/ijc.27871. Epub 2012 Nov 5. # http://www.ncbi.nlm.nih.gov/pubmed/23015513

 
1453 - Lemmens VEPP (2005)

Lemmens VEPP, Janssen-Heijnen M, Verheij CDGW, et al. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg 2005;92(5):615-623. # http://www.ncbi.nlm.nih.gov/pubmed/15779071

 
1454 - Maas HA (2013)

Maas HA, Lemmens VE, Nijhuis PH, et al. Benefits and drawbacks of short-course preoperative radiotherapy in rectal cancer patients aged 75 years and older. Eur J Surg Oncol. 2013;39(10):1087-93. # http://www.ncbi.nlm.nih.gov/pubmed/23958151

 
1455 - Morris M (2007)

Morris M, Platell C, McCaul K, E, et al. Survival rates for stadium II colon cancer patients treated with or without chemotherapy in a population-based setting. Int J Colorectal Dis. 2007;22(8):887-95. # http://www.ncbi.nlm.nih.gov/pubmed/17235506

 
1456 - Rutten HJ (2008)

Rutten HJ, den Dulk M, Lemmens VE, et al. Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 2008 May;9(5):494-501. # http://www.ncbi.nlm.nih.gov/pubmed/18452860

 
1457 - Sakamoto J (2004)

Sakamoto J, Ohashi Y, Hamada C, et al.. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials. J Clin Oncol. 2004;22(3):484-92. # http://www.ncbi.nlm.nih.gov/pubmed/14752071

 
1458 - Steenbergen van LN (2012)

Steenbergen van LN, Lemmens VE, Rutten HJ, et al. Increased adjuvant treatment and improved survival in elderly stadium III colon cancer patients in The Netherlands. Ann Oncol. 2012;23(11):2805-11. # http://www.ncbi.nlm.nih.gov/pubmed/22562836

 
1459 - Wildes TM (2010)

Wildes TM, Kallogjeri D, Powers B, et al. The Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colorectal Cancer is Independent of Age and Comorbidity. J Geriatr Oncol. 2010;1(2):48-56. # http://www.ncbi.nlm.nih.gov/pubmed/21113435

 
1460 - Zuckerman IH (2009)

Zuckerman IH, Rapp T, Onukwugha E, et al. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. J Am Geriatr Soc. 2009;57(8):1403-10. # http://www.ncbi.nlm.nih.gov/pubmed/19563521